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“It is surprising that people do not believe that there is imagination in science. It 
is a very interesting kind of imagination, unlike that of the artist. The great 
difficulty is in trying to imagine something that you have never seen, that is 
consistent in every detail with what has already been seen, and that is different 
from what has been thought of; furthermore, it must be definite and not a 
vague proposition. That is indeed difficult”― Richard P. Feynman, The Meaning 
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The NF-κB essential modulator (NEMO) is an important human protein, in 
charge of ensuring the activation the NF-κB signalling pathway in response to 
canonical stimuli. Very little consensus exists about the structure, dynamics, and 
the role of the protein. Here we offer evidence to support the dynamic nature 
of NEMO, with binding to ligands inducing a ligand-dependent conformational 
change in the protein. We propose the use of an optical phenomenon known as 
Red edge excitation shift (REES) as a new tool to study and quantify protein 
dynamics. We also emphasise the importance of taking into consideration the 
effect of the intracellular environment on modulating the structure and 
dynamics of NEMO. Furthermore, we shed light onto the cytoplasmic role of 
NEMO in mediating an important enzyme:susbstrate interaction as part of NF-
κB activation. These findings underline the dynamic nature of NEMO and its 
sensitivity to the environment and may also explain the diversity of data 
published of NEMO so far. Moreover, we also offer evidence to support the 
importance of NEMO presence for the interaction between IKKβ:IκBα during 
NF-κB canonical activation. These are potentially crucial aspects to be 
considered when developing therapeutic targets that aim to modulate the 
abnormal NF-κB response in many human medical conditions.  

 1 
































1. NF-κB signalling pathway – role and species distribution  
 
 Cell signalling is a strictly regulated process, with many key molecules ensuring 
the proper transfer of information both inside and between cells. These signalling 
pathways are crucial for regulating vital cellular processes such as cell development 
and differentiation (Dumstrei et al., 2004), autophagy (He and Klionsky, 2009), 
apoptosis (Muñoz-Pinedo, 2012), inflammation (Lawrence, 2009), and others.  
The NF-κB signalling pathway is an important human regulatory network, 
predominantly acting on the immune and nervous systems, involved in inflammation 
(Brambilla et al., 2005), neurogenesis (Koo et al., 2010), neuroprotection (Fridmacher 
et al., 2003), neuronal development (Correa et al., 2004), and neuronal inflammation 
(Shih et al., 2015).  
 
The pathway was first described in 1986 through the discovery of one NF-κB 
protein acting as a nuclear factor interacting with the enhancer element of the 
immunoglobulin κ-light chain of activated human B cells, hence the name NF-κB and its 
role in activating the immune system (Sen and Baltimore, 1986). With developments in 
genetic tools, the presence of NF-κB proteins has been shown to also be found in 
zebrafish (Correa et al., 2004), insects (Hetru and Hoffmann, 2009), invertebrates such 
as sponges (Gauthier and Degnan, 2008),  cnidarians (eg. sea anemones, hydra, coral) 
(Wolenski et al., 2011; Sullivan et al., 2007; Meyer et al., 2009), and even the protist 
Capsaspora owczarzaki (Sebé-Pedrós et al., 2011). Refer to Figure 1 for detailed 
species distribution of NF-κB proteins. Recently, the presence of NF-κB has been 
reported in the horseshoe crab (Carcinoscorpius rotundicauda) (Wang et al., 2006), 
also known as one of the most ancient arthropods (Størmer, 1952). In addition to 
motif homology shared with their vertebrate equivalent, the horseshoe crab NF-κB 
proteins may even be able to respond and interact with mammalian κB proteins (Wang 
et al., 2006). In contrast, NF-κB-like transcription factors appear to be missing in yeast 
and nematodes (Irazoqui et al., 2010; Pujol et al., 2001), where it is thought that other 
signalling pathways contribute to mediating immune responses to pathogens.  
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Figure 1. NF-κB proteins and receptors species distribution (adapted from (Gilmore 
and Wolenski, 2012). The family members for each NF-κB protein and receptor protein 
found in various model organisms, listed from morphologically simple organisms (left) to 
more complex organisms (right). TLR, Toll-like receptor; MyDD88, MyD88 adapter protein 
myeloid differentiation primary response protein 88; IRAK, IL-1R-associated kinases; 
TRAF, TNF-receptor associated factor protein.   
A comprehensive phylogenetic analysis of the origin of the NF-κB proteins and 
receptors has been reported previously, with specific focus on the distribution of 
the Rel Homology domain-containing proteins (Gilmore and Wolenski, 2012). Here the 
authors trace the origin of NF-κB to 1,000 million years ago, with subsequent species 
distribution coinciding with development of higher order organisms. This offers 
answers for the conserved function in mediating the immune response in response to 
inflammatory stimuli and controlling cell survival and apoptosis of NF-κB in complex 
organisms (Gilmore and Wolenski, 2012).  
 
1.1 NF-κB: stimuli, target genes, and its role in health & disease  
 
A variety of stimuli are known to activate the NF-κB signalling pathway 
(Gilmore and Wolenski, 2012). These include, but are not limited to:  pathogens 
infections including viruses (Santoro et al., 2003; Harhaj and Sun, 1999) and bacteria 
(Rahman and McFadden, 2011), cytokines (eg. TNFa) (Middleton et al., 2000), 
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radiation (UV) (O’Dea et al., 2008) and physiological conditions (e.g. ischemia) 
(Duckworth et al., 2006). So far, more than 150 target genes were linked to NF-κB 
activation (Yang et al., 2016), but as some of these regulate the expression of other 
transcription factors, the NF-κB regulatory gene pool may in fact include far more. 
Amongst the NF-κB target genes are also the genes encoding for various NF-κB 
proteins, evidencing the self-regulatory nature of this pathway (Ten et al., 1992).  
 
NF-κB has also been linked to a variety of diseases and medical conditions, resulting 
from aberrant NF-κB activity or various mutations/deletions in in the NF-κB genes 
themselves (Smahi et al., 2002). Many studies also suggest conflicting NF-κB 
involvement in many cancers and its potential as a target for therapeutics or (Gamble 
et al., 2012; Hoesel and Schmid, 2013).    
1.2 NF-κB proteins 
 
The NF-κB signalling pathway is composed of three protein families: the NF-κB 
transcription factor proteins, the inhibitors IκBs, and, the IKK proteins. In unstimulated 
cells, inhibitor IκBs bind to various NF-κB proteins and sequester them in the 
cytoplasm in the absence of a stimulus (Baeuerle and Baltimore, 1988). Upon 
stimulation, the IκB:NF-κB protein complex is targeted by IKK proteins, which 
phosphorylate the IκBs on specific serine residues (depending on the type of IκB 
protein and type of stimulus), thus targeting them for degradation and freeing the NF-
κB proteins (Gilmore, 2006). Following release from inhibitors, NF-κB proteins are able 
to translocate to the nucleus and regulate gene expression in response to specific 
stimuli. See Figures 1-2 for  NF-κB proteins, receptors and species distribution. 
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Figure 2. NF-κB protein families, including NF-κB, IKK, and IκB proteins.  Shown in 
green are the five members of the NF-κB  transcription factors (RelA/p65, RelB, c-Rel, p50, 
p52), blue are the IKK proteins (IKKα, IKKβ, IKKγ/NEMO), and in orange are the IκB inhibitors 
(IκBα, IκBβ, IκBε, IκBζ, BCL-3, p100, p105). 
 
1.2.1  NF-κB transcription factors 
 
In most vertebrates including humans, there are five NF-κB transcription 
factors: RelA (or p65), RelB, c-Rel, p50 (formed by cleaving of its precursor p105), and 
p52 (formed from cleaving its precursor p100)(O’Dea and Hoffmann, 2009; Gilmore, 
2006). Their main function as transcription factors is to bind to nucleic acids and 
regulate gene expression upon binding of a stimulus.  
A common feature of these five proteins is the presence of a 300-amino acid 
sequence at the N-terminus, called the Rel homology domain or RHD (Ghosh et al., 
1998).  All but two NF-κB transcription factors also have a transactivation domain or 
TAD, located at the C-terminus (Ishikawa et al., 1993; Ryseck et al., 1992). Both the 
RHD and TAD carry functional roles. The RHD domain is required for dimerization and 
DNA binding (Rothwarf and Karin, 1999). The nuclear localisation signal required for 
translocation of the transcription factors into the nucleus is also located within the 
RHD region (Verma et al., 1995). The TAD region of RelA, RelB, and c-Rel is required to 
initiate transcription (Ghosh et al., 1998; Schmitz et al., 1995). For p50 and p52 
proteins lacking the TAD domain, transcription is achieved though binding to TAD-
containing proteins either part of NF-κB or various non-Rel proteins able to induce 
transactivation (Lernbecher et al., 1993). 
In contrast p50 and p52 contain instead ankyrin repeats (Betts and Nabel, 1996; Xiao 
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et al., 2001). The ankyrin repeats are found in many different proteins, including the 
inhibitors IκBs, thought to be important for mediating protein interactions (Mosavi et 
al., 2004). In the case of p50 and p52, the ankyrin repeats may also control their 
cytoplasmic localisation (Wan and Lenardo, 2009).  
 
NF-κB transcription factors form homo- or heterodimers, with a total of 15 
theoretical dimerisation possibilities out of which 12 have been demonstrated so far to 
be able to bind to nucleic acid (Huxford and Ghosh, 2009).  The targets of these 
transcription factors consist of DNA sequences between 9-11 base pairs long (known 
as κB binding sites) which are either part of enhancer or promoter domains of genes 
(DiDonato et al., 1996).  
Dimer combinations appear to be influenced by the type of stimulus present and the 
genetic promoter (Wang et al., 2012). Dimer exchange upon binding to promoters has 
also been reported and appears to be stimulus specific (Saccani et al., 2003). Various 
explanations have been given for this, one relating to dimer exchange being linked to 
controlling the timing of transcription (to potentially coincide with other cellular 
events) (Saccani et al., 2003). Studies have shown that although p50 and p52 dimers 
cannot initiate transcription as they lack the TAD domain, they have been found to 
bind to DNA and prevent other NF-κB dimers from binding (Ten et al., 1992).  
1.2.2 IκB proteins 
 
The IκB family of proteins consists of seven members, including: IκBα, IκBβ, 
IκBε, IκBζ, BCL-3 (B-cell lymphoma 3), p100, and p105 (Hayden and Ghosh, 2012). An 
additional IκB protein was reported in mice, IκBγ, resulting from an different 
processing of the p105  (Grumont and Gerondakis, 1994). All IκB proteins share a 5-7 
repeat of a 33-amino acid domain known as the ankyrin domain at their C-terminus 
(Verma et al., 1995), essential for binding to NF-κBs and cytoplasmic anchoring (Blank 
et al., 1991).   
 
IκBs function as inhibitors of NF-κB transcription factors and different IκBs will 
bind to different NF-κB dimers with different affinities, depending on the stimulus and 
the type of cell they are found in. This interaction occurs between the RHD domain of 
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NF-κB dimers and the IκB ankyrin repeats (Malek et al., 2003).  Structural studies have 
shown that these complexes are able to stay in the cytoplasm due to the nuclear 
localisation sequence (NLS) of the transcription factors being masked by the 
interaction with the IκBs (Beg et al., 1992).  This was thought to be the main 
mechanism by which the NF-κB response was regulated, as the anchoring of the NF-κB 
proteins in the cytoplasm by IκBs prevented them from binding to DNA and initiating 
transcription (Baeuerle and Baltimore, 1988). However, this was later challenged by 
the presence of some NF-κB:IκB complexes in the nucleus (Wessells et al., 2004). X-ray 
crystal structures show some NF-κB:IκB complexes only manage to conceal one NLS of 
the transcription factors, thus allowing the complex to still translocate to the nucleus 
(Huxford et al., 1998). Moreover, the presence of IκBs in the nucleus may function to 
competitively bind NF-κBs over DNA, thus regulating transcription (Sue et al., 2011). An 
active shuttling between cytoplasm and nucleus and vice versa is also facilitated by the 
presence of two leucine-rich regions in the C- and N- termini of most IκBs, known as 
the nuclear export signal (NES) (Arenzana-Seisdedos et al., 1997), also present in some 
NF-κBs (Harhaj and Sun, 1999; Huang and Miyamoto, 2001).  
 
1.2.3 The IKK complex  
 
Whilst inhibition of NF-κB is achieved through binding to IκBs, activation is 
dependent on the activation of the inhibitor kinase of IκB complex, IKK. This is 
comprised of three proteins: the kinases IKKα (IKK1) and IKKβ (IKK2), and a non-
catalytic member known as IKKγ or NEMO (NF-κB essential modulator). The kinases 
share three structural characteristics: a kinase domain located at the N-terminus, a 
leucine zipper (required for dimer formation and activation), and a helix-loop-helix 
domain at the C-terminus (also important for activation and protein interactions) 
(Zandi et al., 1998). The two kinases also show a high degree of sequence similarity 
within their catalytic regions, with a 50 % sequence identity (Cheng et al., 2012) and 
65 % similarity in their catalytic domain (Rothwarf and Karin, 1999). IKKα and IKKβ may 
form homo- or heterodimers, with the latter preferentially found in cells due to their 
increased catalytic ability (Mercurio et al., 1997; Huynh et al., 2000) . The X-ray crystal 
structures of human IKKβ  (Liu et al., 2013) and IKKα (Polley et al., 2016) are in Fig.3.  
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Figure 3. X-ray crystal structure of human IKKβ (A) and IKKα (B) kinase  (Figures 
adapted from Liu et al., 2013 and Polley et al., 2016).  A, IKKβ structure at 2.8 Å 
resolution seen as a dimer of dimers (PDB ID: 4KIK). B, IKKα structure at 4.5 Å resolution 
seen as trimer of dimers (PDB ID: 5EBZ). Both structure consist of an N-terminal kinase 
domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization 
domain (SDD). 
 
A specific region within the C-terminus of both IKK enzymes, known as the 
NEMO binding domain (NBD) and containing the LDWSWL sequence was shown to 
play a crucial role in facilitating binding to NEMO (May et al., 2000). The two kinases 
display different affinities for binding to NEMO (Rushe et al., 2008), with IKKβ having a 
higher affinity, KD= 2.2 ±0.8 nM (Cote et al., 2013).  Experimental studies have also 
demonstrated an additional function for the C-terminus of both IKKα and IKKβ in 
control of enzyme dimerisation (McKenzie et al., 2000; Kwak et al., 2000).  In addition 
to dimerisation and binding to NEMO, IKK activation also requires phosphorylation of 
specific serine residues on the two kinases (Makris et al., 2002; Mercurio et al., 1999),  
specifically S176 and S180 for IKKα (Régnier et al., 1997; Ling et al., 1998) and S177 and 
S181 for IKKβ (Zandi et al., 1998; Mercurio et al., 1997). 
 
Structural analyses offer insight into the conformational changes that follow 
phosphorylation and activation of IKKα and IKKβ. Activated dimers assume an apo 
conformation that allows for efficient substrate access (Liu et al., 2013; Polley et al., 
2013), whilst inactive/non-phosphorylated dimers show different, more compact 
conformations (Xu et al., 2011; Larabi et al., 2013). IKK phosphorylation can be 
achieved through two main routes. It is thought that IKK kinase dimerisation facilitates 
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conformational reorganisation whereby trans-autophosphorylation can occur (Polley 
et al., 2013; Xu et al., 2011). Additionally, it has also been shown that other kinases my 
also induce phosphorylation of IKKα and IKKβ (Malinin et al., 1997; Zhao and Lee, 
1999), due to NF-κB crosstalk with other signalling pathways. Activation of NF-κB will 
not proceed in the absence of phosphorylated IKK kinases, as demonstrated by 
mutation studies (Rogers et al., 1986). The many ways of IKK phosphorylation offer a 
guarantee that activation of the signalling pathway can proceed in response to a 
plethora of stimuli.  
 
Activated kinases function to target IκBs for proteoasomal degradation. This is 
a two-step process: firstly, IKK kinases will phosphorylate specific IκB serine residues 
(DiDonato et al., 1996; Traenckner et al., 1994). This acts as a signal for the 
recruitment of an E3 ubiquitin ligase (β-TrCp) (Christian et al., 2016), which further 
modifies the IκBs through the addition of a lysine48-ubiquitin at particular lysine 
residues (Amir et al., 2004). This is the final step in ensuring IκBs proteoasomal 
degradation and the freeing of NF-κB dimers, thus achieving the activation of the 
signalling pathway.   
 
The substrates of IKKα and IKKβ extend beyond the IκBs, with the two kinases 
having been associated with phosphorylation of other proteins including the H3 
chromatin histone protein (Anest et al., 2003), and other signalling molecules (Lee et 
al., 2007). It is clear that not only is the IKK complex vital for NF-κB functioning, but it 
also enhances the ability of NF-κB to interact with other regulatory pathways and 
affect various cellular functions, such as with Toll-like receptor signalling pathway 
during activation of specific immune responses following viral infection (Kawai and 
Akira, 2007). 
1.3 NF-κB activation: canonical vs non-canonical  
 
Activation of NF-κB is dependent on the activation of the IKK complex and the 
subsequent release of NF-κB proteins from their cytoplasmic inhibitors. However, 
depending on the type of stimulus, presence of NF-κB proteins, and type of response 
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required, two different activation mechanisms can be described for this pathway: the 
canonical (classic) and non-canonical (alternative) pathways (Gilmore, 2006). Refer to 
Figure 3 for detailed diagram on NF-κB activation. Generally, the canonical pathway 
relies on the activation of the IKKβ enzyme, the targets of which are IκBα, IκBβ and 
IκBε (Hoffmann et al., 2006). IKKα activation and its subsequent targeting of p100 for 
phosphorylation are characteristic of the non-canonical pathway (Xiao et al., 2001). 
Some evidence also exists for IKKα involvement in the processing and degradation of 
IκBα during canonical activation (Adli et al., 2010). As such, the main difference 
between the two activation pathways in the dependence on NEMO of the canonical 
pathway, a characteristic distinctly not shared with the alternative pathway. 
 
A comprehensive list of all NF-κB canonical stimuli and target genes has been 
published by Matsuda et al. (Matsuda et al., 2003); these include:    
• Bacterial products (Lipoteichoic acid) (Kao et al., 2005), fungal products 
(Glycosylphosphatidylinositols) (Zhu et al., 2005),  and viral products (Ebola 
viral matrix & glycoprotein) (Martinez et al., 2007); 
• Physiological stress conditions: appendicitis (Pennington et al., 2000), , 
hypothermia (Fairchild et al., 2005); 
• Physical stress: sleep deprivation (Brandt et al., 2004), simulated microgravity 
environment (Sharma et al., 2008); 
• Inflammatory cytokines: IL1 (Kida et al., 2005); human septic serum (Kumar et 
al., 2005); thrombopoietin (Romanelli et al., 2006); 
• Environmental hazards: cigarette smoke (Preciado et al., 2008); 
• Therapeutics: diclofenac (Cho et al., 2005), proteasome inhibitors (Dolcet et al., 
2006), epinephrine (Lymperopoulos et al., 2006) 
• Hormones: insulin (Madonna et al., 2007); prostratin (Williams et al., 2004), 
relaxin (Ho et al., 2007); 
• Chemical agents: cadmium (Hyun et al., 2007); fluoride (Zhang et al., 2008), 
MDMA (Tiangco et al., 2005); 
 
 11 
The molecular basis of NF-κB signalling pathway is a complex network of a variety of 
different stimuli and specialised receptors that ensure the signal transmission and 
appropriate cellular response.  For the canonical activation, these receptors include 
tumour necrosis factor receptor (TNFR) and Toll-like receptor/interleukin-1 receptor 
(TLR/IL-1R) superfamilies. A characteristic shared by all these receptors is that 
activation does not rely on the enzymatic action of the receptor bur rather requires 
ligand binding and subsequent conversion of the signal by specialised adaptor proteins 
to ensure stimulation of kinases (Hayden and Ghosh, 2014). It has been proposed that 
ligand binding acts as a signal to initiate the formation of specific oligomeric 
receptor/ligand assemblies (Hayden and Ghosh, 2014).   
• Activation via TNFR 
In response to cytokine stimuli (eg. TNF-α) TNFR receptors allow activation of NF-κB  
activation to occur through ligand-induced trimerisation of the TNFR and the 
subsequent recruitment of TNFR-associated factors (TRAFs) to the receptors 
(Napetschnig and Wu, 2013). This interaction is often mediated through interactions 
with adaptor proteins (Ye et al., 2002; Xie, 2013): for example, binding of TNF-α 
induces association of the adapter protein TRADD with the TNFR1 receptor 
(interaction mediated through death domain) which consequently also results in the 
binding of TRAF2/RIP1 to the complex (Pobezinskaya and Liu, 2012).  In addition to the 
death domain, the RIP (Receptor Interacting Protein) homotypic interaction motifs 
(RHIM)  and TRAF (TNF Receptor Associated Factor) domains have also been involved 
in mediating signal transduction during TNFR activation of NF-κB  (Li et al., 2013). 
TRAF2 acts as a target for cIAP1/2 (Mahoney et al., 2008) , which in turn binds the 
LUBAC complex (consisting of HOIP, HOIL and SHARPIN) (Ikeda et al., 2011), while RIP1 
interacts with NEMO to mediate the interaction between TAK1 and the IKK complex 
through NEMO (Yang et al., 2011), thus ensuring the activation of NF-κB .  
• Activation via TLR/IL-1R 
The TLR/IL-1R receptors specifically recognise pathogen-associated molecular patterns 
(PAMPs) which for the activation of NF-κB  include: lipopolysaccharides of gram-
negative bacteria, peptidoglycan and lipoteichoic acid of gram-positive bacteria, viral 
RNAs, and a number of externa stress signals (Napetschnig and Wu, 2013).  Following 
ligand-induced activation, TLRs and IL-1Rs form dimers or undergo conformation 
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change (Latz et al., 2007; Tsukamoto et al., 2010) or may undergo conformation 
change (Liu et al., 2008; Kang et al., 2009). Similarly, to activation through TNFR, these 
conformational changes promote complex molecular assemblies. In the case of TLR/IL-
1R receptors, these include protein assemblies which consists of three protein 
complexes and they rely on interactions with various K48- and K63-polyubiquitin 
chains. These protein complexes are formed in a stepwise manner by interaction of 
various IRAK and TRAF proteins, which start with association at the membrane of 
Complex I (MyD88, Tollip, IRAK-1, IRAK-4 and TRAF6) and II (TRAF6-TAK1-TAB1-
TAB2/TAB3). Here, IRAK1 undergoes ubiquitination and the remaining IRAK/TRAF 
protein complex translocate to the cytoplasm where interactions with E2 ubiquitin-
conjugating enzyme (Ubc13/Uev1A) and K63-polyubiquitin chains promote association 
with TAB2, ultimately leading to the activation of TAK1. TAK1 subsequently 
phosphorylates and thus activates IKKβ, resulting in the activation of the NF-κB 
canonical pathway (Verstrepen et al., 2008; Napetschnig and Wu, 2013).  
• Activation via T- and B-cell receptors 
Activation of the non-canonical NF-κB pathway requires T- and B-cell receptors, and is 
initiated when stimulated by B-cell activating factor belonging to the TNF family (BAFF) 
(Morrison et al., 2005), lymphotoxin b (LTb) (Madge et al., 2008) and CD40L (Seigner et 
al., 2018). It has been proposed that the T-cell receptor (TCR) uses the LAT-SLP76 
and/or the GLK complex to activate PKCθ (Smith-Garvin et al., 2009; Chuang et al., 
2011), while CD28 stimuli activate PKCθ through PI3K and PDK1 (Garçon et al., 2008; 
Kang et al., 2017). Once activated PKCθ promotes the formation of the CBM complex 
(CARMA1, BCL10, MALT1) (Schulze-Luehrmann and Ghosh, 2006). The CBM complex 
interacts with the ubiquitin ligases TRAF6, TRAF2 and/or MIB2 to allow for signal 
transmission to the IKK complex (Paul and Schaefer, 2013), resulting the activation of 
the pathway.  
IKKα may also play a role during canonical activation, however, attempts to 
understand this have so far yielded inconsistent results. IKKα is thought to function 
similarly to IKKβ and target IκBα for degradation  (Kim et al., 2010) or associate with 
NF-κB inhibitors (Shembade et al., 2011). Studies in mice show that IKKβ and NEMO 
deficiency result in embryonic death (Li et al., 1999; Rudolph et al., 2000), whilst mice 
lacking IKKα show developmental and morphological issues (Hu et al., 1999). These 
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findings suggest the evolutionary and cooperative importance of the two activating 
pathways, with the canonical pathway responsible for controlling much of the immune 
response, whilst the alternative pathway could be seen to function as an extension or 
even as an additional regulator of NF-κB signalling.  More NF-κB activating pathways 
undoubtedly exist; for example tyrosine phosphorylation of IκBα instead of serine is 
able to activate NF-κB in response to oxidative stress and does not depend on 
degradation of IκBα (Takada et al., 2003; Imbert et al., 1996).  
 
Figure 4 illustrates a simplistic diagram of the canonical and alternative NF-κB, with the 
corresponding receptors and focus only on the events after IKK activation and omitting 
the cascade of interactions described above.  
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Figure 4. Canonical and alternative NF-κB activating pathways and their specific 
proteins. Schematic showing the activation of NF-κB in response to canonical and non-
canonical stimuli. P, phosphorylation; U, ubiquitination; NF-kBp,  NF-kB precursors. 
Activation of the IKK kinases complex during canonical activation is carried out by various 
kinases (depending on the nature of the stimulus) which promote association with NEMO 
(canonical) or IKKα (alternative), thus activating the IKK complex and ensuring targeting of 
IκBs for proteasomal degradation. TLR, TNFR, BCR, TCR are the receptors for canonical 
stimuli; CD40, BAFFR, LTβR, RANK are the receptors for alternative pathway stimuli.  
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 The NF-κB alternative pathway is activated by a select few types of stimuli and 
its activation is essential for more specialised cellular functions such as development of 
the lymphatic system (Sun, 2011), as well as neuronal and bone functioning (Dejardin, 
2006). NEMO is not required for this pathway and activation of IKKα is credited to its 
interaction with the NF-κB-inducing kinase (NIK) (Xiao et al., 2001). Additionally, the 
alternative pathway has a much slower rate and a long-lasting activity compared to the 
canonical activation (Hoffmann and Baltimore, 2006; Shih et al., 2011; Sun, 2011). As is 
the case for NF-κB, the activation of IKKα by NIK leads to targeting of NF-κB inhibitors 
(in this case p100), as well as the subsequent proteoasomal degradation of NIK, thus 
acting as a self-regulatory unit (Razani et al., 2010). 
 
1.4  NF-κB essential modulator (NEMO): structure, function, and 
importance  
 
NEMO forms the non-catalytic subunit of the IKK complex together with the 
two kinases, IKKα and IKKβ. It is a 48-kDa protein, and as the name suggests it function 
as the main regulator of the NF-κB canonical activation (Rothwarf et al., 1998; 
Yamaoka et al.,1998). NEMO ensures the activation of the canonical pathway by 
associating with the IKKβ kinase, which induces activation of the kinase either through 
autophosphorylation or phosphorylation by RIP or TAK enzymes (Wu et al., 2010; 
Wang et al., 2001).  Following this IKKβ can bind to specific inhibitors such as IκBα and 
thus free the sequestered NF-κB proteins, which can now enter the nucleus and 
regulate transcription. Even though NEMO is the main activator of the canonical 
pathway, it is often assigned a passive role in achieving this. Most published reports 
suggest NEMO acts a ‘scaffold’ protein, ensuring IKKβ and its substrates are in close 
proximity to each other for their interactions to occur (Schröfelbauer et al., 2012).   
The exact mechanism of action of NEMO within the NF-κB signalling pathway is 
still a debatable topic.  Embryonic lethality is observed in mice lacking NEMO, and in 
cells lacking NEMO, the canonical activation of NF-κB is also not observed (Rothwarf et 
al., 1998; Rudolph et al., 2000).  
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1.4.1 NEMO structure  
 
Many studies have attempted to elucidate the structure of NEMO. The only 
available X-ray structures are of truncated versions of the protein and/or bound to an 
interacting partner, most of them showing regions that display helical structures (Lo et 
al., 2009; Rahighi et al., 2009; Ivins et al., 2009; Tokunaga et al., 2009). The 419-amino 
acid protein is thought to have two coiled-coiled domain CC1 and CC2 at the N- and C-
terminus, respectively, and an alpha-helical domain at the n-terminus. The C-terminus 
also includes the NOA domain, a leucine zipper and zinc finger, as depicted in the 
Figure 5.  
 
 
Figure 5. NEMO known structural details and predicted disordered regions (Figure 
adapted from Catici et al., 2015). i, NEMO regions, including: α-helical domain, coiled coil 
region 1 (CC1), coiled coil region 2 (CC2), NEMO Optineurin Abin (NOA or UBAN or ABIN), 
leucine zipper (LZ), and zinc finger (ZF); ii, X-ray crystallography solved NEMO structures 
(PDB ID: 3BRV, 3CL3, 2ZVN, 2JVX); iii, part of NEMO predicted to be disordered as 
determined using PONDR-FIT, ANCHOR, IUPred, and SPINE-D; iv, specific NEMO regions for 
interaction with IKKβ (amino acids 44-111) and poly-ubiquitin (amino acids 253-337 & 386-
409).  
 
At the N-terminus, the CC1 domain facilitates interactions with the C-terminus of IKK 
enzymes (Rushe et al., 2008), while the CC2 –LZ domain ensures interactions with 
various poly-ubiquitin partners (Rahighi et al., 2009; Ivins et al., 2009; Tokunaga et al., 
2012). Interactions with poly-ubiquitin are essential for NEMO and NF-κB activation, 




1.4.2 NEMO ZINC FINGER  
 
The zinc finer (ZF) is a shared protein motif found in both prokaryotes and eukaryotes, 
required for interactions with nucleic acids, proteins, and lipids (Gozani et al., 2003; 
Hall, 2005; Gamsjaeger et al., 2007; Eom et al., 2016), with possible links to many 
human diseases (Cassandri et al., 2017). The name is derived from the structural 
arrangements of amino acid residues present in different numbers (most commonly 
cysteine and histidine) around a Zinc ion. The structure of the NEMO ZF, determined 
using nuclear magnetic resonance, shows the regions adopt a ββα conformation 
(Cordier et al., 2008; Cordier et al., 2009), similar to other ZF proteins (Malgieri et al., 
2015). The structure can be seen in Fig.6. 
 
Figure 6. Structure of human NEMO ZF region (Figure adapted from Cordier et al., 
2008). The structure was determined using nuclear magnetic resonance and is shown here 
bound to a Zn2+  (PDB ID: 2JVX). Gradient from blue to red shows the 394–419 residues of 
human NEMO.  
 
The function of the NEMO ZF is to facilitate ubiquitin binding and ensure NF-κB 
activation (Cordier et al., 2009; Ngadjeua et al., 2013). Mutations within the NEMO ZF 
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can results in mice embryo lethality (Smahi et al., 2000), are associated with 
impairment of NF-κB signalling (Fusco et al., 2008; Ngadjeua et al., 2013) and are 
observed in many clinical conditions, such as ectodermal dysplasia with 
immunodeficiency (Döffinger et al., 2001). Complete activation of IKK requires the 
presence of NEMO ZF, whilst mutations allow only for partial activation, being 
responsive to some but not all activating signals (Makris et al., 2002).  
1.4.3 NEMO LEUCINE ZIPPER 
 
The leucine zipper (LZ) is common pattern observed in many protein structures, 
consisting of regions of leucine repeats every seven residues (Hakoshima, 2005). LZs 
typically display helical arrangements, as a result of the structural organisation of the 
leucine residues within the LZ regions. The non-Leucine residues also contribute to the 
overall stability of the regions by ensuring burying of hydrophobic amino acids and 
through the presence of stabilising non-covalent interaction (Lee et al., 2003). 
Consequently, due to their structure and stability, LZs have been assigned roles in 
promoting protein dimerisation. Within NEMO, the CC2-LZ region is thought to play a 
role in promoting NEMO dimer formation and to facilitate binding to poly-ubiquitin 
chains (Grubisha et al., 2010) and consequently NEMO activation (Bloor et al., 2008).  
1.4.4 NEMO NOA DOMAIN 
 
In addition to LZ, the NEMO Optineurin Abin (NOA or UBAN or ABIN), is also 
known to facilitate ubiquitin interactions. Mutations in the NOA domain have been 
found in a number of diseases associated with NEMO (Rahighi et al., 2009; Filipe-
Santos et al., 2006).  The X-ray crystal structures of mouse CC2-LZ regions (including 
NOA domain) showing a coiled-coil structure are shown in Fig.7. 
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Figure 7. X-ray crystal structures of mouse NEMO CC2-LZ including the NOA domain 
bound to ubiquitin (Figure adapted from Chiaravalli et al., 2011). NEMO structure 
solved at 2.9 Å, showing the CC2, NOA, and LZ domains, shown here bound to two molecules 
of diubiquitin (PDB ID: 2V4H).  
1.5 NEMO:UBIQUITIN INTERACTIONS 
 
Ubiquitin is a small protein abundant in all eukaryotic cells with a plethora of 
functions, including tagging of molecules to undergo proteoasomal degradation 
(Pickart, 2004), cell signalling (Haglund and Dikic, 2005), DNA repair (Uckelmann and 
Sixma, 2017), and others. Ubiquitin owns its many functions to its ability to form 
complex ensembles with other ubiquitin proteins, linking at specific lysine residues (K6, 
K11, K27, K29, K33, K48, K63) and resulting in poly-ubiquitin chains (Komander and 
Rape, 2012). It can also exist as linear or Met 1-linked polyubiquitin chains, whereby 
the C-terminus of one ubiquitin can bind the N-terminal methionine residues of 
another ubiquitin (Komander and Rape, 2012; Rittinger and Ikeda, 2017).  
 
Within NF-κB signalling, ubiquitin has been demonstrated to play important 
roles in initiation of activation of the pathway, mainly through non-covalent 
interactions with NEMO (Hadian et al., 2011; Gautheron and Courtois, 2010), through 
the LZ and NOA domains.  
NEMO binds to a variety of ubiquitin chains, including linear (Met1 (Rahighi et al., 
2009)), K11 (Hadian et al., 2011), K48 (Yuan et al., 2014), K63 (Laplantine et al., 2009). 
NEMO activation upon binding to ubiquitin is not yet fully understood, and a few 
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mechanistic models have been proposed to explain this functional interaction. 
Potentially binding of ubiquitin functionalises NEMO by ensuring the protein assumes 
a conformation that promotes recruitment of IκBα, to facilitate the interaction 
between IKKβ: IκBα (Schröfelbauer et al., 2012). This is thought to be achieved through 
ubiquitin allosteric control, as the binding sites for ubiquitin and IKKβ do not overlap 
(Catici et al., 2015).  Other studies suggest that activation of IKKβ is achieved through 
trans-autophosphorylation following conformational changes within the IKK complex 
(Polley et al., 2013), upon binding of ubiquitin to NEMO (Rahighi et al., 2009). A similar 
model suggests that NEMO ubiquitination acts as a tag for the recruitment of kinases 
that can phosphorylate IKKβ and thus activate it. This is supported by localisation of 
NEMO to the cell membrane (Nakamori et al., 2006; Konig et al., 2012), where the 
enzyme TAK1, an activator of IKK (Wang et al., 2001) is activated in response to NF-κB 
stimuli (Jiang et al., 2002). TAK1 phosphorylates IKKβ at the Ser 177, which induces the 
autophosphorylation of the Ser 181, thus leading to the activation of IKKβ (Zhang et 
al., 2014). Activated IKK enzymatic complexes have also been reported in various 
membrane compartments of axons in vitro (König et al., 2018).  Similar mechanisms 
were reported in a study where binding of ubiquitin to the enzyme RIP1 promoted the 
interaction and ubiquitination of NEMO and subsequently allowed for the recruitment 
of TAK1 and activation of IKK complex resulting in NF-κB activation (Ea et al., 2006).  
Refer to Fig.8 for detailed activation models.  
 
The CC2-NOA-LZ (known as NEMO CoZi) binds linear ubiquitin chains with an affinity of 
1.6  µM, approximately 100 times higher than K63 ubiquitin, due to each NEMO 
monomers binding in a two-way fashion to neighbouring  ubiquitin chains (Lo et al., 
2009). NEMO ZF contributes a second ubiquitin binding site, with no notable 
preference for Met1 or K63-linked ubiquitin (Laplantine et al., 2009). Structural studies 
report that NEMO CoZi domain assumes a dimeric conformation and binds linear 
ubiquitin resulting forming a heterotetrametric complex of NEMO dimers with two 
linear ubiquitins. Specifically, hydrophobic patches of one NEMO monomer interact 
with the Leu8-Ile44-Val70 triad of the distal ubiquitin, while the polar regions of the 
other NEMO monomer bind to a surface adjacent to the proximal ubiquitins 
hydrophobic patch (Rahighi et al., 2009). Binding to K63-linked chains is mediated 
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through one binding side, with only the hydrophobic NEMO residues being involved in 
this interaction (Yoshikawa et al., 2009). Binding to linear ubiquitin functions to 
activate NEMO and promote interactions with the IKK complex (Fujita et al., 2014; 
Tokunaga et al., 2012), thus initiating activation of NF-κB.  
 
NEMO has also been reported to bind Met1/K63-ubiquitin hybrid chains (Emmerich et 
al., 2013). While Met1 chains activate NEMO and promote IKK association, the 
presence of K63 chains is thought to facilitate the translocation of the NEMO:IKKβ 
complex to the membrane to allow IKKβ activation through interactions with TAK1 
enzyme (Emmerich et al., 2013). As activation of TAK1 requires K63-ubiquitin chains 
(Xia et al., 2009), potentially the role of NEMO binding to K63-ubiquitin hybrid chains is 
to ensure both the IKK complex and their activating kinases (such as TAK1) are 
colocalised to the same polyubiquitin chain, thus facilitating the activation of the NF-
κB canonical pathway.  
 
The multitude of polyubiquitin binding possibilities for NEMO accounts for the variety 
of models for NEMO-dependent IKK and NF-κB activation, where different activating 
mechanisms function to ensure that transmission of a plethora of stimuli for NF-κB 







Figure 8. Proposed mechanisms for ubiquitin mediated NEMO and NF-κB activation. 
Models for the activation of NEMO upon binding to ubiquitin and subsequent activation of NF-κB in 
response to canonical stimuli. P, phosphorylation; U, ubiquitination.  
 
A generalised ubiquitin activation model of NEMO and NF-κB is proving difficult 
to predict due to the variety of NF-κB activating stimuli and the diversity of cells 
containing the signalling pathway. It is possible that the NEMO:ubiquitin interaction is 
stimulus dependent. Reports show stimulation of NF-κB through TNF and IL-1 involve 
different ubiquitin proteins, illustrating another layer of specificity within the pathway 
(Tarantino et al., 2014). Consequently, the above-mentioned models should not be 
considered mutually exclusive, but rather a synergistic representation of the 
complexity of NF-κB signalling.  
 
As polyubiquitin chains play crucial role in activating NF-κB, a number of 
deubiquitinates have been found to negatively regulate the pathway (Harhaj and Dixit, 
2011).  A20 deubiquitinase controls inhibition of NF-κB by associating with the C-
terminal domain of NEMO and ensuring deubiquitination of K63-linked ubiquitin 
chains  (Zilberman-Rudenko et al., 2016). Similar results have been reported for 
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deubiquitination of K63-linked ubiquitin chains from TRAF6, resulting in termination of 
NF-κB (Lin et al., 2008). Cezanne or Cellular zinc finger anti-NF-κB deubiquitinase 
inhibits NF-κB by targeting K11-ubiquitn chains on substrates present in the TNFR 
complex (Bremm et al., 2010). Another deubiquitinase, cylindromatosis (CYLD) targets 
both NEMO and TAK1 K11-lysince chains and acts as a tumour suppressor (Kovalenko 
et al., 2003).  
 
1.6 NEMO OLIGOMERIC STATE  
 
A consensus has yet to be reached about NEMO oligomerisation state. 
Experiments using only the C-terminal coiled coil region show the oligomerisation 
state of NEMO is concentration dependent, with the CC2 region existing as monomer, 
dimer, and trimer, at various protein concentration (Agou et al., 2004). Full-length 
recombinant NEMO was reported to also exist as dimers (Huang et al., 2002) and 
trimer (Rothwarf et al., 1998) under in vitro cross-linking conditions . In contrast, 
purified NEMO from HeLa cells appears to form tetramers (Tegethoff et al., 2003), 
whilst other studies report HeLa cells purified NEMO to exist in its dimeric and trimeric 
forms (Agou et al., 2002). NEMO pentamers were also identified in cross-linking 
experiments of recombinantly produced protein (Fontan et al., 2007) and from 
truncated NEMO N-termini (Lo et al., 2008).   
Many of these discrepancies arise due to different cross-linking and purification 
conditions, specific NEMO regions studied, as well as differences in cell type and 
protein concentration. These findings also reveal the plethora of conformations 
available for NEMO to access and illustrate the dynamic nature of the protein. The 
majority of these studies agree that the presence of a binding partner contributes 
towards the type of NEMO oligomeric state observed. Taking into account the range of 
NEMO roles both within and outside NF-κB and its increased number of interacting 
partners in the cell (~100) (Fenner et al., 2010) suggests that the many theories about 
NEMO oligomeric state will be challenging to unite. Instead, the oligomeric state of the 
protein should be viewed in lieu of the functional significance of NEMO 
conformation(s).  
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1.7 NEMO - lack of consensus on structure and a case for disorder  
 
The degree of disorder or molecular flexibility for NEMO is predicted to be 
between 41-49 % (Catici et al., 2015). These findings suggested the existence of 
intrinsically unstructured regions at both the N- and C-termini, and have been 
corroborated with far UV-circular dichorism measurements (Catici et al., 2015). The 
predicted disordered NEMO regions also appear to overlap with the regions proving 
challenging to structurally characterise using standard structural techniques such as X-
ray crystallography or nuclear magnetic resonance. The findings suggest that NEMO 
adopts a molten globule state, with the protein capable of undergoing functional 
conformational change when bound to different ligands.   
 
Very little consensus exists within literature about the nature of these unstructured 
regions, and of NEMO overall. One study reports a ‘native’ coiled-coil conformation at 
the C-terminus of NEMO upon the addition of a disulphide bond at two specific 
cysteine residues (Zhou et al., 2014). Indeed, the two cysteine residues located at 
positions 54 and 347 do form disulphide bonds in vivo and in response to treatment 
with H2O2 (Herscovitch et al., 2008). However, such findings must be considered with 
caution, as the study predicts the overall protein structure based on a truncated 
construct. 
An alternative approach examines the use of NEMO binding partners (or 
mimics of such) in structural studies to elucidate protein functional structural changes, 
such as binding to IKKβ (Guo et al., 2014). The structure of truncated human NEMO 
bound to a viral protein (vFLIP) was solved using X-ray crystallography and shows the 
protein sequence corresponding to amino acids 150-272 is a helical conformation and 




Figure 9. X-ray structure of human NEMO bound to viral protein vFLIP (Figure 
adapted from Bagnéris et al., 2008). Human NEMO amino acid region 192-252 solved at 3.2 
Å resolution (PDB ID: 3CL3), bound to vFLIP amino acids 1-178.  
 
The vFLIP protein is an important NEMO binding partner as it is used to control 
activation of NF-κB following viral infections. vFLIP, also known as viral flice-interacting 
protein, is a viral protein associated with Kaposi sarcoma-associated herpes virus 
(KSHV) (Jenner et al., 2001). The protein is able to bind to NEMO and activate the IKK 
complex (Matta et al., 2003), as well as protect against  apoptosis of infected cells 
(Tolani et al., 2014).  
 
The NEMO:vFLIP complex was subjected to further structural characterisation using 
electron paramagnetic resonance (EPR) spectroscopy (Bagnéris et al., 2015). In this 
study a truncated human NEMO protein (with missing parts of the C- and N-termini) 
was reported to adopt helical conformations across the entirety of the protein, with no 
evidence for unstructured regions. The study also used IKKβ fragment (644-756) and 




Figure 10. Model of full-length NEMO incorporating X-ray crystal structures of solved 
NEMO domains (Adapted from Bagnéris et al., 2015). The figure includes solved 
structures of NEMO (shown in magenta) bound to IKKb ,vFLIP, and diubiquitin (shown in 
grey), and a theoretical model for regions missing crystallographic data (shown in green). 
This This research was originally published in the Journal of Biological Chemistry, Bagnéris, 
C., et al. (2015) Probing the solution structure of IκB kinase (IKK) subunit γ and its interaction 
with Kaposi sarcoma-associated herpes virus flice-interacting protein and IKK subunit β by 
EPR spectroscopy. Journal of Biological Chemistry, 290(27), pp.16539–16549. 
 
Recently, new evidence has emerged that challenges the model of NEMO as a rigid 
molecule. Using size exclusion chromatography coupled with small-angle X-ray 
scattering (SEC–SAXS), it was shown that NEMO is not one long coiled-coil but rather is 
capable of undergoing conformational change when interacting with vFLIP (fused to a 
MBP tag), as well as in response to interacting with ubiquitin (Hauenstein et al., 2017).  
The SAXS structure of full-length structure of full-length human NEMO can be seen in 
Fig.11. 
 
Figure 11. Structure of NEMO bound to vFLIP (not shown here) as determined by 
small-angle X-ray scattering (Figure adapted from Hauenstein et al., 2017). Full-length 
human NEMO as determined by SAXS following ab initio modelling showing the refined 




The structure shows NEMO adopt a ‘comma’ shaped conformation, ~ 320 Å in size, 
smaller than the predicted extended coil-coil structure. The authors report a compact 
conformation for unstimulated NEMO, proposing a model where both the N- and C-
termini are capable of undergoing conformational change; both in the MBP-vFLIP 
bound state (due to allosteric regulation), as well as for unbound NEMO (a movement 
thought to control activation of NEMO in absence of stimuli). Based on these findings, 
a new model for NEMO structure has been proposed, where the protein exists mostly 
as a coiled-coil, with parts of the protein capable of undergoing conformational change 
upon binding to a ligand, a conformation similar to molten globule (Hauenstein et al., 
2017).  
1.7.1 WHAT IS PROTEIN DISORDER? 
 
As mentioned, much debate exists about the structure of NEMO and its 
potential dynamic nature. Protein disorder is now accepted as a more common feature 
in nature, with proteins from all kingdoms of life (including viruses) exhibiting varying 
degrees of disorder (Xue et al., 2012; Ward et al., 2004; Dunker et al., 2008).  The 
concept was first met with much scepticism, as it challenged the central dogma of 
protein biochemistry where proteins fold to assume a stable native conformation in 
order to be considered functional inside the cell. Intrinsically disordered proteins 
(IDPs) are protein that lack an obvious native conformation, but appear to be 
functional (Uversky, 2011). Crucially, many IDPs have been shown to carry out 
important roles, including in: cell signalling and regulatory networks (Tantos et al., 
2012; Haynes et al., 2006), cell division (Galea et al., 2008), acting as chaperones 
(Treweek et al., 2010; Reichmann et al., 2012; Ivanyi-Nagy et al., 2005), scaffold 
proteins (Cortese et al., 2008; Xue et al., 2013), forming complex molecular assemblies 
(eg. in the ribosomal complex contain disorder regions (Peng et al., 2014)).  
 Although present in all phyla of life, the abundance of protein disorder is now 
seen as a potential evolutionary development in response to the complexity of 
multicellular life (Pancsa and Tompa, 2012; Schad et al., 2011). The disorder regions 
within proteins are also rich in post-translational modification sites, thus allowing for 
another layer of structural and potentially functional heterogeneity in disordered 
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proteins (Collins et al., 2008; Gao and Xu, 2012). 
 
The free energy landscape (FEL) model of protein folding accounts for the 
existence of disordered proteins and their subsequent folding following molecular 
interactions or changes in the environment. FELs encompass a series of energetic ‘hills’ 
and ’valleys’, each corresponding to a particular folding intermediate, with the protein 
native state usually residing at the bottom of the funnel-like energy landscape.  Unlike 
proteins with a well-defined native structure, disordered proteins or proteins that 
contain disordered regions are described as having a more ‘rugged’ FEL, accounting for 
the high degree of structural flexibility (Shown in Fig.12). The conformations on a 
disordered protein FEL will exhibit different degrees of thermodynamic stability, even 
in the absence of a well-defined folded structure.  
 
 
Figure 12. Cartoon representation of a hypothetical  free-energy landscape (FEL) of 
globular proteins vs disordered. Disordered protein FELs are typically described as more 
‘rugged’ compared to non-disordered (or globular) proteins, the FELs of which are much 
more ‘funnel-like’ . 
 
There are a number of advantages to protein disorder. These include: ligand 
binding promiscuity (Tompa et al., 2005), control through allostery (Ferreon et al., 
2012), accommodation of many PTM sites (Xie et al., 2007). Due to their many 
advantages, disordered proteins also have industrial applications, including in 
biomineralisation (Boskey and Villarreal-Ramirez, 2016), cryo-protection of biological 
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agents (Matsuo et al., 2018), and potentially assist in the design of novel drug targets 
(Cheng et al., 2006; Metallo, 2010).  However, disordered protein have also been 
linked to a number of pathological conditions, including neurodegenerative diseases 
(such as Parkinson’s disease and Alzheimer’s diseases), and various cancers (Uversky et 
al., 2014).  
 
1.7.2 NEMO flexibility and ligand induced conformational change 
 
NEMO as a molten globule exhibits many of the characteristic features of IDPs, 
including: presence of amino acid sequence specific for disordered regions (Radivojac 
et al., 2007; Dunker et al., 2008), the ability to accommodate an array of PTMs (Sebban 
et al., 2006; Wuerzberger-Davis et al., 2007; Mabb et al., 2006). Conformational 
flexibility is present in other NF-κB proteins as well. For instance, the X-ray crystal 
structure of inhibitor IκBα bound to p50 and p65 shows very little evidence of 
flexibility (Jacobs and Harrison, 1998). However, experiments using 8-
Anilinonaphthalene-1-sulfonic acid (ANS) and amide exchange report that IκBα 
undergoes conformational change upon binding to NF-κB proteins, showing molten 
globule-like behaviour with specific regions within the ankyrin repeats displaying 
varying degrees of flexibility (even upon binding to p50 or p65) (Truhlar et al., 2006). 
Similar conformational changes in IκBα have also been reported using other structural 
techniques (Croy et al., 2004; Sue et al., 2008; Trelle et al., 2016).  
  
 More recently, studies using super-resolution microscopy have observed for 
the first time the organisation of NEMO oligomers determined in two cell types which 
appear to be missing in patients suffering from a NEMO-associated condition known as 
Incontinentia pigmenti (Scholefield et al., 2016). The formation of the NEMO ‘lattice' 
was also highly dependent on ubiquitin binding, suggesting that ubiquitin guides the 
NEMO oligomerisation. The authors also report that the catalytic subunit of IKK 
contribute towards lattice formation. These complex protein assemblies are thought to 
be important for activation of the IKK complex, and offer more information for 
understanding the role of NEMO in the activation of NF-κB signalling (Scholefield et al., 
2016). Evidence for NEMO:IKK protein cellular assemblies has also been provided in a 
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previous study where canonical and non-canonical NF-κB stimuli promoted complex 
protein assemblies at the cell membrane in U20S cells (Tarantino et al., 2014). As a 
result, a new model of NEMO oligomerisation and activation has been proposed, 
whereby the complex NEMO lattices are formed by N-termini of one protein 
interacting with one of more N-termini of another NEMO molecule, with similar 
interactions happening at the C-termini (Scholefield et al., 2016). As such, multimers 
can be observed, which have already been proposed as a potential mechanism for IKK 
and NF-κB activation. See Fig.13 for proposed NEMO oligomerisation model based on 
the structure of the NEMO lattice.  
 
Figure 13. Proposed mechanism for NEMO oligomerisation. Shown in green are IKKβ 
dimers, in pink are chains of ubiquitin, light orange are NEMO dimers (Based on model 
proposed by Scholefield et al., 2016). The model shows the proposed mechanism by which 
NEMO oligomerisation is driven by interaction with IKKβ and ubiquitin chains. These lead to 
the formation of NEMO lattice structures, whereby the N-terminus of one NEMO monomer 
interact with the N-terminus of another NEMO monomer, with similar interactions proposed 
for NEMO C-termini.  
 
1.8  NEMO in health & disease  
 
A number of pathological conditions have been associated with NEMO. These include 
conditions arising due to genetic modifications of the NEMO gene, such as 
immunodeficiency (Fusco et al., 2008), anhidrotic ectodermal dysplasia with 
 31 
immunodeficiency (Smahi et al., 2000), and Incontinentia pigmenti (Hanson et al., 
2008). The latter is considered one of the more severe conditions as it often results in 
male embryonic lethality (Scheuerle and Ursini, 1993). The IKBKG gene (the gene for 
NEMO) is located on the long arm of the X-chromosome (Xq28) (Fusco et al., 2008), 
and transmission of a mutated version to a male embryo is not compatible with life 
(Wettke-Schäfer and Kantner, 1983).  Improper NEMO and NF-κB functioning have also 
been linked to play crucial roles in a number of inflammatory diseases (Maubach and 
Naumann, 2017) and some cancers (Park and Hong, 2016). Many studies have 
focussed on identifying targets capable of modulating the activation of NEMO and NF-
κB in human disease (Zilberman-Rudenko et al., 2016; Luedde et al., 2007). These have 
raised concerns about the complex effects and safety of suppressing NEMO or NF-κB 
activation, as they control important physiological processes in cells. Pharmacological 
development is further complicated by the crosstalk between NF-κB and other 
regulatory networks, as the effects of modulating NEMO and NF-κB activation could 
extend beyond the canonical activation of NF-κB.  
 
One of the most studied targets for inhibition of NF-κB activation through 
inhibition of the formation of the NEMO: IKKβ complex is a short peptide mimicking 
the NEMO-binding domain of IKK enzymes, known as the NBD peptide (May et al., 
2000). The 11 amino acid peptide has been shown to reduce inflammation in murine 
models of inflammatory diseases in vitro (May et al., 2000). More recently, the peptide 
was part of a phase I clinical trial for the treatment of canine B-cell lymphoma, 
successfully reducing the growth of malignant B-cell, with no toxicity effects reported 
(Habineza Ndikuyeze et al., 2014). Other promising therapeutic effects were also 
observed upon treatment with NBD in mice models of acute lung injury (Huang et al., 
2016), as well as mouse (Reay et al., 2011; Peterson et al., 2011) and dog (Kornegay et 
al., 2014) models of muscular dystrophy. Although many animal studies report positive 
results, the cost associated with the production of the inhibitory peptide and its 
reduced half-life suggest further exploring of other therapeutic routes (Zhao et al., 
2018; Rhodes et al., 2018).   
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Studies looking at inhibiting NEMO-mediated activation of NF-κB have also focussed on 
developing therapeutic peptides that bind to the NEMO NOA domain, to inhibit 
activation through ubiquitination of NEMO, rather than target the IKK complex 
(Chiaravalli et al., 2011). More recently, an inhibitory peptide (iNUB) targeting the 
NEMO NOA domain was reported to modulate canonical activation of NF-κB signalling 
in response to some stimuli (Vincendeau et al., 2016). The peptide impairs NEMO 
binding to ubiquitin and is hypothesised to be used to treat some NF-κB conditions 
while still allowing activation through other stimuli.  
 
Despite considerable scientific advancement in understanding NEMO and NF-κB 
signalling, it is clear that further analysis of the structure, function, and their links to 
protein dynamics holds the key to answering many of the questions about the role of 
the NF-κB master regulator NEMO and develop better therapeutics for the treatment 
of NF-κB associated disorders.  
 
1.9 AIM & OBJECTIVES  
 
The aim of this PhD study is to understand the biophysical factors governing 
the structure, function, and dynamics of NEMO. To achieve this a combination of 
biophysical & biochemical techniques will be applied, such as pressure and 
temperature perturbations, red edge excitation shift spectroscopy, and isothermal 
titration calorimetry-based enzyme assays. Previous studies address the dynamic 
nature of the NEMO and emphasize the importance to taking into account its 
interactions with NF-kB ligands when considering its structure and dynamics. As such, 
the first objective of this study was to validate the use of an optical phenomenon 
known as Red edge excitation shift (REES) in studying protein dynamics. Whilst many 
structural techniques are available to use in elucidating protein structures, this study 
focused not on one particular NEMO conformation, but rather on understanding the 
breadth of conformational states available to the protein under specific conditions (ie. 
macromolecular crowding or ligand binding). REES spectroscopy is a technique that 
reports on the relationship between fluorophores and their surrounding 
environments. In the case of NEMO, a single tryptophan amino acid located at the N-
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terminus of the protein in a region of the protein involved in interacting with the IKKb 
enzyme will be used as an intrinsic fluorophore.  Peptide mimics of all NEMO 
interacting partners will be used so as to avoid any fluorescence signal arising from the 
complex proteins and ensure that the REES signal observed is attributed to NEMO 
conformational change.   
 
Secondly, information about the thermodynamics of NEMO conformational change 
can best be probed using hydrostatic pressure and temperature perturbations. In this 
instance, 8-Anilinonaphthalene-1-sulfonic acid (ANS) will be used an extrinsic 
fluorophore now allowing for monitoring of protein global conformational changes. 
These findings will complement the results from the local NEMO REES probe and help 
understand any differences in the dynamic nature of the protein and determine 
whether different parts of the protein exhibit different degrees of dynamics. Similarly, 
the effects of NEMO ligand binding on the thermodynamics of the protein will also be 
evaluated using p/T perturbations to further characterise the NEMO functional 
conformational change. In addition to testing the NEMO conformational changes in 
simple buffered conditions, thus study also aims to mimic the intracellular milieu, 
focussing on understanding the effect of the physical parameters of the intracellular 
milieu on the structure and dynamics of NEMO. 
 
Understanding the role of NEMO inactivating the NF-kB signalling is of great interest, 
especially seen as a high number of clinical conditions are linked to improper 
functioning of NEMO/NF-kB. In order to elucidate the role of NEMO in mediating the 
interaction between the enzyme IKKb and its substrate, the inhibitor IkBa during 
canonical activation of the pathway. The kinetics of the IKKb enzyme will be monitored 
using isothermal titration calorimetry (ITC), both in the presence and absence of 
NEMO. Using ITC allows for monitoring the enzyme reaction under continuous 
conditions, and whilst a number of studies have tackled this question previously, but 
this is the first time the full length-NEMO and IKKb are used. The results of these 
measurements will help better understand the scaffold role of NEMO and the  
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Taken together, these objectives will offer a comprehensive understanding of NEMO 
conformational change in response to ligand binding and changes in the environment, 
as well as help in understanding the scaffold role of NEMO and the complex activation 
of the NF-kB signalling. The different experimental set-ups described above ensure a 
detailed and complementary analysis of the biophysical factors affecting the structure, 













































2.1 Spectroscopic methods to study protein conformational change  
 
The central dogma of biochemistry states that there is an intrinsic relationship 
between protein structure and function. Proteins carry out important cellular 
functions, based on their native structures and cellular localisation (Uhlen et al., 2010). 
Intrinsically disordered proteins or conformationally dynamic proteins challenge the 
structure-function relationship, as they have been proven to have specific cellular 
functions even in the absence of a defined native structure (Uversky, 2011; Forman-
Kay and Mittag, 2013). Many available techniques aimed at determining molecular 
structure pose obstacles to being used on such flexible systems, due to a number of 
factors, including: size restriction and signal-to-noise ratio. Fluorescence spectroscopy 
is a commonly used technique for studying protein conformations, including 
disordered or flexible proteins (Gong et al., 2008; Ferreon et al., 2012). The techniques 
relies on protein intrinsic fluorescence (Gorinstein et al., 2000) or in the absence of 
intrinsic fluorophores, extrinsic probes are commonly used to monitor protein 
structures and conformational change (Hawe et al., 2008). NEMO contains one 
intrinsic fluorophore, allowing for its intrinsic fluorescence to be easily measured using 
fluorescence spectroscopy to better understand the structure and conformational 
change of the protein.  
2.2 Fluorescence – Principles and Applications  
Fluorescence is a type of photoluminescence and together with 
phosphorescence has long been used as a technique in chemical and biological 
research (Sanders et al., 1994). The basic principle of fluorescence depends on the 
ability of a compound or molecule to absorb and subsequently emit light (Lakowicz, 
2006). In order to do so, molecules rely on electrons from the outermost electronic 
shell to move to a higher energy level upon absorption of extra energy applied to the 
system, normally in the form of a photon of a specific wavelength (Valeur, 2001).  
 
The phenomenon was first studied in the 16th century (Valeur and Berberan-Santos, 
2011; Acuña et al., 2009) and nowadays fluorescence underpins many research fields, 
including: forensics research (Denny et al., 2018), medical diagnosis (Lombardi et al., 
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2015; Wang et al., 2016), DNA sequencing (Lewis et al., 2005), microscopy and cellular 
imaging (Sanderson et al., 2014), and many more.  
Briefly, fluorescence can be generally described as a three-step process: 
fluorophore excitation and photon absorption, fluorescence lifetime, and, emission of 
absorbed photon (Lakowicz, 2006). The classic way to illustrate the processes of 
photon absorption and emission that occur when a molecule is excited is through the 
use of a Jablonski diagram (Berezin and Achilefu, 2010). This energy-level diagram 
depicts the main electronic levels of ground and excited state electrons, and the main 
stages of fluorescence. Refer to Fig. 14 for Jablonski diagram.  
 
Figure 14. Jablosnki diagram illustrating the basic principle of fluorescence 
spectroscopy and phosphorescence (Figure adapted from Lakowicz, 2006). S,T, singlet 
and triplet electron states, respectively. The magenta, orange, and green arrows illustrate 
energy absorption, emission through fluorescence, and emission through phosphorescence, 
respectively.  Molecules in the ground state (S0) transition to higher energetic levels or 
excited states (S1 or S2) following absorption of energy. Due to processes such as internal 
conversion, some of the initial energy is lost before the electrons return to the ground state 
from the lowest energetic state of the excited state (S10). Intersystem crossing may also 
occur, whereby electrons undergo spin conversion and transition to the triplet electronic 




An external source is employed to generate a photon of energy (hJex), which gets 
absorbed by a fluorophore allowing it to transition from a ground electronic state (S0) 
to a higher vibrational state of either S1 or S2, known as the excited state (Lakowicz, 
2006; Berezin and Achilefu, 2010). See Figure 14 for details of various electronic states.   
Electronic levels of molecules are comprised of vibrational and rotational levels, 
denoted with 0,1,2 in Fig. 14. The ability of molecules to absorb and emit light and 
populate electronic excited states relies on the source of external energy emitting a 
photon with an energy that matches the energy difference between the different 
electronic states (S0,S1,S2) in order for electronic transition to occur (Lakowicz, 2006).  
 
 
Figure 15. Electronic ground and excited states and corresponding electron spins. The 
arrows illustrate the electron spins for different energetic states, in accordance to Pauli’s 
exclusion principle (Pauli, 1946). When an external energy force is applied, the electron spins 
change and will end up either parallel or antiparallel to the direction of the force ((Galitski 
and Spielman, 2013; Kleinpoppen and Becker, 1999).  The antiparallel state is also known as 
the singlet (S) state, as the total spin number is zero. The ground state of the majority of 
organic molecules will be a singlet state, from which excitation will usually occur(Lakowicz, 
2006; Chen et al., 2017).  
 
2.2.2 Fluorescence Lifetime 
The fluorescence lifetime is the ability of fluorophores to stay in the excited 
state before losing the excess energy and emitting the absorbed photon, subsequently 
returning to the ground state (Lakowicz, 2006).  The fluorescence lifetime is highly 
dependent on the quantum yield (j) of the fluorophore, that is the proportion of 
photons emitted vs photons absorbed (Laverdant et al., 2011; Lakowicz, 2006). 
Different fluorophores will have different fluorescence lifetimes due to: intrinsic 
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properties of the fluorophores (Szabó et al., 2018), temperature (Vyšniauskas et al., 
2015), viscosity and polarity variations (Pant et al., 1995), type of solvent (Magde et 
al., 1999), as well as presence of other molecules in the environment, known as 
quenchers, which can act to decrease fluorescence lifetime (Lakowicz and Weber, 
1973). Additionally, the fluorophore concentration may also lead to a reduction in the 
fluorescence lifetime. This is due to the inner filter effect, a process where the emitted 
photon is re-absorbed by fluorophore molecules instead of being emitted, or the 
concentration of fluorophore is so high that it hinders the detection of the emitted 
photon (Van De Weert and Stella, 2011).  
 
Following excitation and transition to higher electronic levels, in the majority of cases 
due to events such as internal conversion, excited molecules will rapidly relax to the 
lowest vibrational level of S1.  This process is usually on the scale of 10-12 seconds, 
whilst fluorescence lifetime typically requires ~10-8 seconds (Shanker and Bane, 2008). 
As a consequence, emission will occur from the lowest energy level of S1 (Lakowicz, 
2006). Another possible transition from the S1 state is towards the excited triplet state 
(T1 ), in a process called inter-system crossing (Lakowicz, 2006).  This is a complex 
transition and requires the electrons to undergo spin conversion (due to the 
differences in electron spin state between the S and T states) (Chan et al., 2017). The 
emission of a photon from this state is called phosphorescence, and is not often 
observed in organic compound (Lakowicz, 2006). In addition to inter-system crossing 
and internal conversion, S states may also be subjected to other processes by which 
energy loss can occur. In some instances, energy transfer between molecules in close 
proximity can be observed (Shanker and Bane, 2008). It this case it is possible for the 
energy from one excited state molecule (known as donor molecule) to be transferred 
to the neighbouring molecule (known as acceptor molecule), thus causing the latter to 
transition to an excited state (Ma et al., 2014). This process is called Fluorescence 
resonance energy transfer (FRET) or Förster resonance energy transfer, and in this 
instance, no emission or absorption occurs; instead, the energy transfer is achieved 
through coupling of donor and acceptor dipole moments (Förster, 1948). This is 
observed in nature in photosynthesis, a process where light is captured by specialised 
cells and subsequently transferred to chlorophylls, in an important process of plant 
 40 
metabolism (Johnson, 2016). FRET can also be applied to studying molecular 
interactions (Ma et al., 2014), to the design of chemical or biochemical sensors and is 
often used in combination with other techniques (Chen et al., 2013; Sekar and 
Periasamy, 2003).  
2.2.3 Emission 
The last stage of fluorescence is the emission of a photon (hJEM) and return of 
fluorophore electrons to the ground state.  Due to the energy loss during fluorescence 
lifetime, hJEM photons will have a lower energy than hJEX photons and therefore be at 
a longer wavelength (Lakowicz, 2006). This phenomenon is called Stokes shift or Stokes 
law, named after Sir. G. G. Stokes who was the first to report this phenomenon in 1852 
using quinine fluorescence (Stokes, 1852).  This is often observed due the emission and 
excitation spectra of different fluorophores not overlapping, but rather being mirror 
images of each other (Voet and Voet, 2011). This is due to the similar distance 
between the electronic levels of the ground and excited states, compared to the 
reduced distances between the excited levels themselves, i.e., S1 and S2 (Lakowicz, 
2006).  
2.3 Fluorescence fundamental principles  
 
Fluorescence is governed by two fundamental rules, which include Stokes shift 
and Kasha’s rule.  The first rule, Stokes law (or Stokes shift) shows that emission of a 
photon will always occur at longer wavelengths compared to the excitation 
wavelength (Stokes, 1852), as a result of a combination of processes whereby some of 
the initial photon energy is lost (Lakowicz, 2006). Various fluorophores and 
chromophores display different Stokes shift, depending on: their rigidity (Piatkevich et 
al., 2013; Abbyad et al., 2007), their dipole moments (the overall electronic 
displacement of the molecule following excitation) (Stopel et al., 2014), the polarity of 
the environment the fluorophore is in (Haidekker et al., 2005), temperature (Sasaki et 
al., 2003; Watanabe et al., 2017) and pH (Abbyad et al., 2007; Baruah et al., 2006). The 
Stokes shift phenomenon is seen in many fluorophores as well as in proteins, with 
Stokes shift spectroscopy having many applications, including in cellular imaging (Gao 
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et al., 2017) and potentially even for biomedical research in cancer fingerprinting and 
detection (Pu et al., 2013).  
A second characteristic of fluorescence is the fact that emission spectra do not 
depend on the excitation wavelength, a phenomenon known as Kasha’s rule (Kasha, 
1950). Due to the Stokes shift, emission will always occur from the lowest level of the 
S1 state, and thus is independent of the excitation wavelength, as described previously. 
This is sometimes also referred to as the Kasha-Vavilov rule, as Vavilov showed that 
fluorescence quantum yields are also not influenced by the excitation wavelength 
(Birks, 1971; Lakowicz, 2006). 
 
2.3.1 Exceptions: Inhomogenous Broadening of Spectra  
Inhomogenous broadening of spectra is an optical phenomenon whereby as the 
excitation energy shift to higher wavelengths, the same can be observed for the 
emission spectra (Azumi et al., 1976; Itoh and Azumi, 1973; Itoh and Azumi, 1975).  
This is known as the red edge excitation shift (REES) phenomenon and has been 
reported to occur in fluorophores located in polar or viscous environments (Azumi et 
al., 1976; Itoh and Azumi, 1973; Itoh and Azumi, 1975). REES can be explained 
photophysically by the presence of different relaxation rates for the fluorophore and 
the environment upon excitation. If the time required for the newly excited 
fluorophore to undergo dipole reorganisation and relaxation is slower than that of the 
environment in which it is, emission is observed from a higher energy excited 
fluorophore instead of the relaxed state (Demchenko, 2002).  See Figure 16 for 




Figure 16. Jablosnki diagram showing the red edge excitation shift (REES) 
phenomenon. tR, tF, relaxation time and fluorescence time, respectively. The magenta, 
orange, and green arrows illustrate energy absorption, emission through fluorescence, and 
emission through phosphorescence, respectively. Green and brown arrows show the dipole 
moment of the fluorophore and environment, respectively.   
 
Essentially, the REES effect reports on the interactions between the fluorophore and 
its environment. If the relation rates of the environment are slower than that of the 
fluorophore, when the fluorophore returns to the ground state upon emission, the 
environment will be different to that of the initial ground state. This is because the 
environment relaxation rates are slower compared to the fluorophore, and the new 
ground state when photoselected during further excitation will give rise to 
Inhomogenous  broadening of spectra as a result of different relaxation rates and 
dipole-moments reorganisation following excitation.  
The REES effect is strongly dependent on the interaction between solvent and 
fluorophore and can be used to photoselect for various fluorophore: environment 
conformations which possess different energetic requirements (Demchenko, 2002; 
Itoh and Azumi, 1975).  Although initially reported in 1973 (Itoh and Azumi, 1973), 
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REES has only more recently become a useful tool in studying protein dynamics and 
conformational change (Haldar et al., 2011; Chakraborty and Chattopadhyay, 2017).  
2.4 Fluorescence in proteins  
 
There are two categories of fluorophores: intrinsic (naturally occurring fluorophores) 
and extrinsic, a class of compounds that need to be added to desired samples to aid 
fluorescence (Lakowicz, 2006). The major contributor to protein fluorescence is the 
indole group (Teale and Weber, 1957). See Figure 16 for indole structure.  
 
 
Figure 17. Structure of indole group. 
 
This molecule is excited by light at 280 nm wavelength and will emit in the 340 nm 
wavelength region (Lakowicz, 2006).  Due to its sensitivity to the environment, 
fluorescence of the indole group is often used as a probe for protein research 
(Ghisaidoobe and Chung, 2014). The emission of the indole group has been reported at 
higher energies (or lower wavelengths) in the compact structures of folded proteins 
(known as a blue-shifted emission), whereas the solvent exposed backbone of 
denatured proteins contributes to a lower energy emission (or higher wavelengths), a 
process known as red-shifted emission (Lakowicz, 2006). 
 
In proteins, three naturally occurring fluorophores exist: tryptophan, tyrosine and 
phenylalanine (refer to Figure 18 for amino acid structures). However, only tryptophan 
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possesses the indole ring, and as such is the most commonly used in fluorescent 
studies, also due to its sensitivity to the environment solvation and polarity (Lakowicz, 
2006). Phenylalanine and tyrosine are not often used as intrinsic fluorophores due to 
their low quantum yield and quenched emission, respectively (Munishkina and Fink, 
2007).  This is mainly attributable to the different photophysical properties of the 
three amino acids, with the asymmetric indole ring of tryptophan allowing for a 
greater electronic redistribution upon excitation, a phenomenon not observed for 
tyrosine and phenyl-alanine fluorescence (Teale and Weber, 1957).  
 
 
Figure 18. Structures of aromatic amino acids. 
 
In addition to amino acids, other cellular components also contribute to the intrinsic 
biological fluorescence, and these include: elastin (Deyl et al., 1980), collagen (Menter, 
2006), nicotinamide dinucleotide (NADH) (Aubin, 1979) and flavins (Benson et al., 
1979).  
 
Changes in spectroscopic characteristics of fluorophores such as intensity of the 
fluorescence emission, modulation of the fluorescence spectra, fluorescence lifetime, 
fluorophore quenching and others are quantifiable variables that allow fluorescence to 
be combined with a number of other techniques to offer detailed descriptions of 
protein behaviours. Some of these techniques include: fluorescence anisotropy (allows 
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for detection of changes in fluorophore between during excitation and emission) 
(Gijsbers et al., 2016), fluorescence quenching (monitoring of protein binding and 
conformational change) (Mátyus et al., 2006), FRET (analysis of protein complexes and 
protein dynamics) (Ma et al., 2014). Fluorescence is a very versatile and information 
rich technique and thus used frequently in characterisation studies of proteins. 
3. Hydrostatic pressure and temperature perturbations to study protein  
conformational change  
 
Pressure and temperature have traditionally been used to study protein denaturation, 
the first ever such studies dating back to 1914 (Bridgman, 1914). Over the last 30 
years, pressure perturbations have become commonly used in association with other 
techniques, such as nuclear magnetic resonance spectroscopy (Roche et al., 2015), 
infrared spectroscopy (Liu et al., 2014), stopped flow (Luong and Winter, 2015), 
fluorescence spectroscopy (Dang et al., 2012), molecular dynamics simulations (Golub 
et al., 2017), to obtain information beyond the denaturing role of pressure and thus 
answer questions about protein structure, function, and dynamics.  
 
Proteins respond to the presence of a perturbant in the environment following Le 
Chatelier’s principle. Thus, with increasing pressure, the equilibrium of a system will 
shift in such a way as to minimise the effect of the perturbant. For proteins, this means 
that an increase in pressure will promote a conformational shift to more compact 
protein conformations (Akasaka, 2006). These changes can be described using the 
following equation [Eq.1]:  
∆𝑮 = 	−𝑹𝑻𝒍𝒏𝑲 = ∆𝑬 + 𝑷∆𝑽 − 𝐓∆𝐒																										[𝒆𝒒. 𝟏] 
 
where, DG, DE, ∆V, ∆S, are changes: in Gibbs free energy, internal energy, volume, and 
entropy, respectively, and R, T, K, P represent the gas constant, temperature, 
equilibrium constant, and pressure, respectively.   
Similarly, an increase in temperature for proteins results in the system reacting in such 










where, ∆𝐻, ∆𝑆, R, T, K are enthalpy change, entropy change, universal gas constant, 
and equilibrium constant, respectively.  
 
Here, the effect of temperature on the system in accordance with Le Chatelier’s is 
observed on the equilibrium constant of the reaction. In the case of protein structure, 
the equilibrium between native and unfolded states is affected by changes in 
temperature (Campbell, 1985).  
3.1 Thermodynamic effects of pressure and temperature  
 
The primary structures of most proteins will not be affected by pressures lower 
than 10kbar, as they are mainly stabilised by covalent bonds (Mozhaev et al., 1996); 
higher order oligomers are sensitive to pressures over 3 kbar (Royer, 2005). Similarly, 
protein secondary structures are often insensitive to pressures of up to 3 kbar 
(Iwadate et al., 2001; Lerch et al., 2015), with most proteins denaturing at pressures 
between 4-10 kbar (Mozhaev et al., 1996; Oliveira et al., 1994; Ruan et al., 2001; 
Herberhold et al., 2003; Kamatari et al., 2004) . Non-covalent interactions are most 
sensitive to pressure changes, as they are major contributors to protein stability (Nick 
Pace et al., 2014; Černý and Hobza, 2007).   
 
Under the effect of pressure, proteins will adopt more compact conformations, in 
accordance with Le Chatelier’s principle. This is governed by a variety of the 
thermodynamics parameters including changes in: enthalpy (ΔH), entropy (ΔS), 
compressibility (Δβ), expansivity (Δα), heat capacity (ΔCp), and specific volume (ΔV).  
 
Specific volume or partial molar volume refers to the space occupied by the protein, 
internal cavities and solvation envelope included (V=Vprotein+Vvoid+Vsolvent) (Akasaka, 
2006); this will be different for each different protein conformation, especially varying 
between the native state and unfolded state. The differences in the specific volume 
arise mostly due to hydration changes and packaging of protein cavities (Cioni and 
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Gabellieri, 2011). These changes in hydration state and overall volume give an 
explanation to the existence of various protein states, which populate the FEL and can 
be easily accessed using hydrostatic pressure. The major difference between native 
and unfolded protein state is in the hydration state, as unfolded proteins have an 
increased surface area compared to native structures, thus showing an increased 
hydration (Royer 2005).  
 
The magnitude and sign of ΔV are sensitive to pressure and temperature changes, as 
both affect the structure and solvation of proteins. Generally, under denaturing 
pressures, proteins exhibit a positive ΔV at lower pressure and a negative value is seen 
at higher-pressure ranges (Kauzmann, 1987). Similarly, temperature denaturation 
leads to an increase and positive value in ΔV compared to native state (Chen and 
Makhatadze, 2017). Although pressure is largely seen to induce compaction (Akasaka, 
2006), the seemingly contrasting values and sign of ΔV arise due to differences in 
internal voids (Dellarole et al., 2013) and degree of hydration (Royer, 2005).   
 
Thermal expansion coefficient (α) represents the fluctuation in volume of the system 
(solvent included) with respect to temperature (Vasilchuk et al., 2014). The sign and 
value of the expansion coefficient of proteins are sensitive to temperature and 
pressure perturbations. Individual α values for different amino acids have been 
determined experimentally (Lin et al., 2002; Mitra et al., 2006); the general trends 
suggest that at low temperatures, polar residues show positive and increased α values, 
(possibly due to solvent electrostriction). On the other hand, non-polar residues show 
increased and negative values for α at low temperatures; this is thought to arise as a 
result of reorganisation of water molecules (Lin et al., 2002; Mitra et al., 2006).  
 
Thermal compressibility coefficient (β) reports on the changes in the volume of the 
system in response to pressure (Heremans and Smeller, 1998).  
Thermal compressibility can also be used as a probe of the free energy landscape of 
proteins, as it is sensitive to conformational heterogeneity (Frauenfelder et al., 1990). 
Studies show that generally, amino acids possess negative compressibility (Millero et 
al., 1976), due to the differences in compressibility between them and solvent 
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(Kharakoz and Sarvazyan, 1993). However, the presence of protein internal cavities 
negates this, with the overall protein compressibility carrying a positive sign (Kharakoz, 
2000).  Cavities are an important contributor to the compressibility of macromolecular 
structures, and protein compressibility is not often uniform. Computer simulations 
shows that this arises due bigger cavities being more compressible than smaller 
cavities (Paci and Marchi, 1996).  The presence of different secondary structures also 
contribute to uneven compressibility, as helices appear to be less sensitive to pressure 
perturbations compared to non-helical regions (Iwadate et al., 2001) 
 
Thermodynamics defines enthalpy (H) as: 𝐻 = 𝐸 + 𝑃𝑉, where E represents the total 
energy of the system, and PV is the product of the volume of the system and the 
pressure.  
 
Entropy (S) is usually defined as a measure of the level of randomness or disorder in a 
system. For proteins, entropy refers to conformational entropy, reporting on the 






              
In thermodynamics, the Gibbs free energy represents the energy available for the 
system to carry out work. For proteins, the Gibbs free energy is a thermodynamic 
measure of how energetically favourable conformational changes are. Energetically 
favourable conformations are not a measure of probability of conformational changes 
occurring.  
∆𝑮 = 	∆𝑯 − 𝑻∆𝑺																									[𝒆𝒒. 𝟒] 
 
 
Heat capacity (Cp) :The heat capacity is a measure of changes in the entropy and 
enthalpy of the system in response to changes in temperature (Prabhu and Sharp, 
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2005). Heat capacity is perhaps the most information rich parameter, but also the 
most challenging to describe. In protein, the heat capacity is related to changes in 
solvation (Prabhu and Sharp, 2005); covalent and non-covalent interactions are also 
major contributors towards protein Cp (Gómez et al., 1995). As pressure induces 
solvation changes in protein structures, pressure perturbations offer access to 
understanding and measuring the changes in heat capacity that follow the effect of 
pressure. This is important for understanding the nature of the conformational 
observed and the unique behaviour of proteins under pressure and temperature 
perturbations.  
 
3.2 Protein structure and the role of water  
 
Unlike temperature, which changes the internal energy of the system, pressure 
perturbations will only affect the activation volume of the system. This can be 
expressed with the following (Eq.5): 
{
∆𝒍𝒏𝑲




As protein structures cannot be considered independent of their solvation envelope 
and their internal cavities, the fluctuations in the activation volume of the proteins 
when under pressure can be explained to arise because of changes in these two 
features (Levy and Onuchic, 2004). See Figure 19 for schematic.  
 
Figure 19. Representation of protein solvation envelope and internal cavities. The 
cartoon shows a representation of a globular protein (sand colour) with small internal 
cavities where water might be present, the protein hydration shell, as well as the bulk 
solvent around the protein.  
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Water is found both outside the protein, as well as inside protein cores, and it 
has also been shown to aid with protein folding and stabilisation (Huggins, 2016). The 
main role of the solvation envelope is to ensure stability of the protein by promoting 
hydrogen bonding (Shiraga et al., 2016; Levy and Onuchic, 2004). On the other hand, 
water molecules found inside protein cavities assume more ordered configurations, 
with some having been reported to interact with the protein backbone and side chains 
(Martini et al., 2013). Internal cavities are the results of side chain and residues 
packaging during protein folding and are important contributors to stabilising proteins 
(Roche et al., 2012). The molecules in the protein solvation envelope show a different 
behaviour compared to the bulk solvent, having a more dynamic nature, particularly 
important for conformationally dynamic proteins (and their functions) (Fenimore et al., 
2002). 
 
Water from the protein core may be replaced with bulk water, as some amino acids 
can function as a two-way valve, allowing for water exchange between solvent and 
protein, as well as protein core and solvent (Masson et al., 1999). This has been 
reported in the case of human butyrylcholinesterase, where two residues, aspartate-
70 and glutamate-197, were found to contribute to the stabilisation of the protein 
(Masson et al., 1999), by allowing water exchange between solvent Û protein. 
Mutations within the two residues resulted in changes to this, allowing water to move 
in one direction only, from the protein core to the solvent, thus safeguarding access to 
internal cavities (Masson et al., 1999). The diversity of protein primary structure offers 
many explanations for the different pressure effects observed on some proteins.  
3.3 Hydrostatic pressure and protein denaturation 
 
Hydration state changes are the main contributors to protein structure changes 
under pressure. It was initially thought that protein unfolding under the effect of 
pressure resulted as a consequence of water molecules penetrating the protein cores 
(Silva et al., 2014) and inducing denaturation in a similar manner to chemical 
denaturants. Theoretical and experimental data corroborated these findings, 
suggesting that the main contributor to protein denaturation under pressure is the 
relocation of water from the bulk solvent to the protein core, instead of an increase in 
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solvation envelope (Hummer et al., 1998). Increased hydration of the protein core may 
be seen as a contradiction to Le Chatelier’s principle, whereby proteins generally 
become more compact under high pressure. To further investigate this, high-
resolution NMR studies on ubiquitin at pressures of up to 2.5kbar reported no transfer 
of water molecules into protein cavities (Fu et al., 2012). As ubiquitin denatures at 
pressure above 5kbar, it is possible that the protein is initially unaffected by water 
penetration at non-denaturing pressures, with the possibility of it becoming more 
prone to water penetration at higher/denaturing pressures (Day and García, 2008). On 
the other hand, high-pressure crystallography studies of a T4 lysozyme variant 
mutated to contain a substantial hydrophobic cavity reported the presence of water 
molecules inside the cavity at 2kbar pressures (Collins et al., 2005). Pressure 
denaturation of proteins is a complex process, and these studies show the difficulty in 
generalising the effects of pressure in the absence of a full pressure range 
examination.  
 
3.4 Effect of hydrostatic pressure and temperature on protein structures  
 
The pressure ranges at which proteins unfold and the degree of compaction and 
hydration state change will all be protein specific. That proteins undergo compaction 
under the effect of pressure is clearly the result of many contributing factors.  
• Electrostatic interactions  
An increase in pressure promotes disruptions of electrostatic interactions in protein 
molecules (Mozhaev et al., 1996). This is due to breaking of ionic bonds leading to a 
decrease in the overall volume as a result of electrostriction (Heremans and Heremans, 
1989). Disruption of important electrostatic interaction in the active site of 
chymotrypsin under pressure results in the inactivation of the enzyme, with its 
function being restored upon decompression (Heremans and Heremans, 1989). 
However, in the case of glutamate dehydrogenase it was found that electrostatic 
interactions were important contributors towards protein stabilisation during pressure 
perturbations (Sun et al., 2001). In this case, the stabilisation was due to the newly 
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adopted protein conformations not allowing for protein aggregation to occur (Sun et 
al., 2001).  
Electrostatic interactions have been found to contribute positively to protein 
stabilisation in response to thermal increase generally (Okazaki et al., 2012), as 
evidenced by their abundance in thermophilic proteins compared to the mesophillic 
homologues (Xia et al., 2018). However, this stabilisation appears to be sequence 
specific (Ma and Cui, 2006), and is not the sole contributor to protein thermal 
stabilisation (Ji and Liu, 2011).  
• Hydrogen bonds  
In contrast to ionic bonds, pressure has been shows to have stabilising effects on 
hydrogen bonds (Nisius and Grzesiek, 2012). This is thought to arise due to 
compression of protein resulting in reduction of some H-bond lengths (Hua Li et al., 
1998). However, some H-bonds are still sensitive to pressure, as is the case for longer-
range interactions, observed in the structure of pressure-treated ubiquitin (Nisius and 
Grzesiek, 2012). These findings show that the contribution of H-bonds to protein 
stability under pressure is not homogenous, with some being sensitive to pressure 
perturbations.  An increase in temperature has the opposite effect on H-bonds; these 
tend to be destabilised by a thermal increase due to the distances between the atoms 
increasing with an increase in temperature (Nisius and Grzesiek, 2012).  Due to these 
differences, some protein H-bonds are more sensitive to temperature than other, eg. 
residues H-bonded with water will be more sensitive to temperature compared to H-
bonds from the protein core (Baxter and Williamson, 1997).  
 
• Disulphide bonds 
The presence of disulphide bonds in protein structures may help stabilise native 
conformations (Pace et al., 1988). Lysozyme, which has a total of four disulphide 
bonds, is structurally insensitive to increased pressure, with the subsequent 
conformation however showing structural similarity to the native state and being 
stable enough to be observed using NMR measurements (Akasaka, 2003). In contrast, 
the effect of increased pressure on apomyopglobin, a protein with no disulphide bonds 
(but similar in size to lysozyme), leads to a conformational change resulting in a 
unstable protein structure (Kitahara et al., 2002; McCarthy and Grigera, 2006). 
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Disulphide bonds are less sensitive to temperature changes, and as such are often 
used in the thermostabilisation of various protein (Liu et al., 2016; Siddiqui et al., 
2005). 
 
• Oligomers  
Protein oligomers have been found to be sensitive to pressure between 0.3-3 kbar, 
readily dissociating from their supramolecular structures at such pressures (Payens 
and Heremans, 1969; Nieuwenhuysen et al., 1980). Evidence also exists for some 
oligomeric proteins from thermophilic and hyperthemophilic organisms being 
stabilised by pressure (Sun et al., 1999; Michels and Clark, 1997). Factors such as 
increased hydrophobicity and more efficient amino acid packing appear to be 
responsible for stabilisation of these oligomeric proteins (Hei and Clark, 1994). 
Temperature increase leads to an increase of the internal energy of the system, and 
for proteins this means that new conformational states situated higher up on the 
energy landscape can be populated now. As such, oligomerisation and higher order 
fibril formation are observed. In the case of heat shock protein 90 (Hsp90), it was 
found that the rate of oligomerisation increased with an increase in temperature 
(Giese and Vierling, 2002). This is thought to help with the chaperone function of the 
protein (Chadli et al., 2000).  
An increase in α-synuclein oligomerisation and subsequent fibril formation is also 
observed upon an increase in temperature (Bhak et al., 2014).  
3.5 Pressure & temperature- more useful tools than just for protein 
denaturation 
 
The applications of pressure & temperature perturbations to research extend 
beyond using it as a tool to study protein folding/unfolding. Pressure studies can also 
be applied to understanding protein aggregation and misfolding. In the case of 
chemically induced aggregation of rhodanese by urea, dissociation of protein 
aggregates at pressure 2kbar was reported (Gorovits and Horowitz, 1998). In contrast, 
the homodimeric interferon-γ protein forms aggregates following cycles of 
compression and decompression using pressure, an effect that is abrogated by the 
addition of sucrose (an osmolyte) (Webb et al., 2001). Similarly, application of pressure 
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leads to fibril formation in the tumour suppressor protein p53 (Ishimaru et al., 2003). 
p53 in an important target for cancer research, and its interactions NF-κB activator 
have been shown to be required for NF-κB activation under certain stimuli  (Schneider 
et al., 2010). Sucrose shows similar protecting effects against pressure denaturation in 
proteins, promoting more compact conformation and a reduction in DV (Ruan et al., 
2003).  
High pressure has been successfully used in viral research to support 
therapeutic formulations of inactivated viruses (Tian et al., 2000; Pontes et al., 2001) , 
as the use of live viruses still poses immunogenicity and attenuation issues (Minor, 
2015; Bull, 2015). Pressure has also been applied in the food industry for the 
prevention of food-transmitted diseases (Da Poian et al., 1996; Considine et al., 2008). 
Pressure is an attractive option, as it does not introduce any exogenous substances or 
additives to foods, thus also preserving flavours (Considine et al., 2008; Da Poian et al., 
1996).  
 
The application of pressure to study macromolecules offers a plethora of information 
about their structure and dynamics. Traditional structural biology methods pose their 
own limitations to using them to study conformationally heterogeneous proteins. 
Consequently, non-denaturing pressure and temperature perturbation can be 
considered as an attractive alternative.  They offer comprehensive information on the 
free energy of landscape of proteins, which can be used in the design of better 
therapeutics and answering fundamental biological questions.  
 
 
4. Using isothermal calorimetry to study the enzyme  kinetics  
 
 
The canonical NF-κB signalling pathway requires the activation of IKKβ enzyme 
to target NF-κB inhibitors for proteoasomal degradation and thus free the NF-κB 
transcription factors to allow them to initiate DNA regulation (Gilmore, 2006).  
Understanding the initial phosphorylation step has been the topic of much research. In 
particular, understanding the role of NEMO during the IKKβ: IκBα interaction, as the 
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canonical activation is NEMO-dependent. Although NEMO is often assumed to play a 
scaffold, more passive role within the signalling pathway, it is important to determine 
whether its role extends beyond this and its ability to potentially assist in the 
phosphorylation of IκBα.  
4.1 What are enzyme and enzyme catalysed reactions? 
 
Enzymes are an important class of proteins that function to speed up the rate 
of chemical reactions and are thus also called biocatalysts. They are found across all 
kingdoms of life (including viruses) and many important cellular processed require the 
presence of enzymes. Enzymes also play roles in a number of diseases, with many 
being used either as markers or therapeutic targets for various medical conditions (Du 
et al., 2015), and may even be used to help with biofuel production  (Noraini et al., 
2014). 
 
Enzyme-catalysed reactions consist of three main stages: the formation of the enzyme-
substrate complex, product formation, and release [Eq.6]; 
𝑬 + 𝑺	 ⇆ 𝑬𝑺 ⇆ 𝑬𝑷⟶ 𝑬+ 𝑷				[𝒆𝒒. 𝟔]	 
				  
where E,S,P stand for enzyme, substrate, and product, respectively.  
 
The first step relies on molecular recognition between enzymes and their various 
substrates. Although high substrate specificity appears to be an essential step in 
ensuring the formation of the correct enzyme-substrate complex, studies have shown 
that enzymes also display promiscuity, both for the nature of the substrate and type of 
enzymatic reaction catalysed (Pandya et al., 2014; Pabis and Kamerlin, 2016).   
4.2 How do enzymes work? 
 
How enzymes catalyse chemical reactions is still an active topic in biochemistry 
research. Enzyme works to speed up the rate of chemical reactions by lower the 
energy barrier of a reaction, more specifically, lowering the DG‡ (activation energy) of 
the transition state (Voet and Voet, 2011). The mechanisms whereby DG‡ can be 
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lowered include: solvation changes (Warshel et al., 1989), steric reorganisation, 
electrostatic and dipole (re)organisation (Kamerlin et al., 2010; Ariafard and Yates, 
2009). Other catalytic mechanisms of lowering DG‡ also include: acid-base catalysis, 
covalent bond catalysis, and  metal-ion mediated (Voet and Voet, 2011). Combinations 
of experimental and computational methods all demonstrate that the successful role 
of biocatalysts results most probably from a combination of the mentioned 
stabilisation methods (Devi-Kesavan and Gao, 2003; Garcia-Viloca et al., 2004; Náray-
Szabó et al., 2013), rather than one contributing factor. 
4.2.1 Michaelis-Menten kinetics 
 
Michaelis-Menten kinetics is often used to best describe the efficiency of 
enzyme-catalysed reactions. As substrate concentration increases, so does the rate 
until a point is reached- Vmax or the maximum velocity - where all enzyme active sites 
are fully occupied by substrates, and increasing the substrate concentration will no 
longer affect the rate (Voet and Voet, 2011).  This can be defined using the Michaelis-







where, V is the enzyme velocity, Vmax is the maximum enzyme velocity, and Km is the 












where, k1, k-1 are the rate for the forward and the reverse reaction, respectively, and 
k2 is the rate of product formation.  
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From the Michaelis-Menten plot, Km is also the point at which half the enzyme active 
sites are occupied by substrate.  If the concentration of the enzyme is known and the 






         
The turnover rate is expressed in time-1 and is a measure of how many substrate 
molecules each enzyme molecule has converted per unit time. A variety of information 
about the catalytic efficacy of enzymatic reactions can be extracted from the values of 
Km and kcat. A high value for the Km suggests the enzyme has a low affinity for the 
substrate (as the time it takes to reach Vmax will be longer), whereas a small value for 
Km would indicate a high affinity for the substrate (which would decrease the time 
needed for the enzyme to reach Vmax). This is crucial information for the development 
of pharmaceuticals that target enzymatic reaction.  
4.3 Methods to study enzyme kinetics 
 
Traditionally, the way to study enzymes reactions is through the use of 
colorimetric assays and spectroscopy. These methods rely on the ability of a substrate 
to absorb and/or emit light that can be detected using a spectrometer or fluorimeter. 
This technique provides an easy, simple, and cost-effective way of measuring initial 
enzyme kinetics. However, not all enzymes will have a chromophoric or flurophoric 
substrate associated with their reaction. To tackle this, such substrates have been 
coupled to a secondary molecule (usually another enzyme) which will have a 
colourimetric assay associated with its catalytic activity. This technique was first 
proposed by McClure (McClure, 1969) and Easterby (Easterby, 1973) and is now 
commonly used in commercially available enzyme kits, which can easily be added to 
desired enzymes and substrates. These offer quick and cheap ways to analyse enzyme 
kinetics and only require the use of a spectrometer. 
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Chromatography methods such as liquid chromatography in combination with 
mass spectrometry (LC-MS) offer an alternative to labelling and immobilising 
techniques. LC-MS monitors the formation of products from an enzyme reaction by 
detecting their mass and ionisation state and then correlating it to the concentrations 
of starting molecules (Maillard et al., 2013). Whilst informative, some of the concerns 
with using LC-MS include degradation of products and loss of product during sample 
preparation (Chakravarti and Chakravarti, 2015), as well it not being suitable for 
application to continuous enzyme assays.  
 Continuous- or stopped-flow assays can also be used to study enzyme kinetics. 
These offer a tremendous advantage in increased instrument sensitivity and the ability 
to record rates for really fast reaction times (Hartwell and Grudpan, 2012). The basic 
principle relies on the rapid mixing of macromolecules in a mixing chamber and the 
detection of product formation using specialised detectors on a very fast (near 
physiological) timescale (Mitić et al., 2017). These detectors allow for the monitoring 
of the unique spectral fingerprints of molecules to be detected (which includes 
fluorescence or absorption methods). This technique also offers the possibility of 
linking with structural characterisation methods, such as Circular Dichroism, nuclear 
magnetic resonance or pressure perturbations, thus allowing for a detailed 
characterisation of the catalytic reaction. However, continuous – or stopped-flow 
methods require high quantities of samples that can increase the cost of performing 
such experiments.  
More recently, the kinetics of the TEM1 β-lactamase on conversion of a 
fluorogenic substrate CCF2 was monitored in in vivo in live HeLa cells using confocal 
microscopy (Zotter et al., 2017). The authors report the detecting enzyme kinetics in 
live cells for the first time, and also highlight the importance of considering the result 
of in vitro studies that failed to take into account the complexity of the intracellular 
environment. Not all enzyme substrates contain a fluorogenic or chromogenic 
substrate, and as such studying enzyme kinetics through confocal microscopy cannot 
be applied to all systems.  
4.4 The use of isothermal calorimetry to study enzyme kinetics 
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A common trait to all chemical reaction is the presence of heat, and as such 
they are classed as being either exothermic (generating heat) or endothermic 
(absorbing heat). The heat of chemical reactions has been used in calorimetry 
techniques to study protein interactions (Dębowski et al., 2016; Dutta et al., 2015), 
and more recently has also been applied to the understanding of enzyme kinetics (Atri 
et al., 2015).  
Calorimetry has been used as far back as the 1800s, with the first calorimeters 
used to measure metabolic heat produced in rodents (Black and Robinson, 1803). 
Modern calorimeters have been designed to display high levels of sensitivity and are 
coupled with advanced software to aid in the analysis of complex measurements 
(Keller et al., 2012). Consequently, calorimetry measurements have many applications, 
including in therapeutics research (Brower et al., 2010), validation of molecular 
dynamics simulations (Jensen et al., 2010),  in  food science (McRae et al., 2010), 
understanding protein-protein interactions (Long et al., 2010), membrane association 
of proteins (Bartels et al., 2010), and assembly of molecular complexes (Kononenko et 
al., 2010).  
 
The basic principle of isothermal calorimetry relies on small volumes of a molecule of 
interest being injected (known as titrant) at set intervals into a solution of another 
molecule.  Following each addition of the titrant into the sample cell, the heat 
displacement of the reaction is determined for each injection. The power difference 
between the sample cell and a reference cell is then used to analyse the 
thermodynamic events that follow each injection. See Fig. 20 for schematic of a 




Figure 20. Schematic diagram of standard titration calorimeter where temperature is 
kept constant (isothermal calorimeter). Enzyme molecules shown in purple, substrate 
molecules shown in green. Inset, example of thermogram for a typical ITC kinetic 
measurement, where following each injection the return to baseline is not observed (as it 
would be for ITC binding experiments), but instead the power displacement (dQ/dt) is used 
to calculate enzyme rate.  
 
The reference cell is usually filled with a solution of water and is kept at a constant 
temperature throughout the measurement. The sample cell contains one of the 
molecules studied and following addition of titrant the instrument will compensate for 
the heat change, depending on the nature of the reaction (endothermic or 
exothermic). The sample cell is also constantly stirred through the action of the syringe 
to ensure proper dispersal of the titrant.  
 
For binding measurements, a set number of ITC injections of equal volume and equal 
spacing are used, with the first injection being of a small volume and often discarded 
due to potential of leaking of sample during thermal equilibration. Upon completion, a 
thermogram is generated, with each heat peak (positive for exothermic reaction and 
negative for endothermic reactions) corresponding to a single injection. The peaks 
correlate to the power applied by the instrument to ensure the temperature between 
the sample cell and reference cell is kept constant. Integration of these peaks 
generates information about the total the number of binding sites observed and the 
thermodynamics parameters of enthalpy and entropy (which can be used to calculate 
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heat capacity and Gibbs free energies for the binding events) (Lehoczki et al., 2016). 
More recently, isothermal calorimetry has been applied to the study of enzyme 
kinetics (Bianconi, 2007; Rohatgi et al., 2015). Even though it was first used more than 
40 years ago (Spink and Wadsö, 1976), it did not become a common technique to 
study enzymatic reactions until more recently, greatly helped by the development of 
modern instruments and software.  
 
Isothermal calorimetry for the study of enzyme kinetics can be used in two 
different ways, either through a single injection experiment or through multiple 
injections (Atri et al., 2015). The functioning principle is similar to standard calorimetry 
measurements, with the difference being that in the case of kinetics, the 
measurement of instrument power or heat flow relates directly to the reaction rate 
and enthalpy of the experiment (Freyer and Lewis, 2008; Lonhienne et al., 2001).  
Refer to Figure 21 for baseline shift differences in binding vs kinetic measurements 
using ITC.  
 
 
Figure 21. Cartoon of isothermal titration calorimetry baseline in binding 
measurements (A) and enzyme reaction (B). A, A simple binding experiment baseline 
signal returning to initial levels following each injection. B, in an enzyme kinetics experiment 
a baseline shift is observed under steady-state conditions, with changes the thermal power 
(dQ/dT) being used to calculate enzyme rate.  
 
When analysing binding events using ITC, a return to baseline is an indication of stable 
reaction where no baseline drifting due to improper thermal equilibration or presence 
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of buffer contaminants can be detected (Duff, Jr. et al., 2011). However, kinetic 
experiments are more complex, and it has been demonstrated that turnover events 
accompany baseline shifts for each new steady-state (Todd and Gomez, 2001; Rana et 
al., 2016). However, this phenomenon  is only observed in the case of using the 
multiple injection ITC method for enzyme kinetic and is not present in single-injection 
kinetics measurements (Transtrum et al., 2015). This is due to the experimental setup 
differences in between the two methods, where steady-state kinetics are not required 
for the single-injection method.  
In single injection measurements, a single injection (usually containing an 
enzyme solution) is added to the sample cell containing the enzyme of interest, and 
the reaction is monitored for a period of time (Transtrum et al., 2015; Di Trani et al., 
2018). The data generated offer substantial details on the thermodynamics and 
kinetics of the reaction, but are often deemed too complex and require further 
analysis or control experiments (Transtrum et al., 2015; Atri et al., 2015). 
The multiple injection method relies on two experiments being carried out to 
determine enzyme kinetics. The first injection experiment is a simple single injection of 
the substrate into sample cell, to measure the enthalpy of the reaction when the 
substrate was completely used up (Mazzei et al., 2014; Rana et al., 2016). This is 
obtained by integrating the area under the peak (corresponding to the injection) and 
dividing the value by the substrate concentration and the volume of the sample cell 
(Mazzei et al., 2014). Following this, a second experiment is carried out where multiple 
injections of the substrate are used to monitor the heat rate at different substrate 
concentration and the reaction is kept in steady-state (Mazzei et al., 2014). The 
calculated value for DH in the single injection experiment is used to calculate the 
reaction rate from the second experiment following Michaelis-Menten kinetics (Mazzei 
et al., 2014). Whilst the analysis of the obtained isotherm is simpler compared to the 
single-injection technique, the limitations of the multiple injection kinetics relate to 
the high volume of sample required.   
 
Despite the limitations of both techniques, calorimetry is emerging as an attractive 
alternative to many standard spectroscopic assays in the study of enzyme kinetics. Its 
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main advantages include the possibility of testing variable substrate concentration in 
one experiment, as well as no need for colourimetric or isotopic labelling (Noske et al., 
2010). However, complex data analyses and the high volumes of sample are two 




Chapter 3: The red edge excitation shift phenomenon can be used to unmask protein 
structural ensembles: implications for NEMO-ubiquitin interactions 
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Accompanying commentary for chapter 3: 
 
Protein disorder is slowly emerging as a prevalent characteristic of many protein 
families, including proteins involved in signalling networks. Characterising the 
dynamics and structure of disordered proteins/proteins with disordered regions is 
proving challenging using traditional structural methods, as they pose size constraints 
and such proteins are too unstable to be used. As such, techniques that directly report 
on the dynamics of conformational change may employed. One such technique is the 
use of red edge excitation shift (REES) spectroscopy, as it allows for the 
characterisation of the dynamic nature of protein conformational change and can also 
be used to study molecule interactions (Chakraborty and Chattopadhyay, 2017; Haldar 
et al., 2011).  
 
NEMO is an important and medically relevant human protein, responsible for the 
activation of the NF-κB signalling pathway (Gilmore, 2006). NEMO controls the NF-κB 
response to a variety of stimuli, and it does by complex interactions with the IKK 
enzyme complex, specifically the enzyme IKKβ. To date, little consensus exists about 
the structure of NEMO, with new studies suggesting a dynamic protein, capable of 
undergoing conformational change when bound to various ligands (Hauenstein et al., 
2017).  
 
We first established the use of REES as a probe to look at protein conformational 
change, by comparing the spectra of native, thermally denatured and chemically 
denatured protein. Our results showed great differences in the spectra of the three 
samples and validated the sensitivity of the REES probe (a single tryptophan residue 
located at the N-terminus of NEMO) to changes in the environment of the protein. 
Following this, the effect of molecular interaction was monitored using peptide mimics 
of two important in vivo binding partners, NBD as a mimic of the IKKβ enzyme, and 
IκBα as a mimic of the IκBα inhibitor. The results obtained show that the two peptides 
interact with NEMO differently, inducing a more compact NEMO conformation in the 
case of IκBα, whilst binding to NBD result in a more flexible conformation. NEMO 
conformation was also monitored in response to binding to linear poly-ubiquitin chains 
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of various lengths. This is an important interaction, as it thought to be one the main 
events activating cellular NEMO in response to stimuli binding (Napetschnig and Wu, 
2013). Our results show that binding of poly-ubiquitin induced global conformational 
changes in NEMO, and further validate the single tryptophan probe, as the ubiquitin 
binding site is located in the C-terminus, not where the REES probe is. Finally, we also 
show that REES spectroscopy can be coupled with hydrostatic pressure perturbations 
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To understand complex molecular interactions it is necessary to account for molecular 
flexibility and the available equilibrium of conformational states. Only a small number 
of experimental approaches can access such information. Potentially steady-state red 
edge excitation shift (REES) spectroscopy can act as a qualitative metric of changes to 
the protein free energy landscape (FEL) and the equilibrium of conformational states. 
First, we validate this hypothesis using a single Trp containing protein, NF-κB essential 
modulator (NEMO).  We provide detailed evidence from chemical denaturation 
studies, macromolecular crowding studies and the first report of the pressure-
dependence of the REES effect. Combined these data demonstrate that the REES effect 
can report on the ‘ruggedness’ of the FEL and we present a phenomenological model, 
based on realistic physical interpretations, for fitting steady-state REES data to allow 
quantification of this aspect of the REES effect. We test the conceptual framework we 
have developed by correlating findings from NEMO ligand binding studies with the 
REES data in a range of NEMO-ligand binary complexes. Our findings shed light on the 
nature of the interaction between NEMO and poly-ubiquitin, suggesting that NEMO is 
differentially regulated by poly-ubiquitin chain length and that this regulation occurs 
via a modulation of the available equilibrium of conformational states, rather than 
gross structural change. This study therefore demonstrates the potential of REES as a 
powerful tool for tackling contemporary issues in structural biology and biophysics and 












There is an increasing realization that the molecular mechanism of many human 
proteins, particularly those involved in signaling networks, are governed by molecular 
flexibility and protein structural disorder. That is, proteins that mediate multiple 
signaling inputs may fold into ligand specific conformations, providing high specificity 
to a number of structurally dissimilar ligands (Uversky, 2013). Underpinning these 
notions is the free energy landscape (FEL) model of protein structure, which interprets 
molecular heterogeneity (structural disorder and flexibility) as a series of equilibrated 
energetic minima on a multi-dimensional free energy surface (Tsai et al., 2001). 
Proteins that are highly flexible or exist as different discrete conformational states are 
considered to have a rather ‘rugged’ FEL. For signaling proteins, understanding how 
the FEL is altered on ligand binding is key to understanding the molecular mechanism 
of biological signaling networks. 
Detecting ligand induced conformational change (folding) and the relationship to the 
equilibrium of protein conformational states is challenging. EPR (Sobolewska-Stawiarz 
et al., 2014), single molecule (SM) (Laursen et al., 2014; Ferreon et al., 2013), Ion 
mobility mass spectrometry (IM-MS) (Ruotolo et al., 2005) and NMR (Sugase et al., 
2007) studies can be used for this purpose with different levels of resolution. There is 
now evidence that an optical phenomenon called Red Edge Excitation Shift (REES) may 
provide unique information on protein conformational change and the equilibrium of 
conformational states (Chattopadhyay and Haldar, 2014). REES is a phenomenon 
where low energy excitation of a fluorophore leads to a red shift in the maximum of 
the emission intensity, ∆𝜆lffk|.This phenomenon may manifest where there are a 
range of discrete fluorophore solvation states and therefore potentially reflects the 
equilibrium of conformational states that are accessible to a protein (Chattopadhyay 
and Haldar, 2014; Demchenko, 2002). 
The REES effect is governed by interactions between a fluorophore and the 
surrounding solvent in the ground and excited states. REES is observed as a result of 
the change in the dipole moment of the fluorophore following excitation and the 
speed at which solvent reorganisation occurs around the newly excited fluorophore 
(Chattopadhyay and Haldar, 2014; Demchenko, 2002). In a fully solvated environment, 
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the fluorescence lifetime (τF) occurs at higher rates compared to the lifetime of 
environmental relaxation (τS). In this case, the emission wavelength of the 
chromophore is independent of the excitation wavelength. When τF < τS, for example 
in a rigid molecular environment such as some folded protein states, the 
intermolecular interactions between the fluorophore and its environment do not 
change and dipolar relaxation does not occur during fluorescence emission (Weber 
and Shinitzky, 1970; Galley and Purkey, 1970). A consequence of this is that the 
fluorescence emission occurs at higher energy since photons are emitted from the 
excited state instead of a lower energy relaxed state. It is possible to select for 
individual solvation environments within an equilibrium by using low energy excitation 
(photoselection), for example by using lower energy photons or longer wavelengths 
located at the red edge of the excitation spectrum (Chattopadhyay and Mukherjee, 
1999). Excitation at a lower energy selects for fluorophores in a solvent relaxed 
environment, which require less energy to become activated. Experimentally one 
observes a red shift in the emission maximum with respect to excitation wavelength. 
There have been a few reports where emission arising from a single Trp residue gives 
an observable REES effect in the folded and molten globule like states (Kelkar et al., 
2010), while the REES effect disappears or is rather reduced in unfolded states  (Mitra 
et al., 2015; Chattopadhyay et al., 2003). The REES effect is therefore a unique probe 
for proteins with a high degree of molecular flexibility resulting in an ensemble of 
solvent environments around the Trp probe. For proteins, such an ensemble may arise 
from a broad equilibrium of conformational states, such as in molten globule 
intermediates of highly flexible or dynamic proteins (Mitra et al., 2015; Jain et al., 
2013; Rawat et al., 2004). 
NF-κB essential modulator is the key regulatory element in the NF-κB signaling 
pathway, controlling much of the nervous and immune system (Gilmore, 2006). NEMO 
regulates the activity of a kinase, IκB kinase-β (IKK-β), which has a diverse range of 
phosphorylation targets, for example, IκBα (Schröfelbauer et al., 2012), huntingtin 
(Thompson et al., 2009), and insulin receptor 1 (IRS-1) (Nakamori et al., 2006). NEMO 
putatively ensures the specificity of IKK-β for IκBα, by facilitating the recruitment of 
IκBα to the kinase (Schröfelbauer et al., 2012). Subsequent proteoasomal degradation 
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of IκBα then allows the NF-κB complex to enter the nucleus and induce expression of 
pro-inflammatory and anti-apoptotic genes. Despite the importance of NEMO to 
normal human health and disease associated processes, remarkably little is known 
about the molecular mechanism of action of NEMO and, in particular how NEMO is 
able to show specificity to a considerable number of interaction partners (Fenner et 
al., 2010). We have recently provided evidence that NEMO is a flexible protein that 
undergoes ligand specific conformational change, and have hypothesized that the non-
ligand bound protein adopts a broad equilibrium of conformational states (Catici et al., 
2015). We have previously used the emission of NEMO’s single intrinsic Trp residue 
(W6) as a spectroscopic reporter of ligand-induced NEMO conformational change 
(Catici et al., 2015).  
Herein we explore the use of REES spectroscopy to inform on the structural and 
mechanistic determinants of NEMO-ligand binding. First, we develop a new framework 
for the quantitative interpretation of steady-state REES data, validated by folding and 
pressure perturbation studies. This then allows us to use the REES data quantitatively 
for a series of NEMO-ligand bound states. We develop our putative model for the 
molecular mechanism of NEMO’s functional interactions, structure and how this 
connects to the NEMO free energy landscape and conformational change. 
 
Results and Discussion. 
NEMO W6 shows a detectable REES signal. Figure 22 shows the variation in emission 
spectrum (Figure 22A and Figure 22B) and center of spectral mass (CSM) (Figure 23B) 
of NEMO W6 versus excitation wavelength.  
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Figure 22. NEMO W6 REES effect A, Contour plot showing the change in the structure of 
the emissions spectra with increasing 𝝀𝑬𝒙𝒎𝒂𝒙 for NEMO W6 signal. The dashed white line 
shows the change in the 𝝀𝑬𝒎𝒎𝒂𝒙	for each emission spectrum and is to aid the eye only. B, 
Relative change the intensity of W6 emission (𝝀𝑬𝒎𝒎𝒂𝒙 shown as a dashed red line to aid the 
eye) for increasing 𝝀𝑬𝒙𝒎𝒂𝒙. Inset, the corresponding change in CSM with 𝝀𝑬𝒙𝒎𝒂𝒙 calculated from 
Eq. 11. Solid line is the fit to Eq. 11. The data plotted are the average of n=3 experimental 
repeats. All measurements were performed at 10° C.  
	
Typically, the magnitude of the steady-state REES phenomenon is reported as the 
simple difference in CSM or ∆𝜆lffk|. From Figure 22, we observe a notable increase in 
red shift in the emission spectra (compared to other W REES values of 5 nm shift 
(Raghuraman and Chattopadhyay, 2006)), with an increase in CSM of 17.7 nm and an 
increase in ∆𝜆lffk| of 15 nm from λex 292-310 nm. Essentially, the data are treated by 
the linear function: 
CSM = Rλex + CSM0                [eq. 11] 
where R is the REES magnitude expressed as the change in CSM per nm of the 
excitation wavelength, λex. In this model the y-intercept, CSM0, does not have an 
obvious physical meaning and is not typically reported. The solid grey line in Figure 23B 
inset shows the fit of the NEMO REES data to Eq. 11, giving R = 0.96.  
The extracted REES signal with NEMO W6 is notable (17 nm shift) compared to 
other reported values (5 nm shift (Raghuraman and Chattopadhyay, 2006) and is even 
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more relevant given that NEMO W6 is already relatively solvent exposed. NEMO W6 is 
a   class III Trp according to the Burstein classification (Reshetnyak et al., 2001). Class III 
Trp residues are not typically thought to exhibit a detectable REES effect (Demchenko 
and Ladokhin, 1988) due to increased solvent exposure, thus giving rise to an 
essentially single solvated environment. However, we would point to the example of 
denatured spectrin which retains a measurable REES signature, despite being mainly 
solvent exposed (Mitra et al., 2015). These findings have been rationalized as reflecting 
a partially ‘unfolded’ state with residual structure, comparable to a molten globule 
state. We have previously suggested that NEMO is a native molten globule (Catici et 
al., 2015) and so our findings of a 17 nm REES effect for an already red-shifted 
tryptophan are consistent with our previous results of NEMO adopting a molten 
globule-like conformation .Physically, these findings suggest that NEMO adopts a very 
broad equilibrium of conformational states, where there are multiple discrete 
solvation environments for W6; this could arise both from a series of W6 micro-
environments as well as from the stabilization of different Trp rotamers.  
Pan et al have previously demonstrated that even solvent exposed Trp residues 
can display a broad range of ∆𝜆lffk| values, arising from different Trp rotamers (Pan et 
al., 2006)  and calculate a range 344 – 365 nm from molecular dynamics simulations 
for a range of cyclic peptides. This would seem consistent with our data that show a 
similar range of ∆𝜆lffk| values, with the highest value being ∆𝜆lffk|	= 363 nm at λex = 
310 nm. This value is the same as for free Trp in our buffer giving ∆𝜆lffk|	= 363 nm 
(Figure 24), suggesting this excitation wavelength is capturing essentially the most red-
shifted (solvent exposed) conformational state. Further, Maglia et al reported a REES 
effect in a single Trp variant of DD-carboxypeptidase attributable to at least three 
different Trp rotamers (Maglia et al., 2008) . These rotamers may be stabilized through 
differing H-bonding to the Trp amide carbonyl (Xu et al., 2009). As such it is difficult to 
directly separate the contribution of differing Trp rotamers and increased 
conformational heterogeneity of the peptide backbone to the REES signal. Below, we 
explore the contribution of different Trp rotamers to the NEMO REES. 
 An artificial REES effect could arise if there is an observable convolution of our Trp 
signal with the background Tyr signal from NEMO. We excite NEMO from 292 nm 
 75 
upwards specifically so that there is essentially no Tyr emission relative to Trp 
emission. However, we have explored how a small Tyr signal would affect our REES 
data by monitoring the REES data for 10 µM Tyr in buffered solution and subtracting 
this from our NEMO REES data. These data are shown in Figure 23 in detail.  
 
 
Figure 23.Emission spectra of tyrosine and NEMO W6. A, Emission spectra of tyrosine 
and buffer excited at 292 nm. The raw spectra, buffer spectra and difference spectrum are 
show in red, black, and green lines, respectively. B, The emission spectrum of 2 µM NEMO 
and 10 µM tyrosine (from A) excited at 292 nm. The total emission of Tyr is 0.5 % of the total 
NEMO emission. C, The emission spectrum of NEMO excited at 292 nm (black line; left axis) 
and 310 nm (blue line; right axis). The grey and cyan lines show the subtraction of the 
emission spectrum of 10 µM Tyr from the NEMO emission spectra at 292 nm and 310 nm, 
respectively. The red dashed line shows the emission spectrum of L-Trp (excitation at 310 
nm) in the same buffer, with the intensity normalized for comparison. D, The resulting REES 
effect for NEMO (black) and for the Tyr subtracted spectra for 10 µM Tyr (red). All 
measurements were carried out at 10° C. 
	
We find that accounting for the small Tyr signal arising from NEMO’s intrinsic Tyr 
residues gives essentially no difference to our REES data. Further, we have monitored 
the REES signal from a single Tyr containing fragment of Staphylococcus aureus 
complement evasion second immunoglobulin-binding protein Sbi domain III and IV 
that, like NEMO, contains structurally disordered regions (Upadhyay et al., 2008). 
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These data are shown in Figure 24. We do not find a detectable REES signal arising 
from Tyr emission as is expected because of the symmetrical nature of the Tyr ring 
system (0 nm shift). Together, these data demonstrate that the signal we monitor, as 
expected, arises essentially entirely from NEMO’s single intrinsic Trp. 
 
Figure 24. Sbi does not display a detectable REES effect. A, Contour plot showing the 
change in the structure of the emissions spectra with increasing 𝝀𝑬𝒙𝒎𝒂𝒙. The dashed white line 
shows the change in the 𝝀𝑬𝒎𝒎𝒂𝒙	for each emission spectrum to aid the eye only. B, Relative 
change the intensity of W6 emission (𝝀𝑬𝒎𝒎𝒂𝒙 shown as a dashed black lineto aid the eye for 
increasing 𝝀𝑬𝒙𝒎𝒂𝒙. Inset, the corresponding change in CSM with 𝝀𝑬𝒙𝒎𝒂𝒙 calculated from Eq. 11. 
Solid line is the fit to Eq.11.	 
	
Establishing a quantitative analysis of REES data. The fit of our REES data to Eq.11 is 
poor and does not account for the curvature in the data. This is the case for all 
reported steady-state REES data where a high number of data point are collected (12-
20 data points). For REES data to be used in comparative studies, the reporting of R in 
Eq. 11 will therefore be wildly inaccurate. To identify a numerical model that would 
best fit these data we have measured the change in the CSM of NEMO Trp emission 
across an extended range of Trp absorption (shown in Figure 26), incorporating the 
emission maximum of the Trp. The REES effect should be detectable at the far-red 
edge of the absorption spectrum, with little or no effect at the absorption maximum, 
since photoselection and hence REES will only occur under low energy excitation. From 
Figure 25, this trend is apparent.	 
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Figure 25. A phenomenological model to fit REES data. The excitation spectrum of 
NEMO W6 (emission at 348 nm) is shown as a grey line (right-hand axis) across an extended 
wavelength range. The variation in CSM with 𝝀𝑬𝒙𝒎𝒂𝒙 for NEMO W6 is shown as black circles 
(lef-hand axis) and the solid line is the fit to Eq. 12 but with a sum of two Gaussians to 
capture the ascending and descending limb of the REES data. 
	
That is, we observe little or no REES effect occurring at the maximum of the excitation 
spectrum but a measurable REES effect at the red edge of the spectrum (17 nm shift in 
emission). We note that the observed changes in CSM are dominated by NEMO’s 
intrinsic Trp residue and not convolved of contributions from Tyr emission since we 
have shown above that, consistent with theory, Tyr emission does not give a 
measurable REES effect and does not convolute our REES data (Figure 23). Indeed, we 
monitor emission from λEx = 292 nm, where there is essentially no emission 
attributable to tyrosine as shown in Figure 24. 
We find that the REES data in Figure 25 can be best represented by a Gaussian 
probability distribution of the form: 







Where A is the area, w is the full width at half-maximal (fwhm), m is the mid-point and 
R0 is the y-intercept and m = 𝜆?llAfk| , where 𝜆?llAfk|  is the excitation wavelength that 
gives the most notable change in the emission peak wavelength. The data in Figure 25 
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are fit to Eq. 12 and illustrate the low energy excitation at the red edge of the protein 
absorption spectrum. The fit of Eq. 12 to the experimental data is excellent and 
captures the expected relationship we describe above.  
Potentially, the magnitude of A extracted from fitting Eq. 12 to a plot of 
excitation wavelength versus 𝜆lffk|, can be used as a qualitative comparator to assess 
changes in the extent of the REES phenomenon. The magnitude of R0 should represent 
the minimum 𝜆lffk|  value, in the absence of the REES effect. This magnitude is 
commonly used to reflect the degree of solvent exposure of Trp residues and can be 
used as a metric of folded/unfolded states. We discuss the interpretation of these 
values in more detail below. This simple model clearly neglects a range of contributing 
factors such as the proportion of excited molecules, the small contribution from 
changing excitation energy at different excitation wavelengths, the number of discrete 
conformational states that are photo-selectable and the contribution from dipole 
rotation in the excited electronic state. However, Eq. 12, unlike Eq. 11 is based on a 
realistic physical rationale and provides a means to extract meaningful quantitative 
data from the full range of REES data. We note that other distribution functions can 
and have been used in relation to extracting information from spectral features, 
including Lorentz and log-normal distributions (Djikanović et al., 2007; Caarls et al., 
2010). Ultimately, we do not try and accurately recapitulate the absorbance/excitation 
spectrum of the fluorophore but instead wish to have a physically meaningful probe 
beyond the arbitrary use of a simple linear function. 
Validating REES as a quantitative probe of molecular heterogeneity. Having established 
a quantitative model to compare REES data, we now test the hypothesis that REES can 
be used to reflect changes in the equilibrium of protein conformational states. To 
achieve this we monitor the REES effect with both denatured and stabilized NEMO as 
well as pressure-perturbation studies that systematically alter the equilibrium of 






Table 1. Results of fitting NEMO-ligand complex REES data to Eq. 11 and Eq. 12. 
 Aa R0 (nm) Ra 
Native, denatured, crowded  
NEMOnative 1 ± 0.1 363.2 ± 0.19 1 ± 0.13 
NEMOdenat 0.37 ± 0.4 375.0 ± 0.5 0.21 ± 0.01 
NEMO + Sbi (20 
mg/ml) 
2.24 ± 0.51 360.5 ± 0.45 1.07 ± 0.12 
Binding partners   
NEMO + IκBα 0.85 ± 0.04 364.1 ± 0.62 1.35 ± 0.1 
NEMO + NBD-
Phe 
1.33 ± 0.31 363.0 ± 1.5 0.98 ± 0.1 
NEMO + Ub4 0.77 ± 0.05 364.6 ± 0.77 1.06 ± 0.1 
NEMO + Ub10 1.23 ± 0.0.1 362.8 ± 0.25 0.93 ± 0.11 
a, Values are relative to the extracted value for NEMO alone. 
Typically denatured proteins do not give rise to an observable REES effect since the 
peptide backbone will become fully solvent accessible. In this case the solvent 
relaxation will be very rapid, and no REES effect observed, effectively because there is 
one discrete solvation state (fully solvated). We have incubated NEMO in 6M 
guanidine to denature the protein and the corresponding change in the center of 
spectral mass (CSM) versus λex is shown in Figure 26. We favor the use of CSM instead 
of the magnitude of ∆𝜆lffk| as we find this metric gives a more robust REES signal and 
the magnitude of ∆𝜆lffk| may be highly error prone. However, we note the result using 
∆𝜆lffk|  are essentially the same. A decrease and red-shift in Trp emission is typically 




Figure 26. The effect of denaturation and crowding on NEMO REES. The REES data for 
native NEMO (black circles), denatured NEMO (grey circles) and crowded (20mg/ml Sbi) 
NEMO (orange circles) are fit to Eq.12 (solid lines). The inset shows the extracted value of A 
from Eq. 12. The error bars are the standard deviation from 3 measurements. 
	
From Figure 26 the incubation with guanidine has resulted in denaturation of NEMO, 
with a red-shift in CSM giving R0 = 363.2 ± 0.19 nm to R0 = 375 ± 0.5 for the native and 
denatured protein, respectively. Note that this is not the REES effect but reflective of 
the solvent exposure of NEMO W6 on denaturation. The denatured NEMO shows a 
dramatically reduced REES effect. Denatured NEMO shows only a 4 nm shift from λex 
292 to 310 nm and fitting to Eq. 11 gives R = 0.21 ± 0.01 and a relative decrease 
compared to native NEMO of R = 1 ± 0.13. Fitting to Eq.12 also gives a notable 
decrease in the REES effect, A = 0.37 ± 0.4 (compared to A= 1 ± 0.1 for native NEMO). 
The relative change in the REES effect is similar using either approach and this argues 
strongly that our fitting approach using Eq.12 is robust. 
Macromolecular crowding is a key feature of the intracellular milieu arising 
from the very high concentrations of other species in the cytosol. Crowding reduces 
the available solvent for other molecules in solution through the excluded volume 
effect, which effectively increase the concentration of e.g. protein and restricts the 
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accessible conformational states through hard-core repulsions between the crowding 
agent and the protein. Macromolecular crowding can alter protein conformation, 
typically inducing folding and stabilization (Dhar et al., 2010). Crowding therefore 
potentially provides a means to explore the contrasting physical effect of denaturation 
on the REES effect, where the protein is more folded/stabilized. We have used a 
protein as the crowding agent, Sbi (reported above), instead of a synthetic crowding 
agent since protein is much more consistent with the intracellular environment. Sbi 
lacks any intrinsic Trp residues and does not give rise to a REES signal that would 
convolute our NEMO signal (Figure 24). Incubating NEMO with a high concentration of 
Sbi (20 mg/ml) gives a dramatic change to the both the absolute Trp emission and also 
the REES effect as shown in Figure 26. We note that the emission spectra have had the 
signal arising from Sbi subtracted and so there is no contribution from Sbi Tyr 
emission. The emission is blue shifted (R0 = 360.5 ± 0.45  nm) compared to NEMO in 
the absence of Sbi (R0 = 363.2 ± 0.19) and more intense (~1.4 times increased 
emission), suggesting that the NEMO Trp is less solvent exposed and therefore that 
NEMO is more ‘folded’ in the crowded environment. Intriguingly the REES effect is 
much prominent in the crowded environment giving a relative increase in A of 2.24 ± 
0.51, compared to A= 1 ± 0.1 for native NEMO. These data therefore suggest that in a 
crowded environment, more similar to the intracellular milieu, NEMO has a more 
rugged FEL, able to explore a broader range of conformational states than observed in 
dilute buffered solution. This is consistent with findings from other studies, for 
example Dhar et al find the phosphoglycerate kinase shows an increase in 
conformational sampling in a crowded environment (Dhar et al., 2010). This is 
consistent with our putative molecular model of NEMO activity that is based on 
allosterically regulated NEMO conformational change. Below, we consider the 
potential mechanistic role of an increased number of available conformational states 
with respect to ligand interactions.  
Based on our native, denatured and stabilized protein analysis (Figure 26) as 
well as the theoretical basis of the REES effect, the magnitude of REES should be 
sensitive to changes in the number of discrete equilibrium conformational states. 
Testing this hypothesis is challenging since few experimental approaches give a direct 
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window into the equilibrium of conformational states. Non-denaturing pressure 
perturbation is an excellent tool for this purpose since it acts to perturb a pre-existing 
equilibrium of structural states characterized by different energy minima on the 
protein FEL  (Akasaka, 2006) and has been used for this purpose in a number of studies 
(Pudney et al., 2009; Hay et al., 2010; Collins et al., 2011). Crucially pressure, unlike 
temperature, does not alter the internal energy of the system, which might otherwise 
be a confounding factor for REES measurements. The observation of a pressure 
dependence on the REES effect itself would therefore be powerful evidence that REES 
is sensitive to the equilibrium of protein conformational states. 
We have previously found that increasing pressure causes a decrease in W6 
emission, suggesting increased solvent exposure (Catici et al., 2015). This finding is 
corroborated by a red shift in the W6 CSM with increasing pressure (Figure 27A), giving 
an increase of 3.0 nm at λex = 292 nm. The change in the magnitude of the value for 
our CSM this is due to a different spectral window used to calculate the CSM for the 
pressure studies. This was necessary due to the optical setup of the pressure cell. The  
∆𝜆lffk| value of W6 at 1 bar is similar to that reported above, giving ∆𝜆lffk| = 348 nm at 
10 °C, 1 bar and λex = 295 nm. Increasing pressure leads to a higher reported value for 
CSM at higher λex values, giving an increase of 8.9 nm at λex  = 310 nm from 1 to 2000 
bar. These data suggest that the REES effect itself is pressure-dependent. 
 
Figure 27. The REES effect is sensitive to pressure variation. A, Variation in REES with 
increasing pressure. Dashed lines are the fits to Eq.14. B, Comparison of low and high 
pressure REES data for NEMO W6 and free Trp. The data show the difference in CSM (ΔCSM) 
versus pressure. C, The pressure dependence of A extracted from the fits in panel A. The 
dashed line is the fit to Eq.13. 
We note that we do not observe any REES effect with free Trp in buffered solution at 
any pressure (Figure 27B) and the changes we observe are protein specific. Fitting the 
REES data to Eq.13 gives the pressure dependence of A, shown in Figure 27C as the 
change in the fraction of A across the pressure range. The pressure dependence data 
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can be adequately fit to a simple, phenomenological model that implies a single 
transition between two states with changing hydrostatic pressure as used previously 









where Rp = 83.13 cm3 mol-1 bar-1 K-1 when the pressure, p, is measured in bar, K0 is the 
equilibrium constant for the change in the relative population of the ith 
conformational state represented by the magnitude of A from Eq.12, extrapolated to 0 
bar and ΔVA is the apparent difference in the volume associated with this equilibrium 
transition.  
Fitting the data in Figure 28 to Eq.13 gives a negative activation volume ΔV = -
24.7 ± 4.7 cm3 mol-1. We have previously measured ΔV for W6 emission and find (as 
we show here) that the emission decreases across the pressure range giving ΔV = 0.81 
± 0.03 cm3 mol-1 (Catici et al., 2015). The difference in sign is simply attributable to 
relative change in direction of the specific signal. What is important is that the 
magnitude of ΔV changing for REES effect compared to W6 emission. Indeed, this 
magnitude of pressure dependence is more consistent with global metrics of NEMO 
conformational change previously measured using the pressure dependence of 8-
Anilinonaphthalene-1-sulfonic acid (ANS) emission (Catici et al., 2015). The REES signal 
may therefore be reflective of the broader equilibrium of NEMO conformational states 
at sites distal to W6. That is, these two values are not necessarily comparable, 
reflecting different aspects of the W6 molecular environment. The key finding from 
the pressure data in the present context is that the REES effect itself is pressure-
dependent with the magnitude of A increasing with pressure. Given that pressure acts 
to perturb the equilibrium of conformational states, this observation suggests that the 
magnitude of A extracted from Eq.12 is exquisitely sensitive to this equilibrium.   
Our findings from denaturation, pressure and macromolecular crowding 
measurements suggest that the REES effect as monitored by Eq.12, is sensitive to 
changes in the equilibrium of conformational states, e.g. by unfolding (chemical 
denaturation), stabilization/folding (macromolecular crowding) or direct perturbation 
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(pressure). As such, we suggest that the magnitude of the REES effect can be used as a 
proxy for the protein free energy landscape (FEL), reflecting the distribution of discrete 
conformational sub-states. Based on our observations for NEMO REES  and fits from 
Eq.12, we have developed a conceptual framework for interpreting protein REES data, 
shown in Figure 28. Our interpretation of the present data explicitly recognises the 
information content that arises from the curvature of the REES data, unlike other REES 
studies where data are fit to linear models only. Within this framework, the changing 
curvature of the REES data (reflected by the magnitude of A extracted from Eq.12) 
describes the progression to a greater or smaller number of discrete conformational 
states. In other words, this can be seen as changes in the FEL, with the FEL becoming 
more rugged or more flat depending on the change in the curvature of the data. In 
addition the intercept with the y-axis, R0, describes whether the protein tends towards 
a folded or unfolded state, in exactly the same way as per the normal analysis of Trp 
emission in protein folding studies, but with the added benefit that it takes account of 
cases where the peak maximum of the emission band shifts with excitation 
wavelength. It is important to note that the terms folded and unfolded encompass 
more minor conformational changes also. So for highly flexible and dynamic proteins a 
blue shifted CSM may simply reflect a more compact conformational state (as we 
suggest is the case from the crowding experiment shown in Figure 26), without 




Figure 28.Conceptual framework for the interpretation of tryptophan REES data in 
proteins based on NEMO W6 experimental data.  This model for REES data is based on 
the trends observed upon NEMO denaturation and presence of crowder, as seen in Fig 
27.Depenidng on how the CSM plot changes, proteins are thought to transition to a ‘more 
folded’ conformation (flat FEL) upon the CSM becoming more less solvent exposed (lower l 
seen on left axis) vs the proteins transitioning to a ‘less folded’ (rugged FEL) state upon the 
CSM becoming more solvent exposed (higher l seen on left axis).  
It is important to recognize that REES data from protein Trp residues will be 
convolved of the signal arising from different Trp rotamers  (Pan et al., 2006). 
However, our observations suggest that at least for NEMO, the REES signal is not 
convolved of a signal from Trp rotamers. That is, the pressure dependence of the REES 
gives an activation volume  of V= -24.7 ± 4.7 cm3 mol-1, and different when compared 
to values obtained based on Trp emission alone (-1.6 ± 0.4 cm3 mol-1) and more 
consistent with measurements that reflect global NEMO conformational change (Catici 
et al., 2015). Moreover, we demonstrate below that ligand binding at sites that are not 
located near the Trp residue alter the REES signal and this is powerful evidence that 
the NEMO REES signal is dominated by the protein’s global structural ensemble. 
Novel insight from REES on the nature of NEMO allostery and ligand induced 
conformational change. Having established that the REES effect, specifically the use of 
Eq.12, can be used as a proxy for the protein free energy landscape, we now consider 
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how the NEMO REES signal varies upon ligand binding. These data should give more 
direct insight into the mechanism of ligand induced conformational change and the 
relationship to the protein FEL. The REES data for NEMO ligand bound states are 
shown in Figure 29A and 29B with the solid lines representing the fit to Eq.12. The 
resulting extracted values of A from Eq.12 are given in Table 1 and also as an inset bar 
chart in Figure 30. For clarity, we report the relative change in R and A compared to 
NEMO alone, extracted from Eq. 11 and 2, respectively. Figure 30A shows NEMO alone 
and bound to either a peptide mimic of IκBα or IKK-β. The IKKβ peptide (termed the 
NEMO binding domain, NBD) contains two Trp residues and so is not suitable for the 
present study as the signal from the peptide would confound our analysis of the single 
NEMO Trp. Instead we have replaced these Trp residues with a conservative amino 
acid, Phe, and we call this peptide NBD-Phe. We find that this modified peptide binds 
to NEMO, giving a decrease in W6 emission of ~ 50 %. From Table 1 and Figure 30A 
there is a difference in the magnitude of A depending on the ligand bound form of 
NEMO. That is, A decreases on IκBα peptide binding (A = 0.85 ± 0.04) but increases on 
NBD-Phe binding (A = 1.33 ± 0.3). If we fit the ligand binding data shown in Figure 29A 
to the simple linear function described by Eq. 11 we find a different trend. That is, 
from Eq. 13, IκBα peptide binding increases the relative magnitude of the REES effect 
(R = 1.35 ± 0.1) and IKK-β peptide binding gives essentially no change in the relative 
magnitude of the REES effect (R = 0.98 ± 0.1). 
 
Figure 29. Ligand induced conformational change occurs by altering the existing 
equilibrium of NEMO conformational states. A, Change in NEMO W6 REES on binding 
IκBα and IKK-β peptides. Solid line is the fit to Eq.12. Inset the extracted relative magnitude 
of A from the fit. B, Change in NEMO W6 REES on binding different linear poly-ubiquitin 
chains, tetra-ubiquitin (cyan) and deca-ubiquitin (blue). Solid line is the fit to Eq.12. Inset the 
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extracted relative magnitude of A from the fit. The error bars are the standard deviation 
from 3 measurements. 
From Figure 30A it is apparent that the REES data are not equivalent with NEMO 
bound to NBD-Phe and NEMO alone as suggested by the fit to Eq. 11. Instead the 
major difference is in the curvature of the data and this is captured by the use of 
Eq.12. Based on our findings from the pressure data discussed above, we suggest that 
these data reflect a decrease in the number of discrete conformational states on IκBα 
binding, but an increase in the number of discrete conformational states on IKK-β 
binding. This trend is supported by our previous NEMO-ligand binding studies 
monitoring the change in ANS emission (Catici et al., 2015), which suggest the 
exposure of hydrophobic residues on IKK binding and the burying of hydrophobic 
residues on IκBα. 
 
NEMO comprises a specific domain that non-covalently binds poly-ubiquitin. 
We have previously found that binding of long chain-length ‘free’ M1-linked poly-
ubiquitin chains to NEMO allosterically regulates ligand affinity and potentially cellular 
localization based on evidence from stopped-flow and liposome binding assays  (Catici 
et al., 2015). Poly-ubiquitin is found as a range of chain-lengths in the cell and we have 
previously provided evidence from ANS binding studies that NEMO undergoes 
different conformational change depending on the chain-length of non-covalently 
bound poly-ubiquitin (Catici et al., 2015). We have explored the REES effect on NEMO 
W6 in the presence of both short (4-mer; Ub4) and long (10-mer; Ub10) poly-ubiquitin 
chains, shown in Figure 30B. From the resulting values of A, given in Table 1, Ub4 
binding gives a decrease in A (A = 0.77 ± 0.05), but Ub10 gives an increase (A = 1.23 ± 
0.1). A simple linear fit to Eq. 11 suggests no difference in REES with either chain 
length giving R of ~ 1 within error (Table 1), despite obvious differences in the 
curvature of the data sets. The absolute magnitude of the REES difference is small, and 
we would focus on the broad trend we observe that potentially suggests that longer 
chain lengths induce a broader range of accessible NEMO conformational states.  
Based on the most current NEMO structural model the poly-ubiquitin binding 
site is not located near the native Trp residue  (Catici et al., 2015; Bagnéris et al., 
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2015). That we observe a change in the REES effect for this Trp is consistent with the 
notion that poly-ubiquitin binding alters NEMO conformation or dynamics in an 
allosteric fashion. The trend for a decrease in REES with shorter poly-ubiquitin chain 
lengths and an increase at longer chain-lengths mirrors the binding of ANS that we 
have reported previously (Catici et al., 2015). That is, we observe a decrease in ANS 
emission (suggesting burying of hydrophobic residues) at short chain lengths and an 
increase (suggesting exposure of hydrophobic residues) at longer chain lengths. 
Combined, these data suggest that shorter poly-ubiquitin chain lengths may drive 
compaction (burying of hydrophobics and a reduction in the equilibrium of 
conformational states) and longer chain lengths may drive expansion (exposure of 
hydrophobics and an increased equilibrium of conformational states) of NEMO. Our 
REES data further suggest that these changes are not large-scale folding or unfolding 
events since the R0 values (Table 1) are essentially the same. Based on these data we 
hypothesise that the allosteric regulation of NEMO by poly-ubiquitin occurs by 
modulating the available equilibrium of conformational states, rather than gross 
structural change.  
Mechanistic consequences for the NEMO-ubiquitin interaction. There is a great 
deal of contemporary interest in the relationship between the equilibrium of native 
protein conformational states and how this equilibrium changes upon ligand binding 
(Vogt and Di Cera, 2013; Nussinov et al., 2014). Based on insight from our current data, 
we suggest that NEMO predominately utilizes a conformational selection model of 
ligand binding and we show this as a schematic in Figure 30. That is, NEMO adopts a 
range of equilibrated conformational states represented by discrete energetic minima 
on the protein FEL. Ligand binding occurs at one of these pre-existing conformers, 
shifting the equilibrium towards the ligand bound population. For example, as we 
show above, IκBα binding gives a reduction in the number of NEMO conformers, 
implying a less rugged FEL for the binary complex. However, we would extend this 
model to suggest that ligand binding may also induce new conformational states, as 
well as expanding the number of discrete states within the population (a more rugged 
FEL) as with NBD and Ub10. A potential mechanistic rationale for this finding is that the 
new conformational space allows new molecular interactions, not accessible to the 
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non-ligand bound protein alone. Indeed, we have previously found that Ub10 enhances 
the affinity of NEMO for IKK-β and IκBα and promotes liposome association (Catici et 
al., 2015). Based on our present data we would hypothesise that this allosteric effect is 
achieved by exposing new high affinity binding sites or additional binding determinants 
for these species.  
 
Figure 30. A schematic depiction of the putative change in NEMO’s free energy 
landscape on interaction with IKK-β, IκBα and different chain-lengths of poly-
ubiquitin. The black energy (E) barrier (left) represent the small number of discrete 
conformational states, tending towards a single major conformational state (orange circle) 
and the right-hand barrier represent an increased range of discrete conformational states 
(coloured circles). We suggest ligand binding modulates the available equilibrium of 
conformational states and that this acts as part of the molecular control of NEMO’s 
functional interactions. The putative NEMO structure is shown as coloured ribbons (solved 
NEMO structures deposited in the PDB; 3BRV, 3CL3, 2ZVN and 2JVX; adapted from (Catici et 
al., 2015)), connected by regions (dotted lines) which can change conformational state 
depending on the nature of the specific NEMO-ligand complex  
A recent study by Bagnéris et al (Bagnéris et al., 2015) have modeled the NEMO 
structure as a parallel coiled coil and have provided experimental evidence for this 
structural model from PELDOR (pulsed electron double resonance studies). We have 
previously found from far-UV CD studies that NEMO is composed primarily of α-helical 
(~50 %) and random coil (~40%) and our present data suggest that the NEMO structure 
occupies an equilibrium of conformational states. We suggest that these data can be 
resolved by a model where NEMO is in a dynamic equilibrium between well folded 
(coiled coil) and locally unfolded (random coil) states (the dotted connecting lines in 
Figure 31). This dynamic equilibrium can then be differently stabilized on ligand 
binding, with IκBα giving rise to an increased proportion of folded content and IKK-
β/poly-ubiquitin giving more unstructured content. This model would then be 
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Protein expression and purification. Full length human NEMO was expressed and 
purified essentially as described previously (Catici et al., 2015). Purified protein was 
dialysed extensively into a buffer comprising 50 mM Tris-Cl pH 8.0, 50 mM NaCl and 5 
mM DTT. All measurements were made in this buffer unless otherwise stated. IKK-β 
and IκBα peptides were commercially synthesised by Genscript, having a purity of > 98 
% and are of the sequence TALDFSFLQTE and DDRHDSGLDSMKD, respectively. The IKK-
β peptide was modified such that the two native Trp residues were replaced with Phe 
residues. M1-linked poly-ubiquitin was purchased from Viva Bioscience. 
Staphylococcus aureus immune modulator protein fragment Sbi-III-IV K173A was 
expressed and purified essentially as described previously (Upadhyay et al., 2008). 
Protein concentration used was between 1 and 5 μM. Peptide concentrations were 1 
mM and poly-ubiquitin concentrations were 1 μM. 
Red edge excitation and high-pressure measurements. All fluorescence measurements 
were performed using a Perkin Elmer LS50B Luminescence Spectrometer (Perkin 
Elmer, Waltham, MA, USA) connected to a circulating water bath for temperature 
regulation (± 1 °C). Samples were incubated for 5 minutes at the given conditions prior 
to recording measurements. Measurements were performed at 10°C, unless otherwise 
stated. Excitation and emission slit widths were 5 nm except for pressure experiments 
where they were 10 nm. The change in the slit width was required due to the optical 
setup of the pressure cell to ensure a low signal-to-noise for the W6 emission signal. 
For NEMO red edge excitation scans, tryptophan emission was monitored from 325 to 
550 nm. The starting excitation wavelength was 292 nm and  subsequently increased 
in 1nm steps for a total of 19 nm.  For Sbi-III-IV, red edge excitation scans, tyrosine 
emission was monitored from 294 to 400 nm, with the excitation wavelength set at 
274 nm. Similarly, the excitation wavelength was subsequently increased in 1nm steps 
for a total of 19 scans. The corresponding buffer or buffer and ligand control was 
subtracted from the spectra for each experimental condition. Specifically, we note that 
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for the crowding experiment with Sbi, we subtract the emission from the Sbi, so our 
signal is not convolved of Sbi Tyr emission in any way. 
An ISS high-pressure cell (ISS, Champaign, UL, USA), fitted with a custom fiber optic 
mounting to the fluorimeter and connected to a circulating water bath for 
temperature regulation was used to record all high-pressure measurements. For 
NEMO high-pressure red edge excitation measurements, tryptophan emission was 
monitored between 325-450 nm.  
The center of spectral mass (CSM) was calculated using the following equation:  
𝑪𝑺𝑴 =	∑(𝒇𝒊𝒙	𝝀𝑬𝒎)∑(𝒇𝒊)                                  [Eq.14] 
where fi is the measured fluorescence intensity and λem is the emission wavelength. 
We would stress the importance of using a consistent wavelength range when 
reporting CSM data, as the magnitude will be dependent on the wavelength range 
chosen. As such we report the CSM across the emission range 325 – 450 nm or 335 – 
450 nm for pressure experiments. 
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Post-paper discussion:  
 
Here we use REES spectroscopy to study NEMO functional conformational 
change, when bound to peptide mimics of two functional in vivo binding partners.  
 
The peptide corresponding to the NEMO-binding domain of both IKK enzymes (NBD) is 
a target of interest for medical research. NBD has been shown to reduce the activation 
of NF-κB, whilst still allowing a weak NF- κB activity (May et al., 2000). Many 
therapeutic attempts have looked at further characterising the mechanisms by which 
NBD selectively inhibits the activity of NF-κB, including in clinical trials (Habineza 
Ndikuyeze et al., 2014).  In a monkey model of Parkinson’s disease, injections of NBD 
were reported to offer neuroprotection and improved motor functions (Mondal et al., 
2012).  More recently in a murine model of Alzheimer’s disease, the protective role of 
NBD was reported following intranasal administration of the peptide (Rangasamy et 
al., 2015).  In mice, treatment with NBD showed positive results which included: 
reduced levels of NF-κB in the hippocampus, neuroprotection and reduction in the 
detectable levels of amyloid-β, and better neurological functions (Rangasamy et al., 
2015). The promising results of many therapeutic studies using NBD suggest the 
importance of understanding the mechanism by which it modulates NF-κB activity, and 
more specifically understand its interactions with the IKK complex.  Our findings 
highlight the effect of NEMO:NBD interaction, whereby it induces a more dynamic 
conformational change in NEMO. This is potentially an important factor to take into 
consideration when designing NEMO-based therapeutics.  
 
This study also establishes the use of REES spectroscopy to detect protein changes 
following denaturation and molecular interactions, which illustrate the applicability of 
this technique to many protein systems, especially where issues arise due to disorder 
or size limitations. The use NEMO W6 emission for REES spectroscopy has proven be a 
good measure of NEMO global conformational change, which is not limited to the 
immediate environment of the fluorophore. We note that the data in Figure 23B do 
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not show a good fit and could have been refitted using the residuals to confirm that 
the fit is poor. However, this fit is just to guide the reader in observing the curvature of 
the data, and subsequent data fitting and discussion of NEMO REES incorporate a fit to 
capture the curvature of the REES data (eq.12).  
The major advantage of using REES spectroscopy is the ability rapidly and easily 
access information about protein conformation without the need for extrinsic labels.  
Whilst other structural biology techniques such as Hydrogen deuterium exchange 
coupled with mass spectrometry (HDX-MS) and NMR are strong candidates, the 
lengthy experimental times coupled with relatively high protein concentrations 
required for NMR pose considerable risks of proteins undergoing unfolding or 
aggregation during data acquisition. REES measurements do not pose such issues as 
the experimental time requirements for REES measurements require between 10-30 
mins, thus removing any concerns about stability of protein over time. 
In terms of HDX-MS limitations include: poor sequence coverage due to presence of 
multiple disulphide bonds (Wang and Kaltashov, 2014) and gas-phase hydrogen 
scrambling (fast and uncontrolled relocation of the incorporated deuterium among 
backbone and side chains (Rand et al., 2010)).  NEMO has two important disulphide 
bonds, required for dimer formation and activation of the protein (Herscovitch et al., 
2008), and as such HDX-MS analysis of active protein is currently not achievable.  
 
On the other hand, the main limitation of REES in lack of detail on the specific 
of the structural conformational changes observed, as it only conveys information 
about the changes in the solvation around the fluorophore. However, this technique is 
very powerful and sensitive to small changes in the environment: here we present data 
that show that binding of NEMO to a peptide mimic of the IKKβ enzyme (NBD) induces 
a more flexible conformation compared to unbound protein. These findings have 
recently been confirmed using X-ray crystallography and molecular simulations, with 
the authors proposing a structural model for NEMO where the protein exhibits a 
dynamic binding interface and allosteric regulation from ligand binding (Barczewski et 
al., 2019), thus perfectly aligning with the results presented in chapter 3.  
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To our knowledge, this is the only the second study to investigate the effect of 
NEMO interacting with IκBα. Therefore, we can only speculate with regards to the 
functional conformational change observed upon NEMO-ligand binding. IκBα functions 
as an inhibitor of the NF-κB canonical pathway and its interaction with IKKβ results 
with its subsequent degradation and activation of the pathway (Traenckner et al., 
1995). NEMO is known to mediate the interaction between IKKβ and IκBα 
(Schröfelbauer et al., 2012) and so potentially the conformational changes reported 
using REES show that upon binding to IκBα, NEMO undergoes a conformational change 
in preparation for binding to IKKβ.   
 
We have described and analysed the kinetics of NEMO binding to IκBα, NBD, 
and various linear-ubiquitin chains using NEMO W6 fluorescence, ANS fluorescence 
and stopped-flow experiments (Catici et al., 2015).  The results show Kd(app) for various 
NEMO:ligand complexes to be as follows:  NEMO:NBD Kd(app) = 2.0 ± 0.1 mM and 
NEMO:IκBα Kd(app) = 0.6 ± 0.2 mM.  The data show that binding to NBD induces a 
different NEMO conformational change compared to binding to IκBα, both globally 
verified using ANS fluorescence, as well different changes in the local environment of 
the W6 probe (Fig.31B). Stopped-flow binding experiments show a multiphasic trend 
indicative of an increase in the number of conformational substates, with both IκBα 
and NBD present (Fig.31C). These finding corroborate the results presented in Chapter 
3, with binding of these two ligands allowing NEMO to access to more conformational 
states, with differences in their solvation, as shown by the ANS in Figure 31 and W6 
REES data Figure 29.  
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Figure 31. Ligand binding is coupled with NEMO conformational change. Solid lines 
are fits to specific equations, as described previously (Catici et al., 2015). A, Relative 
NEMO W6 and ANS emission upon binding to 25 μg/ml polyubiquitin, linear poly-
ubiquitin chains (monoubiquitin to decaubiquitin). B, Relative NEMO W6 and ANS 
emission upon binding to NBD and IκBα (0- 1.2 mM). C, NEMO conformational 
change following binding to NBD and IκBα (0.5 mM) analysed by stopped-flow. D, 
Concentration dependence of NBD and IκBα (0-1 mM) in the presence and absence 
of 25 μg/ml decaubiquitin. All measurements were carried out at 10 °C. 
 
 
We have previously reported on chain length dependence of ubiquitin and binding to 
NEMO and how binding of ubiquitin induces conformational changes, as well as an 
increase in the affinity of NEMO for NBD and IκBα. In the presence of decaubiquitin, 
NEMO-Ubi10:NBD Kd(app) = 0.01 ± 0.04 mM and NEMO-Ubi10:IκBα Kd(app) = 0.09 ± 0.14 
mM. In the cell, NEMO is activated by binding to ubiquitin in a non-proteolytic manor 
following which NEMO bind to (and possibly activates)  IKKβ (vide infra) (Komander et 
al., 2009). Based on previous reports (Figure 31 (Catici et al., 2015)) and the findings 
presented in Chapter 3, we believe that the conformational changes observed in 
NEMO W6 REES upon binding to tetra- and decaubiquitin potentially allows NEMO 
access to functional conformational substates, not available to the unbound protein. 
Improved affinity for ligand binding further supports ubiquitin acting to ‘prepare’ 
NEMO for specific interactions, such as binding to IKKβ enzyme, for example. However, 
 96 
we can only speculate as to what type of conformational states are available to NEMO 
upon ubiquitin binding, due to the limitation of REES spectroscopy. However, it is 
promising to observe changes in the N-terminus of NEMO (W6 location), upon binding 
of ubiquitin at the C-terminus, indicating that the ligand in capable on induces global 
changes in the structure of NEMO. This was recently confirmed also using SAXS 
measurements (Hauenstein et al., 2017). Based on their structural findings, the 
authors observed that unbound NEMO exists in an ‘auto-inhibited’ state, whereby the 
C-terminus is capable of folding back upon itself, thus masking the ubiquitin binding 
region of NEMO. However, upon binding to ubiquitin, the protein adopts an apo 
conformation, with global conformational changes resulting in the elongation of NEMO 
(Hauenstein et al., 2017). These findings offer structural evidence to support the 
changes a observed for NEMO ANS in the presence of ubiquitin reported in Chapter 3 
(Catici et al., 2016).  
 
In conclusion, monitoring the REES arising from NEMO W6 fluorescence, this study 
offers detailed information of the dynamic nature of NEMO, and allosteric regulation 
following binding to various NF-κB proteins, further evidencing the ability of NEMO to 
undergo functional conformational change. This aligns with the aims of the PhD in 
understanding the nature of the protein conformational observed upon ligand binding 
and the potential functional importance of NEMO-ligand interactions. These results 
can be further tested and validated using SAXS measurements, to confirm the changes 
in protein conformation under the different conditions tested in Chapter 3 and allow 




Chapter 4: Mimicking the intracellular milieu exposes the molecular plasticity of NF-





Accompanying commentary for chapter 4: 
 
We have previously demonstrated the use of non-denaturing hydrostatic 
pressure to monitor NEMO conformational change using an intrinsic fluorophore 
(Catici et al., 2016). Here we demonstrate the use of an extrinsic fluorophore, 1-
anilino-8- naphthalene sulfonate (ANS), to study NEMO conformational change in 
response to pressure and temperature perturbations.  In addition, we also monitor the 
NEMO functional conformational change in response to binding to a peptide mimic of 
the inhibitor IκBα.  
ANS is a frequently used probe in studies focusing on protein conformational 
change (De et al., 2005) membrane compositions (Haynes and Staerk, 1974; Slavík, 
1982), and detection of protein aggregates (Kundu and Guptasarma, 2002; Finke and 
Jennings, 2001). The fluorophore offers a number of advantages such as low quantum 
yield (especially in polar environments) and increased sensitivity to the environment 
(Gasymov and Glasgow, 2007).  
Early research on the photochemistry of ANS suggests that ANS emission is due to the 
presence of two distinct excited electronic states (Kosower and Kanety, 1983; Kosower 
and Huppert, 1986), depending on the polarity of the solvent. In addition, a third 
excited electronic state has been observed in aqueous environments; this allows for 
the solvation of the involving electrons, which return to their ground state without 
emitting any radiation, thus explaining the low quantum yield of the molecule 
(Kosower and Kanety, 1983; Kosower and Huppert, 1986). An increase in ANS quantum 
yield is observed in non-water polar environments, due to the different properties of 
water compared to non-water environments (Moore et al., 1985).  
ANS is thought to interact with proteins non-covalently, with the presence of 
hydrophobic (Stryer, 1965) and charged residues (Schonbrunn et al., 2000) on proteins 
enabling this interaction.  NEMO displays a proportion of ~40% disordered regions 
(Catici et al., 2015), and as ANS was a very suitable probe to use to understand the 
behaviour of the protein in different environments.  
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In this study, we also investigate the effect of the physical parameters of the 
cell on the structure and dynamics of NEMO. These include viscosity, crowding, and 
presence of osmolytes, and their effect was studied on free NEMO, as well as 
NEMO:IκBα bound complex. These are important questions to answer, as more studies 
acknowledge and urge that the effect of the cellular environment not be ignored in 
structural and dynamic studies of macromolecules (Wirth and Gruebele, 2013; 
Monteith et al., 2015). Most in vitro conditions fail to take into account the physical 
parameters of the intracellular milieu, which have been reported to exert an effect on 
protein structure, function, and dynamics.  
 
The distribution of NEMO is the cell is heterogeneous, with the protein found in the 
cytoplasm (Gilmore, 2006), at the cell membrane (Nakamori et al., 2006), and even 
inside the nucleus (Kim et al., 2010). Considering the distribution of NEMO in the cells 
and the lack of consensus on the structure and dynamics of the protein, it is apparent 
that a thorough investigation of the effects of the intracellular milieu on NEMO is 
needed. Pressure and temperature perturbations are a suitable technique to study this 
as it offers detailed thermodynamics of protein conformational change and does not 
pose any size limitations compared to other techniques. We have previously 
established the use of it for monitoring NEMO intrinsic fluorescence and local 
conformational change (Catici et al., 2015). The use of ANS will allow for monitoring of 
the global protein conformational change and thus offer a detailed image of NEMO 
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The intracellular milieu is a complex compartmentalized environment governed by a 
range of different physical factors including high concentrations of macromolecules, 
co-solutes and varying viscosities. Typically, protein structure and intra-molecular 
dynamics are considered in isolation as part of a simple buffered solution. However, 
there is building evidence that the thermodynamics of protein folding and motion can 
be affected by the individual physical factors governing the intracellular environment. 
There is an increasing awareness that protein intra-molecular dynamics, governed by 
the free energy landscape (FEL), are crucial to function. In particular, many signalling 
proteins are thought to be conformationally heterogeneous (flexible) in order to 
mediate multiple different ligand interactions. We wished to explore if the different 
physical factors of the intracellular milieu affected the thermodynamics that govern 
protein flexibility in a relevant model system. We have studied changes to the free 
energy landscape of NF-κB essential modulator (NEMO) under different conditions that 
mimic the intracellular milieu using combined pressure/temperature fluorescence 
studies. These studies allow us to go beyond simplistic descriptions of the FEL in terms 
of enthalpic and entropic contributions and expose the role of more crucial 
thermodynamic parameters such as heat capacity and expansivity. We find that the 
NEMO FEL responds differently to different environmental perturbations and 
dependent on ligand binding. Our data allow us to infer how the NEMO FEL varies in 
different cellular micro-environments and points to the intracellular milieu as an 













Proteins have evolved to fold and function inside a complex and heterogeneous 
cellular environment. There are differences in the concentration of macromolecules 
(Rivas et al., 2004), small organic molecules (osmolytes) (Street et al., 2006)  and 
viscosities (Sekhar et al., 2014) depending on the specific cellular micro-environment 
and cell type (Guigas et al., 2007). These different physical properties have been found 
to affect the structure, function, and dynamics of proteins (Gruebele et al., 2016). Such 
studies point to the importance of protein quinary structure – the variance in structure 
arising through interaction with the solvated environment – in governing the fine 
detail of molecular structure and function (Wirth and Gruebele, 2013).Whilst the 
folded structure of most proteins is considered to be the same in vitro as in vivo 
(Gruebele et al., 2016), notable differences in the thermodynamics of protein folding 
have been elegantly demonstrated primarily by whole-cell NMR studies (Danielsson et 
al., 2015; Schlesinger et al., 2011; Maldonado et al., 2011). These studies suggest that 
the free energy landscape (FEL) - a series of energetic ‘hills and valleys’, separating 
discrete conformational sub-states - may be affected by the different physical factors 
of the intracellular milieu (Cheung et al., 2004).  
 
There is now broad appreciation that the intra-molecular dynamics of proteins is key 
to their normal function (Henzler-Wildman and Kern, 2007). Notionally conformational 
heterogeneity might provide some advantage to molecules that mediate multiple 
ligand interactions, for example those involved in signalling networks (Dunker et al., 
2005). Such conformationally flexible proteins could be described as having a ‘rugged’ 
FEL. In particular, the effect of macromolecular crowding (Stagg et al., 2011; Hong and 
Gierasch, 2010) and the presence of osmolytes (Ferreon et al., 2012) have been 
studied in the context of the protein FEL. These effects alter the hydration state of the 
protein, which also affect normal structure and dynamics (Xu and Cross, 1999; Sage et 
al., 1996; Nakasako et al., 2001; Gallat et al., 2012; Beece et al., 1980). 
Macromolecular crowding gives rise to the excluded volume effect, which disfavours 
protein hydration (Kuznetsova et al., 2014). Similarly, osmolytes can give rise to an 
excluded volume effect or bury their osmophobic backbone in the protein core, which 
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can favour protein hydration (Kumar, 2009; Weatherly and Pielak, 2000). Additionally, 
the presence of other cellular components, including other proteins is also known to 
give rise to viscosity.  Increased viscosity hydrates the protein indirectly, by favourably 
interacting with and stabilizing the protein solvation envelope (Gekko and Timasheff, 
1981). Therefore, the intracellular milieu could potentially affect a proteins FEL 
through subtle changes to protein hydration state.  
NF-κB essential modulator (NEMO) governs much of the human immune and nervous 
response, by regulating the interactions of the NF-κB proteins. Briefly, NF-κB is 
sequestered in the cytoplasm by IκBα. NEMO regulates the activity of the kinase IKK-β, 
which phosphorylates IκBα, targeting it for degradation and thus releasing NF-κB 
(Gilmore, 2006). We have provided evidence that NEMO exists in an equilibrium of 
inter-converting conformational sub-states, characterized by a rugged FEL (Catici et al., 
2015), and that the intrinsic flexibility of NEMO is functionally important (Catici et al., 
2015; Catici et al., 2016). NEMO is found in a range of different intracellular micro-
environments; in the cytoplasm (Gilmore, 2006), nucleus (Kim et al., 2010) and at the 
plasma membrane (Nakamori et al., 2006).  
We hypothesize that the sensitivity of NEMO’s FEL to the intracellular milieu may be so 
important that it affects not just the thermodynamics of protein folding but also the 
thermodynamics of the native dynamics and flexibility. Indeed, we have previously 
found that in the presence of a proteinaceous crowding agent NEMO becomes more 
compact, whilst maintaining its intrinsic flexibility (Catici et al., 2016). Herein we 
combine the power of non-denaturing pressure/temperature (p/T) perturbation to 
examine the effect of the major physical factors of the intracellular milieu (crowding, 
presence of osmolyte, and viscosity) on the NEMO FEL, specifically relating to 
functional protein dynamics. We have opted for p/T studies because this allows us 
access to the full suite of thermodynamic parameters that govern the FEL. Crucially, 
the effects of these parameters are assessed for both ligand bound and unbound 
NEMO. We find that the different physical factors we study affect the FEL of NEMO in 
a condition specific manner, showing sensitivity to either the ligand bound or free 
protein. Given the extreme sensitivity of NEMO’s FEL to the intracellular milieu we 
suggest a model where the different micro-environments of the cell act as an 
additional control parameter in governing the normal functional state of NEMO.  
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Results and Discussion 
NEMO conformational state is affected by a mimicked intracellular milieu. We wish 
to understand how the different physical properties of the intracellular milieu affect 
NEMO conformational dynamics and the local FEL around the native state. To achieve 
this we monitor NEMO conformational change as the change in fluorescence emission 
arising from 1-anilinonaphthalene-8sulfonate (ANS) binding (Qadeer et al., 2012)  as 
we have demonstrated previously (Catici et al., 2016) and used in similar studies. We 
focus our study on the effect of macromolecular crowding [polyethylene glycol (PEG; 
100 g/L, MW 20,000)], and the presence of osmolyte (66 mM Betaine HCl). There are a 
range of potential crowding agents one could use, each with specific caveats, and no 
single crowding agent is ‘optimal’. However, PEG is used very commonly in the 
literature (Samanta et al., 2016). The use of crowding agents can be complex, leading 
to an increase in solution viscosity and also charge interactions (Christiansen et al., 
2013). We therefore also explore the effect of increasing viscosity (30% w/w glycerol; 
2.17 cP at 25 °C) and the presence of the monomeric unit of the crowding agent (100 
g/L ethylene glycol, EG).  These different conditions therefore allow us to mimic the 
intracellular milieu and explore the conformational dynamic and thermodynamics 




Figure 32. Relative emission of ANS following binding to NEMO under different 
conditions. The different conditions are as follows: simple buffer (blue), viscogen/glycerol 
(green), osmolyte/Betaine HCl (yellow), crowder/PEG (red),  monomer/Ethylene glycol 
(purple).  A, Binding of ANS (0-800 µM) to NEMO (25 µM) under the different conditions 
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studied. Relative emission is set to the emission intensity maximum for each condition. Solid 
lines are the fit to a skewed Gaussian function and are to aid the eye of the reader. B, ANS 
(0-100 µM) binding to NEMO (25µM) under the different conditions studied. The solid lines 
are the fit to a simple binding isotherm of the form, E = Emax·[ANS]/K+[ANS]. Where E is the 
relative emission and K is the equilibrium constant for the binding of ANS to NEMO. The 
resulting values of K are given in the inset table. For the PEG data (red) we use a more 
complex function given the apparent sigmoidal nature of the binding in this case; E = 
Emax·[ANS]n/Kn+[ANS]n, which is essentially the form of the Hill equation. 
 
We have used 80 μM ANS for each of the conditions studied since above this 
concentration we observe a decrease in ANS emission (Figure 32A). This is most likely 
attributable to the inner filter effect or direct collisional quenching. Higher 
concentrations than ~80 μM will therefore potentially convolute our data with an 
emission signal that is difficult to account for. Titrating ANS against NEMO under the 
different conditions studied gives an effective equilibrium constant for the binding of 
ANS as shown in Figure 32B. We observe saturation behaviour of the ANS emission in 
the range < ~100 μM ANS, with the extracted equilibrium constants (fitting to a simple 
binding isotherm; Figure 32B) falling in the range K ~ 10-40 μM. We note that this is 
not a true Kd values (rather a Kobs)  as we do not have a full understanding of the 
ANS:NEMO molar equivalent of binding, and as such treat it as equilibrium constant to 
inform on saturating ANS concentrations to use in this study.  
 
 The observation of signal saturation therefore implies we are capturing the ANS 
binding to NEMO under each of the conditions studied by using an ANS concentration 
of 80 μM. Ideally one would like to use an even higher concentration of ANS, but we 
note the limitation placed on the concentration that can be used given the observed 
quenching/inner filter effect for ANS described above (Figure 32A). We do not 
therefore rule out that our signal is convolved of ANS binding to very low affinity sites 
(K > 100 μM). Indeed, at the concentration of ANS we use, we are able to fully 
characterise the relatively ‘complex’ binding interaction in the presence of the 
crowding agent, where the data showing a sigmoidal, not hyperbolic relationship. 
However, we are mindful of the challenges using an extrinsic fluorophore as the 
observed signal and so we focus on the major trends in our data below, not the 
absolute magnitudes of extracted values. 
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Figure 33A shows the difference in ANS emission for the different conditions studied. 
ANS binding is broadly indicative of the exposure of hydrophobic patches on proteins 
(Stryer, 1965). We note that the data are background subtracted in all cases under the 
relevant control conditions and so the signals shown in Figure 32 and 33 arise solely 
from the ANS bound to NEMO. We label each condition as a subscript in the text i.e. 
NEMO in simple buffer, with crowding agent, osmolyte, viscogen and crowding 
monomer as NEMOBuff, NEMOCrowd, NEMOOsm, NEMOVisc, NEMOmono, respectively. From 
Figure 33A, we find that NEMOCrowd and the NEMOOsm give an increase in ANS emission 
compared to NEMOBuff, suggesting these conditions drive NEMO conformational 
change.  Conversely, the control conditions (NEMOVisc and NEMOEG) give essentially no 
change in the absolute magnitude of emission, suggesting any subsequent differences 
in our thermodynamic analysis for free NEMO (vide infra) are not the consequence of 
a different conformational state for these conditions. Figure 33B shows the ANS 
emission data for NEMO bound to a peptide mimic of IκBα, IκBα27-39.  
 
Figure 33. The change in NEMO-ANS emission (under different conditions (A) and 
with ligand bound (B)) and NEMO structures comparison with coiled-coil predictions.  
A,B Values are relative to NEMO alone in simple buffer. NEMO concentration is 25µM and 
ANS concentration is 80 µM. C, Comparison of existing NEMO structures (each construct 
solved in isolation) with coiled-coil prediction. The C-terminal zinc finger is not shown. The 
values under each coloured line represent the calculated Tm for coiled coil breakdown and 
are a relative metric of coiled-coil probability and stability. Colours are to show different Tm 
ranges. The colours of the helices represent different regions of the protein.  
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We use a peptide mimic because the background signal from ANS binding to the 
peptide is small and we subtract this signal in all cases. We have previously studied a 
peptide mimic of the NEMO binding region (NBD) from IKK-β but we found this 
complex was unstable, particularly during our p/T studies (below). The NEMO-IκBα27-39 
complex is stable on the ~days timescale. From Figure 33B, consistent with our 
previous reports (Catici et al., 2016), binding of the IκBα27-39 peptide to NEMO gives a 
decrease in ANS emission of approximately 25%. The magnitude of change is similar 
for all conditions, with the exception for NEMOCrowd which decrease by only ~ 5%. The 
smaller difference in ANS emission with PEG might suggest the presence of the 
crowding agent has affected NEMO-ligand binding. Alternatively, in the ligand bound 
form and in the presence of the crowding agent the breadth of available 
conformational states that NEMO are reduced and differently solvated compared to 
free NEMO or NEMOBuff.  
 
We wish to comment on what kind of conformational change we envisage our data 
represent. We have previously provided evidence that NEMO contains regions of 
structural disorder alongside extensive helical structure. To date, only crystal 
structures of partial constructs have been reported that all form a coiled-coil 
architecture composed of NEMO homodimers as shown in Figure 33C. Evidence from 
EPR studies and modelling based on helical register assignment have developed a 
picture when NEMO forms a rod-like coiled-coil architecture across nearly its entire 
length (Bagnéris et al., 2015). From concentration dependence studies, NEMO has 
been shown to form concentration dependent oligomers (Ivins et al., 2009) and these 
may be functionally relevant in forming lattice-like structures, particularly at the cell 
membrane (Scholefield et al., 2016). The conformational changes we monitor below, 
and in our previous work (Catici et al., 2015), do not appear to be consistent with an 
architecture as immobile as an extended, rod-like coiled-coil. Indeed, a recent small 
angle X-ray scattering (SAXS) model of NEMO, suggests that global conformational 
change is possible (Hauenstein et al., 2017), mediated primarily by unordered loop 
regions (Muñoz and Luis, 1995). We have analysed the NEMO sequence (Figure 33C) 
using tools to detect both predicted helical and coiled coil content, Agadir (Muñoz and 
Serrano, 1995)  and bCIPA (Mason et al., 2006), respectively. It is clear from this 
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sequence analysis that NEMO cannot adopt a purely coiled coil architecture as has 
been hypothesized (Bagnéris et al., 2015). Instead, we suggest three regions of coiled-
coil structure, with predicted Tm values in the 19-37 °C range, consistent with μM 
levels of homodimeric affinity (Wiedersich et al., 2008). These coiled-coil regions are 
interspersed by regions predicted to be disordered or isolated helices. The former are 
consistent Gly / Pro rich regions that are predicted to be non-helical and incapable of 
coiled coil formation. We therefore suggest that the conformational changes we 
monitor represent non-trivial variation in structure including transient unwinding of 
helices and coiled-coil, tertiary structural rearrangement and potentially 
oligomerisation state change (Mason et al., 2006).   
 
 
Probing the NEMO FEL in the mimicked intracellular milieu. The ANS binding data 
suggest changes in NEMO’s environment (specifically those that affect the protein 
hydration state) can indeed affect NEMO conformation. We wish to probe if these 
changes affect the NEMO FEL. Combined pressure/temperature (p/T) denaturation 
studies have been used in a number of cases to extract the complete suite of 
thermodynamic parameters that define the FEL for protein folding, so called elliptical 
phase diagrams (Akasaka, 2006). In the present study we wish to explore the FEL 
specifically relating to native protein conformational change. Non-denaturing 
hydrostatic pressure is an excellent probe of native protein dynamics since it acts by 
perturbing the pre-existing equilibrium of states, favouring more compact 
conformations (Prabhu and Sharp, 2005). Non-denaturing pressure therefore gives 
access to the conformational changes that are natively accessible on the proteins FEL.   
For a simple two state transition, e.g. equilibrium between two conformational sub-
states, the temperature dependence of the equilibrium constant is given by, 
𝒍𝒏𝑲 =
−∆𝑮
𝑹𝑻 											[𝒆𝒒. 𝟏𝟓] 
 
The combined p/T dependence of ΔG is then given by, 
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∆𝑮𝑷,𝑻 = 	∆𝑮𝟎 + ∆𝑽𝟎(𝑷 − 𝑷𝟎) + ∆𝜶(𝑷}𝑷𝟎)(𝑻}𝑻𝟎) +
∆𝜷
𝟐
(𝑷 − 𝑷𝟎)𝟐 − ∆𝑺𝟎(𝑻 − 𝑻𝟎) −
∆𝑪𝑷 𝑻 M𝒍𝒏 M
𝑻
𝑻𝟎
Q − 𝟏Q + 𝑻𝟎															[𝒆𝒒. 𝟏𝟔]       
 
where T0 is a reference temperature. ΔH, ΔS, ΔG0, ΔCp, ΔV0, Δβ and Δα reflect the 
changes in enthalpy, entropy, Gibbs free energy, heat capacity, activation volume, 
compressibility and expansivity between the two notional conformational sub-states 
that define the equilibrium, respectively. Note that this model assumes both ∆Cp and 
Δα are constant with respect to both pressure and temperature, and as such the values 
reported in the study reflect the changes in  ∆Cp and Δα in response to changes in the 
experimental conditions tested (eg. presence of crowder or osmolyte) or in response 
to NEMO ligand binding. Fitting Eq. 16 to a plot of ΔG for a matrix of p/T values will 
therefore yield the breadth of different thermodynamic parameters. The equilibrium 
constant for NEMO conformational change is extracted from the relative change in ANS 





𝟏 + 𝑲(𝒑, 𝑻)															[𝒆𝒒. 𝟏𝟕] 
 
where Fi is the integral of the emission intensity of ANS for a given 
pressure/temperature. These data are used to calculate ΔG (Eq. 15) across the p/T 
matrix and then fit to Eq. 16 to extract the thermodynamic parameters. From Figure 35 
the fits of Eq. 16 to the experimental data are excellent, though given the high 
parameter space of Eq. 16, there are relatively increased error values associated with 
some of the extracted parameters. This is always the case in analyses of this type. That 
said, our data show clear difference, outside of error. For these reasons, we focus on 
the broad trends that allow us to characterise the FEL, namely ΔH, reflecting the 
barrier to conformational change; ΔG0, reflecting the probability of conformational 
change; ΔCp, reflecting the ruggedness of the FEL; and Δα, reflecting changes in 
flexibility and solvation. 
The major contribution to ∆Cp in the case of protein conformational change and 
protein folding is the difference in hydration state between the conformational states 
that are accessed (Prabhu and Sharp, 2005; Cooper et al., 2007). Observing an increase 
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in the values of ∆Cp implies there is change in the distribution of ΔH values and by 
extension a range of barrier heights (governed by the magnitude of ΔH) separating 
discrete conformational states (i.e. a rugged FEL). Studies with model systems have 
found that the magnitude and sign of Δα is sensitive to the solvation environment 
(changes to water structure) and upon ligand binding (Royer, 2005; Mitra et al., 2008). 
Zero values of Δα imply a ‘rigid’ protein (Mitra et al., 2008)  and positive Δα values are 
correlated with exposure of hydrophobic residues (Vasilchuk et al., 2014; Schweiker et 
al., 2009). These concepts are summarised as a cartoon in Figure 34, which links the 
changes in the thermodynamic parameters above and the ‘shape’ of the FEL. We note 
that the experimental error for ΔS and Δβ (below) is substantial and no trends could 
confidently be assigned and so we do not consider the trends of any in these data. 
 
Figure 34. A schematic of how different thermodynamic parameters can be 
envisaged to affect a FEL. The grey line (at left) represents a model FEL where the size of 
the barriers is governed by G, the distribution of minima and their barrier sizes is governed 
by Cp and the hydration states associated with the energetic minima is governed by α. 
Changes to these parameters affect the shape of the FEL. At right, we show the change in the 
distribution of H, TS and V values associated with Cp and Cp/α. In black, a single narrow range 
of H, TS and V values results in low values of Cp and Cp/α. In blue are two interconverting 
states with a high barrier giving increased values of Cp and Cp/α. In yellow are two 
interconverting states with a low barrier which gives an even greater value of Cp and Cp/α.   
 
The p/T matrix of ΔG values for each condition is shown as coloured planes in Figures 
35A-F. Figure 36A-E shows the resulting parameters extracted from the fit to Eq. 16 for 
NEMOBuff, NEMOCrowd, NEMOOsm and the corresponding ligand bound states. The 
parameters for the control conditions NEMOVisc and NEMOEG are shown in 36F-I. All 
extracted values are given in Table 2. A comparison of the values for each extracted 
parameter is shown in Figures 35F-I. 
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Table 2. The extracted parameters from the fits of Eq. 16 to the data in Figure 35. 
 NEMOconc NEMOdil NEMOCrowd NEMOOsm NEMOVisc NEMOmono 
ΔG0 (kJ mol-1)a  
+ ligand  
8.7 ± 0.3 
7.0 ± 1.6 
9.3 ± 0.8 
- 
-0.1 ± 0.8 
8.6 ± 0.4 
10.0 ± 1.3 
13.0 ± 0.8 
8.2 ± 0.2 
11.7 ± 1.2 
11.8 ± 2.1 
9.9 ± 2.3 
ΔV0 (cm3 mol-1) a  
+ligand  
-4.7 ± 1.9 
8.5 ± 9.7 
7.7  ± 3.9 
- 
-15 ± 4.8 
9.9 ± 2.3 
2.9 ± 7.7 
4.5 ± 12.7 
0.8 ± 1.2 
5.2 ± 7.2 
5.5 ± 12.9 
4.2 ± 13.5 
ΔCp (kJ mol-1 K-1)  
+ligand  
0.1 ± 0.4 
-4.1 ± 1.9 
0.5 ± 1.2 
- 
8.6 ± 0.9 
0.5 ± 0.4 
1.5 ± 1.5 
-8.0 ± 1.0 
0.5 ± 0.2 
-3.0 ± 1.4 
-3.0 ± 2.5 
-3.7 ± 2.6 
Δα (K-1)  
+ligand  
0.00 ± 0.05 
0.80 ± 0.34 
-0.08 ± 0.14 
- 
-0.53 ± 0.14 
0.12 ± 0.07 
0.01 ± 0.23 
0.03 ± 0.15 
-0.20 ± 0.03 
0.21 ± 0.21 
0.43 ± 0.37 
0.37 ± 0.39 
ΔCp / Δα (kJ mol-1)  
  
59.4 ± 2600 
-5.1 ± 3.0 
-6.3 ± 19.6 
- 
-16.1 ± 4.6 
4.3 ± 4.4 
15.8 ± 40.1 
-250 ± 1100 
-50 ± 154 
-14.4 ± 16.2 
-7.0 ± 8.5 
-10 ± 12.6 
a, Values reported at 1 bar and 37 °C.   
 
We have previously measured (but not fit) the p/T matrix for a dilute solution of NEMO 
(5 μM) (Catici et al., 2015). Here we use a more concentrated solution (25 μM) to 
ensure we capture a reasonable enough ANS signal for robust analysis, particularly 
since some signal changes are small. NEMO’s oligomeric state is highly concentration 
dependent (Fontan et al., 2007). The ANS p/T matrix is different at different NEMO 
concentrations (Figure 35D), suggesting the oligomeric state affects the 
thermodynamics of conformational change. Indeed, from Table 2 and Figure 36B, we 
find that the magnitude of ΔV0 is negative for the more concentrated NEMO, but 
positive for the dilute NEMO. All other parameters are the same within experimental 
error. These data suggest that oligomerisation state change does not itself affect the 




Figure 35. The combined p/T dependence of NEMO-ANS emission for the range of 
conditions studied. Concentrated NEMOBuff - blue (A), NEMOCrowd - red (B), NEMOOsm - 
yellow (C), dilute NEMOBuff - orange (D), NEMOVisc - green (E) and NEMOmono - purple (F). 




Figure 36.Magnitude of calculated thermodynamics parameters. 	A-E, The magnitude 
of ΔG, ΔCp, ΔV and Δα and ΔCp/Δα, extracted from fits of panels A-C to Eq. 16.  Lines are free 
NEMO, stars are ligand bound. F-I, The magnitude of ΔΔG, ΔΔCP, ΔΔV and ΔΔα, showing the 
differences in ΔG between different conditions relative to NEMObuff. A cartoon depiction of 
the data and how they relate to the shape of the FEL is shown in Figures 36A-F. The colours 
match the colour scheme in Figure 35. 
Based on the relative ANS emission of concentrated NEMO vs more diluted protein, we 
have opted to study the range of conditions mimicking the intra-cellular milieu with the 
higher concentration NEMO, to improve the signal-to-noise ratio of our data. 
Moreover, recent evidence suggests that higher-order oligomers of NEMO are likely to 
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be functionally important (Scholefield et al., 2016; Darwech et al., 2010; Xie et al., 
2012) and so this species seems to be the most relevant to study. From Figure 36 and 
Table 2 there are clearly very important changes in thermodynamics for the different 
conditions studied and with respect to ligand binding.  
 
The detailed description and discussion of the results is below, but to aid the reader 
the major trends are:  
1. IκBα27-39 generally makes ΔCp more negative, for all conditions studied.  
2. The osmolyte has very little effect on any thermodynamic parameter for the 
free NEMO but abrogates the effect of IκBα27-39 biding.  
3. The crowding agent has a profound effect on the thermodynamics of the 
system making ΔG0, ΔV0 and Δα more negative and ΔCp more positive. However, 
IκBα27-39 binding directly inverts these relationships, with a clear effect on both ΔV and 
Δα (see Table 2 for specific values).  
Based on the cartoon in Figure 34, we have summarised these findings and how they 
relate to changes in the FEL shown in Figures 36A-I. From Figure 36G, ligand binding 
appears to primarily affect the magnitude of ΔCp, giving a change from a zero/positive 
value to a negative value.  These data suggest that the free NEMO FEL has a relatively 
narrow distribution of ΔH values, suggesting a relatively restricted range of 
conformational sub-states. On ligand binding, the observation of a negative ΔCp 
suggests a transition to a FEL with a much broader distribution of ΔH values and so a 
broader range of conformational sub-states. That is, the NEMO FEL becomes more 
rugged when bound to the ligand IκBα27-39 (depicted in Figure 37D). For NEMOCrowd, 
NEMOOsm and NEMOVisc we observe an increase in ΔG for the ligand bound NEMO 
(Table 2). Therefore, while ΔCp values argue that ligand binding gives access to more 
conformational substates, the increase in ΔG0 suggests that the change in the height of 
the barriers has now changes such that these conformational changes are 




Figure 37. Cartoon showing the effect of the different conditions studied on the FEL. 
A, NEMOBuff; B, NEMOCrowd; C, NEMOOsm shown as a solid line, compared to NEMOBuff shown 
as a dashed line. D, NEMOBuff-IκBα; E, NEMOCrowd-IκBα27-39; F, NEMOOsm-IκBα27-39 shown as a 
solid line, compared to the same ligand free condition shown as a dashed line. G, Model of 
the effect of variation in intracellular environment on the NEMO FEL. Dashed line is for free 
NEMO, solid line is for IκBα27-39 bound.	
 
These data correlate well with our ANS emission data (Figure 32), where IκBα binding 
decreases ANS emission in all cases, suggesting conformational states with exposed 
hydrophobic residues are more restricted.  PEG is used to mimic the excluded volume 
effect (NEMOCrowd), but will also give rise to an increased solution viscosity (5.25 cP 
(Parker et al., 2010)) and electrostatic effects from the monomeric unit. From Figures 
36F-I, we find that the magnitude of ΔG0, ΔCp, ΔV0 and Δα are essentially the same 
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within error for the viscogen (NEMOVisc) and the PEG monomer (NEMOmono) compared 
to NEMOBuff. That is, changes in solution viscosity and electrostatic effects arising from 
the monomeric unit of PEG are not convolving our NEMOCrowd data and so the effects 
we observe are attributable to the excluded volume effect. We note that the viscosity 
of the glycerol solution will vary with temperature from ~3.5-2 cP across the 
temperature range studied, but the key is that the viscosity is increased relative to 
NEMOBuff (0.9 cP) and is of a similar magnitude to that found in the intracellular milieu 
(Auton et al., 2011) 
 
From Figures 36F-I, NEMOCrowd shows differences outside of error for ΔG0 (ΔΔG0 = -8.8 
± 1.1 kJ mol-1), ΔCp (ΔΔCp = 8.5 ± 1.3 kJ mol-1 K-1), ΔV0 (ΔΔV0 = 10.3 ± 6.7 kJ cm3 mol-1) 
and Δα (ΔΔα = -0.52 ± 0.20 K1). These data suggest a complex change to the NEMO FEL 
driven by the excluded volume effect, depicted in Figure 37B. The decrease in ΔG 
argues for lower barriers between conformational sub-states, suggesting a more 
flexible protein. This is mirrored in the measurably negative Δα value for NEMOCrowd, 
which as we describe above, again would suggest a more flexible protein. The change 
in activation volume from a positive to a negative value suggests the conformational 
sub-states accessible to NEMOCrowd are structurally different. Finally, the positive value 
for ΔCp could be indicative of a change in hydration state consistent with a less 
hydrated protein overall. This interpretation is consistent with the increased exposure 
of hydrophobic residues from our ANS studies (Figure 33A) and also the notional role 
of the excluded volume effect. As we discuss above, ligand binding has a global effect 
on ΔG0 and ΔCp. However, NEMOCrowd-IκBα27-39 shows additional, condition specific 
changes. ΔV0 increases, becoming positive (ΔΔV0 = 25.0 ± 7.1 kJ cm3 mol-1) and Δα 
increases, becoming positive (ΔΔα = 0.65 ± 0.21 K-1). From Figure 36H and 5I the 
increase in ΔV0 and Δα is similar to that observed with NEMOBuff (ΔΔV0 = 13.2 ± 11.5 kJ 
cm3 mol-1 and ΔΔα = 0.80 ± 0.34 K-1). Finally, there is an increase in ΔG0, but we also 
see an increase arising from NEMOVisc-IκBα27-39 and so we do not attribute the effect 
on ΔG0 with NEMOCrowd-IκBα27-39 to the excluded volume effect. In summary, despite 
the observed change to the NEMO FEL for NEMOCrowd, the effect is to some extent 
abrogated on ligand binding, at least with respect to ΔV0 and Δα.  
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Binding of osmolytes has been shown in other systems to alter ΔH and ΔS, indirectly 
stabilising proteins by lowering ΔG0  (Verma et al., 2004). From Figures 36A-E and 
Table 2 there is no difference outside of error between NEMOOsm and NEMOBuff for 
any of the extracted thermodynamic parameters. That is, the NEMO FEL hardly varies 
for NEMOOsm and NEMOBuff (Figure 37C). However, NEMOOsm-IκBα27-39 suppresses the 
effect of ligand binding observed for both NEMOBuff and NEMOCrowd. Instead of 
increases in ΔV and Δα on ligand binding, we find that these parameters become 
invariant within error in the presence of the osmolyte (ΔΔV0 = 4.5 ± 12.7 kJ cm3 mol-1 
and ΔΔα = -0.06 ± 0.37 K-1) shown in Figures 36H and 36I. We find a similar pattern of 
invariance in both ΔV0 and Δα with NEMOVisc (ΔΔV0 = 4.4 ± 8.3 kJ cm3 mol-1 and ΔΔα = -
0.22 ± 0.24 K-1). That is, both the osmolyte and viscogen, which both notionally 
increase the protein hydration state, disrupts the ligand induced changes to the 
NEMO FEL, at least with respect to ΔV0 and Δα. Similar to the crowding agent, both 
the osmolyte and viscogen increase the magnitude of ΔG0 for the ligand bound 
complex (Figure 37F).  
Taken together (as summarised in Figure 37A-F) our study illustrates a complex 
interplay between the different physical factors that govern the intracellular milieu 
and NEMO’s FEL. We do not find that hydration state change associated with the 
osmolyte, viscosity change or the monomer of the crowding agent, have an effect on 
the free NEMO FEL outside of error. The only condition that appears to affect the free 
NEMO FEL (within the error of our measurements) is the presence of a crowding agent 
and specifically the excluded volume effect.  We find that the excluded volume effect 
alters the barrier between different conformational sub-states, giving both a broader 
distribution of states and lower barriers between sub-states, a more ‘rugged’ FEL. That 
is, the excluded volume effect tends to make NEMO more flexible. Similarly, we find 
that ligand binding (IκBα27-39) induces a more rugged FEL, with burying of hydrophobic 
residues. Ligand induced changes to the NEMO FEL are affected by the crowding agent 
only to increase the magnitude of ΔG0. However, both the osmolyte and viscogen 
suppress the effects of ligand binding specifically with respect to changes in ΔV and 
Δα. In summary, the major trends in our data are for desolvation (the excluded volume 
effect) to affect the free NEMO FEL and for solvation (binding of osmolyte and 
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increased viscosity) to affect the ligand bound FEL. These findings are summarised as a 
cartoon in Figure 37.  
 
Conclusions 
 The complexity and ubiquity of the NF-κB signalling pathway means that NEMO 
experiences a variety of cellular environments. The protein is usually found in the 
cytoplasm in unstimulated cells, but also in the nucleus and near the plasma 
membrane (Bicknese et al., 1993). We have previously found evidence for a model 
where free NEMO exists in an equilibrium of conformational states, but ligand binding 
potentially ‘functionalises’ NEMO for subsequent molecular interactions, by inducing 
specific NEMO conformations; with different ligands inducing different conformations, 
thus selecting for different functional conformations (Catici et al., 2015). Our present 
study extends this model, suggesting that the ligand bound NEMO is hyper responsive 
to the intracellular milieu, particularly to solvation state change.  
 
There have been a number of efforts to quantify the viscosity and crowding in 
different sub-cellular locations, broadly studying the nucleus, cytoplasm, near the 
plasma membrane and within the plasma membrane. These data suggest, in a 
simplified scheme (Figure 35) that near the PM (the cytogel), the viscosity is only 
slightly increased than in water (~ 3-4 times higher (Liang et al., 2009)), is higher in  the 
cytoplasm proper (~ double than in water(Auton et al., 2011)) and is relatively higher 
still in the nucleoplasm (~4 times higher than water) (Spitzer and Poolman, 2013; Liang 
et al., 2009). 
 Conversely, the degree of crowding in the cytogel is thought to be extremely high, 
referred to as ‘supercrowded’ (Spitzer and Poolman, 2013), but is rather smaller in 
the cytoplasm and less still in the nucleoplasm (Guigas et al., 2007). Based on this 
simplified model of the cell and our experimental findings regarding the effect of 
crowding and viscosity on NEMO’s FEL, we suggest how the FEL will differ for 
NEMO in different sub-cellular compartments, shown in Figure 37G. Our data 
suggests that at the PM, free NEMO exposes hydrophobic residues and binding to 
IκBα does not affect this. However, away from the PM, in the cyto/nucleoplasm, 
NEMO-IκBα will be relatively flexible, adopting a broad range of conformational 
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states. Potentially the different FEL’s and conformational states ‘prime’ NEMO for 
subsequent molecular interactions, specific to the local cellular micro-
environment. We cannot project how such changes would affect NEMO’s 
functional activity in terms of regulating NF-κB signalling since one cannot 
independently perturb the physical factors we have studied inside the cell. 
However, given our previous findings that NEMO flexibility and conformational 
change are key to ligand binding, the present findings point to the importance of 
understanding these principles when considering NEMO’s intracellular activity. 
 
Given the apparent sensitivity of NEMO’s FEL to hydration-state change, and the 
variable cellular localisation of NEMO, we suggest that the intracellular milieu acts as 
an additional control parameter, ensuring the proper protein conformation is achieved 
and ultimately, proper functioning. In other words, the intracellular milieu is capable of 
modulating the NEMO FEL and allows the protein to explore a number of 
conformational states. We suggest this ensures a fine balance between NEMO 
flexibility, stability, and function is achieved inside the cell.  
 
Materials & Methods 
Protein expression and purification.  Full-length human NEMO was expressed and 
purified using a previously described method (Catici et al., 2015).  Purified protein was 
dialysed in a buffer containing 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM DTT.    
Fluorescence and high-pressure measurements. All fluorescence measurements were 
performed using a Perkin Elmer LS50B Spectrometer (Perkin Elmer, Waltham, MA, 
USA) connected to a circulating water bath for temperature regulation (± 1 °C). All 
pressure measurements were performed using an ISS high pressure cell (ISS, 
Champaign, IL, USA), fitted with a custom fibre optic mounting to the fluorimeter and 
connected to a circulating water bath for temperature control (± 1 °C). For high-
pressure measurements, NEMO ANS emission was monitored from was monitored 
from 425 nm to 600 nm, with excitation at 390 nm.  The emission and excitation slits 
were set to 15 nm for high-pressure measurements (in order to reduce the signal to 
noise ratio due to the optical setup of the pressure cell). The starting temperature was 
set to 5 °C, and increased in 5 °C increments up to 25 °C. The pressure dependence at 
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each temperature was monitored at 50, 500, 1000, 1500, and 2000 bar. For all 
fluorescence measurements the appropriate buffer controls were subtracted from 





The cellular environment plays an important role in modulating the structure, 
function, and dynamics of many proteins. Many in vitro conditions do not account for 
the physical parameters of the cell and so do not offer a true image of the 
macromolecules studied. In this study we investigated the role of viscosity, crowding, 
and presence of osmolytes on the structure and dynamics of the human protein 
NEMO. To our knowledge, this study is the first of its kind, reporting on the 
thermodynamics of NEMO conformational change in conditions that mimic the 
intracellular environment. Here we also discuss the effect of the physical parameters 
of the cell on NEMO ligand binding, as illustrated by interactions the IκBα peptide, a 
mimic of an important NF-κB inhibitor. In vivo studies of NEMO have been previously 
published, with the aim of understanding the oligomeric state of the protein 
(Scholefield et al., 2016). Here, the authors report a complex NEMO structure to be 
found inside cells, but do not mention how the intracellular environment may affect it.  
Hydrostatic pressure and temperature perturbations are frequently used in 
studies aiming to understand the thermodynamics of protein conformational change. 
More recently they have been combined with NMR (Kremer et al., 2011) and X-ray 
crystallography (Kurpiewska and Lewiński, 2010) to help understand the 
thermodynamics of specific protein conformations. As this PhD did not aim to 
elucidate specific NEMO conformations but rather understand the breath of 
conformational states NEMO can access under specific conditions, p/T perturbations 
were the most appropriate method. In-cell NMR studies should be considered in the 
future to describe the NEMO conformations observed in the intracellular environment 
and understand the functional significance of any protein conformational change. As 
the NEMO interactome is considerably extensive, future studies should consider 
probing the effect of NEMO binding to a variety of NF-κB ligands for a comprehensive 
structural and functional understanding of NEMO. Similarly, single-molecule FRET 
measurements inside live cells (Sustarsic and Kapanidis, 2015) may also be considered 
to complement NMR and fluorescence studies and, ultimately offer a comprehensive 
image of the structure, dynamics, and function of NEMO in the cell.  With the recent 
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developments in increasing the size limit of molecules subjected to NMR studies 
(Sugiki et al., 2017) and improvements in data analysis software for single molecule 
FRET (LeBlanc et al., 2018) now including intrinsically disordered proteins, NMR and 
FRET studies on NEMO can certainly be pursued in future studies. 
The present study illustrates the importance of considering viscosity and crowding in 
future NEMO structural and functional studies; the results clearly that compared to 
simple buffered conditions, the presence of a crowder affects the dynamic of free-
NEMO, as well as ligand bound-NEMO. This is an important consideration especially 
when attempting to resolve any signal arising from NEMO disorder during NMR or 
FRET. Additionally, the results from this study also which specific conditions give rise to 
less flexible NEMO conformations, which should be used when stability issues arise 
when studying NEMO.  
 
Taking into account all results, it can be concluded that in the case of NEMO, 
the intracellular milieu acts as an additional control to modulate the structure and 
function of the protein. These findings also shed light onto one possible reason for the 
lack of consensus about the conformation of NEMO, as many studies investigate the 
structure and dynamics of NEMO in different conditions (Agou et al., 2004; Rothwarf 
et al., 1998; Tegethoff et al., 2003; Fontan et al., 2007; Lo et al., 2008). The present 
study also answers one of the aims of this PhD project, in contributing towards the 
understanding of the effects on the intracellular environment on the medically 
relevant NEMO. Further studies are advised to consider these when investigating the 




Chapter 5: Understanding the role of NF-κB essential modulator (NEMO) in 




Accompanying commentary for chapter 5:  
 
Activation of the canonical NF-κB signalling pathway relies on the activation of NEMO, 
which facilitates the interaction between the IKKβ enzyme and the inhibitor IκBα 
(Gilmore, 2006). In this study, we attempt to better understand the role of NEMO in 
mediating the interaction between IKKβ and IκBα. In order to do so, isothermal 
titration calorimetry (ITC) is used to understand the kinetics of the IKKβ:IκBα 
interaction, both in the presence and absence of NEMO. In the event that NEMO only 
functions as a scaffold, no change in the measurable reaction kinetics should be 
observed. If, however, the role of NEMO extends beyond this, a change in the reaction 
rate and/or binding affinity should be detected.  The importance of IKKβ:NEMO 
interaction for activation of the enzyme is well known (Schröfelbauer et al., 2012), but 
the role of NEMO in the IKKβ:IκBα has not been thoroughly investigated to date.  
 
ITC offers an excellent alterative to classic biochemical enzyme assays, as the IKKβ:IκBα 
enzymatic reaction does not produce a colourimetric product that can be easily 
monitored using spectroscopy methods. Using ITC also removed the need for further 
tagging of the enzyme or substrate, as the method only measures the heat associated 
with the enzymatic reaction, which is subsequently converted into reaction rate. The 
use of ITC for the study of enzyme reactions has been previously demonstrated 
(Mazzei et al., 2014; Di Trani et al., 2017), and the binding of truncated IKKβ:NEMO 
complexes have also been determined using ITC (Lo et al., 2008). Previous studies have 
reported the kinetics of IKKβ:IκBα using immunoprecipitation labelling (Zandi et al., 
1998). This is the first study that uses ITC kinetic measurements and successfully 
captures the complexity of the IKKβ: IκBα interaction. The results show that NEMO 
plays an important role during the phosphorylation of IκBα, allowing for the reaction 
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The control and regulation of the canonical NF-κB signalling pathway in response to 
specific stimuli is a complex process and it involves the interaction between three key 
proteins: NEMO, the enzyme IKKβ and the NF-κB inhibitor IκBα. Whilst it is known that 
IKKβ phosphorylates IκBα thus ensuring the first step towards its proteoasomal 
degradation, the role of NEMO in mediating this interaction is unclear. Here we use 
isothermal calorimetry (ITC) to measure the kinetics of the IKKβ:IκBα interaction, both 
in the presence and absence of NEMO to better understand its role in activating the 
NF-κB pathway.  Our results show that NEMO improves the kinetics of this interaction 
and potentially acts as an additional control in ensuring a dose-depending 
phosphorylation of IκBα. This is the first study that uses full-length human NEMO as 
well as full-length IKKβ for ITC measurements, and manages to capture the complexity 






The NF-κB signalling pathway is an important regulatory human pathway in 
charge of modulating the response of the immune and nervous systems (Gilmore, 
2006; Mémet, 2006). Canonical activation of the pathway is triggered in response to 
mostly pathogenic stimuli (Israël, 2010) and the reaction is quick, but short-lived 
(Thompson et al., 1995; Tarantino et al., 2014). In contrast, the alternative activation 
pathway of NF-κB is characterised by a slower response and it controls very specific 
functions, such as: organ development (eg. lymph nodes) (Flister et al., 2010; 
Gerondakis and Siebenlist, 2010),  B-cell functioning and growth (Kaileh and Sen, 2012; 
Sasaki and Iwai, 2015), specific neuronal stimulation and protection (Ade et al., 2007; 
Dresselhaus et al., 2018), and even bone development (Boyce et al., 2010; Abu-Amer, 
2013).   
 
In the absence of a stimulus, NF-κB proteins maintain their cytoplasmic localisation 
due to the action of specific inhibitors (known as IκBs) being bound to them. During 
canonical activation of the pathway, degradation of the IκBs is achieved by interactions 
with the IKK complex. Two kinases, IKKβ and IKKα, and non-catalytic IKKγ or NEMO, 
make up the IKK complex. Following binding of canonical stimulus to their specific 
receptor, activation of the IKK complex is triggered. Non-covalent binding of ubiquitin 
to NEMO ensure activation of NEMO; this in turn is thought to induce the activation of 
the IKKβ enzyme by a mechanism which is not yet fully understood (Tegethoff et al., 
2003; Wang et al., 2001; Fang et al., 2017). Once activated, the IKK complex now 
targets the NF-κB-bound inhibitors for proteoasomal degradation, though 
phosphorylation at two specific serine residues (Ser 32 & Ser 36) by IKKβ (Verma et al., 
1995; Zandi et al., 1998; DiDonato et al., 1996), followed by ubiquitination by other 
enzymes (Hatakeyama et al., 1999). These steps ensure the proteoasomal degradation 
of the IκB inhibitors (IκBα in this case), with the cytoplasmic NF-κB proteins now free 
to translocate to the nucleus and initiate gene regulation.  
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NEMO, or the NF-κB essential modulator, is the main activator of the canonical 
NF-κB pathway (Rothwarf et al., 1998; Shoji Yamaoka et al., 1998; Mercurio et al., 
1999; Y. Li et al., 1999). However, the mechanisms by which this is achieved are not 
fully understood. Most studies assign NEMO the function of a scaffold protein, 
ensuring that IKKβ and IκBα are located near enough to ensure the phosphorylation of 
IκBα (Schröfelbauer et al., 2012; Weil et al., 2003). Before this process can occur, 
activation of both NEMO and IKKβ needs to occur. For NEMO, this is achieved through 
non-covalent binding of free (Catici et al., 2015; Rahighi et al., 2009; Ivins et al., 2009) 
or linear chains of ubiquitin (Kensche et al., 2012; Ngadjeua et al., 2013), facilitated by 
the NEMO LZ and NOA domain (Chiaravalli et al., 2011; Laplantine et al., 2009).   
  
That NEMO plays in important role in NF-κB signalling is also evidenced by clinical 
reports of male embryonic death in the absence of the NEMO gene (Scheuerle and 
Ursini, 1993), with similar result recorded for NEMO deficient mice (Rudolph et al., 
2000; Tanaka et al., 1999; Q. Li et al., 1999). Surviving females with NEMO mutations 
exhibit neurological and immune conditions (Fusco et al., 2008; Hadj-Rabia et al., 
2003).  
 
It is clear from these findings that the role of scaffold protein for NEMO is an 
unsatisfactory definition and requires a better investigated. Here we aim to answer if 
the presence of NEMO leads to changes in the kinetics of the IKKβ: IκBα interaction.  
To our knowledge, this is the first study to attempt this, and also the first study to 
determine the kinetics of IκBα phosphorylation by IKKβ through the use of isothermal 
titration calorimetry.  
 
Previous studied have employed radiolabelled IκBα peptides (Huynh et al., 2000) or 
radioisotope labelled γ-ATP analysed by immunoprecipitation/gel electrophoresis  to 
quantify the amount of phosphorylation present (Heilker et al., 1999). Although 
informative, these studies do not take into account the role of NEMO in mediating this 
interaction. Similarly, issues with detection and loss of signal during the washing steps 
pose concerns about the reliability and accuracy of these techniques (Ma et al., 2008).  
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Isothermal titration calorimetry (ITC), a technique often used to study 
molecular binding (Duff, Jr. et al., 2011), has more recently been demonstrated as an 
alternative for enzyme assays (Mazzei et al., 2014). ITC does not require any labelling 
of ATP or substrate, which removes concerns about labelling interfering with protein 
function, or loss of signal due to detection sensitivity.  The principle of ITC is to 
measure the amount of heat released or absorbed during chemical reactions. For the 
study of enzyme kinetics, two ITC methods are available: single injection or multiple 
injections (Atri et al., 2015; Mazzei et al., 2014). Both methods function by titrating the 
substrate into the enzyme (or mixture of enzyme plus molecule(s) of interest) and 
recording the heat flow; this can be used to directly calculate the reaction rate (Morin 
and Freire, 1991; Freyer and Lewis, 2008; Lonhienne et al., 2001). For the multiple 
injection method, an additional measurement is carried out to determine the enthalpy 
of the reaction needed to calculate the final rate (Mazzei et al., 2014; Rana et al., 2016; 
Transtrum et al., 2015). ITC offers the best option to answer fundamental questions 
about the role of NEMO in mediating the phosphorylation of IκBα by IKKβ.  
 
The phosphorylation of the NF-κB inhibitor protein IκBα by the IKKβ enzyme is a critical 
step in ensuring activation of the NF-κB signalling pathway in response to specific 
stimuli (T. D. Gilmore, 2006). Phosphorylation is an important cellular process, as it is 
the basis of many crucial survival-associated responses, including: cell differentiation 
(Van Hoof et al., 2009), cell signalling (Ardito et al., 2017), control of metabolism 
(Humphrey et al., 2015) and apoptotic responses (Niemi and MacKeigan, 2013), as well 
as vital for the proper functioning of the immune (Swamy et al., 2016) and nervous 
systems (Sweatt, 2001), and even used in therapeutic formulations for cancer 
treatment and detection (Nayak et al., 2018). Studies estimate that approximately 30% 
of all proteins undergo phosphorylation (Hunter, 1995), this reversible process 
whereby a phosphate group (PO4) is added to specific proteins residues (usually 
aromatic amino acids) by specific proteins known as kinases (Burnett and Kenedy, 
1954; Tan, 2011; Ardito et al., 2017). In eukaryotes, Serine residues are most 
commonly phosphorylated (~79 % ), followed by threonine (~17 %), and tyrosine (~4%) 
(Olsen et al., 2006).  The relatively high number of phosphorylated proteins is thought 
to be due to phosphorylation being a reversible process that has been shown to induce 
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modulate the structure, function, and localisation of proteins (Johnson and Barford, 
1993; Jenal and Galperin, 2009; Nishi et al., 2011; Bononi et al., 2011; Hunter, 2012), 
and in some cases even promote disorderÛorder switches in protein conformations 
(Antz et al., 1999; Collins et al., 2008).   
 Uncontrolled canonical NF-κB activation has been linked to a number of 
medical conditions, including various types of cancer (Jost et al., 2007; Zhou et al., 
2015; Nakagawa and Rathinam, 2018). Thus, understanding the phosphorylation of 
IκBα is important for the development of better therapeutic agents and disease 
markers for NF-κB associated conditions.  Figures 38-42 present the phosphorylation 
data for IκBα by the IKKβ enzyme as determined by ITC. Herein we set to better 
understand the role NEMO plays in mediating the interaction between the IKKβ 
enzyme and a peptide mimic of the inhibitor IκBα, and thus better characterise the 
role of NEMO as NF-κB essential modulator.  
 
Materials and Methods 
Protein expression and purification. Full-length human NEMO was expressed and 
purified as previously described (Catici et al., 2015). NEMO expression plasmid was 
purchased from Addgene (catalog no. 11966), containing the full-length human IKKγ 
(NEMO) gene also containing a N-terminal His6 tag incorporated onto a pET28a 
expression vector. Escherichia coli BL21 T7 Express cells (New England Biolabs, catalog 
no. C25661) were used for plasmid transformation. Protein expression was induced 
using 0.5mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 25 °C for 12hrs.  NEMO 
was purified from lysed cells using nickel affinity chromatography (HisTrap FF crude 
1ml column) in the presence of 1mM adenosine triphosphate (ATP). Purified protein 
was dialysed in 50 mM Tris/Cl pH 8.0, 50 mM NaCl, and 5 mM TCEP. NEMO was 
previously purified using 5 mM DTT instead (Catici et al., 2015), but this reducing agent 
is not compatible with the use of ITC due its oxidation and subsequent ring-closing 
which  gives rise to artificial baseline signal until the reduced state is no longer formed 
(Salim and Feig, 2009). In order to avoid this, TCEP was used instead.  
Recombinant full-length constitutively active IKKβ enzyme was purchased from MRC 
PPU Reagents Dundee (catalogue no. DU316). All IκBα peptides were purchased from 
GenScript, purity level >95% (seq: LDDRHDSGLDSMKDEEY). Linear polyubiquitin chains 
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were purchased from Enzo Life Sciences (catalogue no. BML-UW0825-0001). All 
samples were dialysed and subsequent ITC measurements were all carried out in the 
following buffer system: 50 mM KCl, 2 mM MgCl2 ,2 mM MnCl2 ,10 mM NaF, 25 mM 
Hepes buffer, 1 mM TCEP, pH. 7.6. It is advised to keep concentration of reducing 
agents 	≤ 1mM when performing calorimetry measurements (Keeler et al., 2013).  
Isothermal titration calorimetry. Measurement were recorded at 20 °C on a MicroCal 
VP-ITC isothermal titration calorimeter (Malvern Panalytical).  All samples were 
degassed by vacuum aspiration for approximately 10 minutes prior to loading. 
Reference cell was regularly cleaned, with water solution replaced every two weeks. 
Enzymatic experiments were set up as follows: first, a simple kinetic experiment was 
performed (M1 experiment), where one concentration of IκBα (39μM) was titrated 
into a solution of either IKKβ (30nM) or IKKβ (30nM):NEMO (1μM)  in order to 
calculate the enthalpy (ΔH) of total substrate conversion. A total of three replicate 
injection of 39 μM IκBα (with 1200s spacing in between each) were performed and the 
substrate conversion reaction was deemed complete upon a complete return of the 
baseline to the initial pre-injection levels.  
Secondly, a more complex experiment (M2 experiment) was set up, where increasing 
concentrations of IκBα (0μM-800μM) were titrated into the sample cell either loaded 














Table 3. Isothermal titration calorimetry experimental set-up for IκBα turnover 
measurements (M2 experiment).  
Injection Concentration of IκBα (μM) Spacing in between each injection (s) 
1 2.78 400 
2 5.57 400 
3 11.12 600 
4 16.68 600 
5 30.52 600 
6 52.57 800 
7 79.95 800 
8 120.67 1000 
9 187.56 1000 
10 292.06 1200 
11 418.32 1200 
12 563.44 1400 
13 746.07 1400 
 
For M1 experiments, an average ΔH was calculated using the method described 










  is heat flow measured at each substrate concentration (essentially the area 
under the curve for each M1 injection),  V is the volume of the sample cells (expressed 
in L), and [S] is the concentration of  IκBα  injection (expressed in µM). The ΔH 
obtained from M1 experiment was used to calculate the enzyme rate from the M2 
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where, v is the rate of the reaction, !$
!#
  is the product formation with respect to time, V 
is the volume (expressed in L), ΔH is the enthalpy as calculated from M1 experiment, 
and !"
!#
 is heat flow measured at each substrate concentration. The term !"
!#
 relates to 
the differences in the baseline after each injection: as the baseline change directly 
reports on the kinetic reactions recorder, !"
!#
 is the difference between the baseline 
recorded after each new injection and the initial baseline level at the start of each 
injection.   
Essentially, using ITC to measure enzyme kinetics using the multiple-injection methods 
requires first determining the enthalpy - ΔH - for the complete substrate conversion 
(M1 experiment) and determination of the thermal power - !"
!#
 -  variation from the 
continuous conversion of substrate to product (M2 experiment). The amount of heat 
observed during catalysis (dQ) is equal to the number of moles of product produced 
times the enthalpy of the reaction (Mazzei et al., 2014; Rana et al., 2016).  
 
 
RESULTS & DISCUSSION 
For each experiment, the corresponding control thermogram was subtracted to give 
thermograms de-convolved of background signals. To achieve this, we used a control 
‘reaction’ where the serine residues in the IκBα were both mutated to alanine, 
rendering the peptide non-phosphorylatable (S32A and S36A). The control 
thermograms are shown in Figure 38. These data show a return to baseline that is non-
zero both in the absence and presence of NEMO and, crucially, with the variant IκBα 
(IκBαS32A,S36A). Since IκBαS32A,S36A does not contain any threonine residues, potentially 
the data in Figure 38 might reflect a background of  phosphorylation of tyrosine 
residues (one tyrosine residue present in the control IκBα). Indeed, tyrosine 
phosphorylation of IκBα has previously been reported (Fan et al., 2003; Gallagher et 
al., 2007; Cullen et al., 2015), but not part of the canonical or alternative NF-κB 
signalling. Activation of the NF-κB pathway through phosphorylation of Tyr42 is poorly 
defined and involves the dissociation from NF-κB complexes (Béraud et al., 1999). 
However, the phosphorylation rate of tyrosine residues on proteins is considerably 
lower compared to serine (<4% vs >79%) (Olsen et al., 2006) and so Tyr 
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phosphorylation does not seem likely.  That said, we are mindful that this could be a 
convolving factor in the observed background signal. A further potential convolving 
factor is phosphorylation of NEMO (Palkowitsch et al., 2008; Prajapati and Gaynor, 
2002) or IKKβ (Shambharkar et al., 2007; Delhase et al., 1999). We consider these 
possibilities in more detail below. 
 
NEMO is a protein capable of undergoing conformational change upon binding to 
various ligands (Catici et al., 2015; Catici et al., 2016; Hauenstein et al., 2017), and the 
thermal fluctuations observed in the control experiment with NEMO in Figure 38 may 
reflect conformational change of NEMO upon binding to IKKβ. 
 
 
Figure 38. Thermal power recorded for control experiments as measured by 
isothermal titration calorimetry. All measurements were carried out in the presence of 1 
mM ATP, 20 °C and with IκBα double serine mutant (IκBαS32A,S36A). Shown in red is the 
corresponding experiment for titration of IκBαS32A,S36A (0-800 μM) into a solution of 30 nM 
IKKβ . Shown in grey is the corresponding experiment for titration of IκBαS32A,S36A (0-800 μM ) 
into a solution of 30 nM IKKβ  and 1 μM NEMO.  Each peak (positive and negative) 
corresponds to an injection of IκBα set at specific times and concentrations. See Table 3 for 
detailed experimental set-up. The data are averages of n=3 biological replicates.  
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We have previously demonstrated that a peptide mimic of IKKβ is capable of inducing 
a NEMO conformational change whereby the degree of flexibility in the protein has 
increased (Catici et al., 2016), which could contribute to the thermal fluctuations 
observed in Figure 38. However, these could also be due to IKKβ undergoing 
conformational change upon binding to NEMO. A model for activation of IKKβ through 
interactions with NEMO has previously been proposed but is poorly understood. 
Potentially binding of NEMO induces a conformational change in IKKβ whereby it 
promotes the binding of substrate (IκBα) (Schröfelbauer et al., 2012). We consider the 
information content of the thermograms, related to protein conformational change in 
more detail below.   
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Figure 39. Thermal power recorded for all IκBα phosphorylation experiments as 
measured by isothermal titration calorimetry. All conditions were tested in presence of 
1μM NEMO, 1mM ATP, 30 nM IKKβ. A, IκBα with NEMO. B, IκBα no NEMO. C, IκBαS32A,S36A 
variant with NEMO. D, IκBαS32A,S36A variant no NEMO. E, IκBαS32A NEMO. F, IκBαS36A no NEMO. 
G, IκBαS36A with NEMO. H, IκBαS36A no NEMO. All data are averages of n=3 biological 
replicates. For each condition the baseline shifts have been minimised in order to 
understand the origin of the positive and negative peaks observed in the kinetic 
experiments. This was done using the “Create final ITC figure“ feature on the OriginMicroCal 
software, which creates a zeroed baseline for each thermogram without altering the peaks.  
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The use of ITC to monitor IKKβ enzyme turnover also affords further information 
relating to the thermodynamic changes accompanying turnover, represented by the 
heat spikes separating the injection and the return to baseline. Specifically, one can 
extract information on the magnitude and sign (exothermic/endothermic) of these 
heat spikes by integrating the individual peaks. Figure 39 shows the baseline corrected 
thermograms for each of the experimental conditions above (black line). That is, we 
remove the information that allows the calculation of the observed rate to focus on 
the changes in the heat spikes of the thermograms. 
 
Figure 39A-H shows the baseline corrected thermograms for all experiments, including 
controls. These thermograms are dominated by negative spikes intervening the return 
to baseline, with some positive spikes at low IκBαS32A,S36A concentrations. In the 
presence of the IκBα peptide with both serines present (Figure 39A and Figure 39B; 
with and without NEMO, respectively) one now observes positive heat spikes at all 
concentrations of IκBα. These data suggest that phosphorylation of the serines 
manifests as positive heat spikes intervening the return to baseline. Figures 39E-H 
confirm this, showing positive heat spikes at high concentration of the single serine 
variants, IκBαS36A (Figure 39E and Figure 39F; IκBαS36A with and without NEMO, 
respectively) and IκBαS32A (Figure 39G and Figure 39H; IκBαS32A with and without 
NEMO, respectively. Indeed, with IκBαS36A no negative heat spikes are observed at all, 
implying that the positive heat spikes are offsetting the negative heat spikes observed 
in the control experiments (Figure 39C-D). Given that the phosphorylation events 
appear to manifest positive heat spikes, and that our control experiments show 
predominately negative heat spikes, it seems unlikely that the background signal we 
observe in Figure 38 is attributable to Tyr phosphorylation on IκBα or Ser 
phosphorylation on either IKKβ or NEMO. 
 
Given that the thermograms (Figure 39) suggest that our background signal is not 
chemical turnover, we consider that part of the signal may be attributable to protein 
conformational change associated with IκBα binding. Indeed, a number of studies have 
demonstrated that NEMO undergoes ligand (Catici et al., 2015; Hauenstein et al., 
2017) and environment induced conformational change (also Chapter 3 and 4 in this 
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thesis). These data therefore suggest that the observed kinetic arising from our ITC 
studies, whilst dominantly convolved of chemical turnover associated with 
phosphorylation of IκBα serines, may well also be convolved of conformational change 
associated with IκBα binding to IKKβ and or NEMO. Without a more detailed kinetic 
study we cannot confidently assert whether putative conformational changes are 
kinetically coupled to chemical turnover. 
 
Regardless of the precise origin of the background thermograms, these control 
experiments allow us to capture turnover of IKKβ, de-convolved from this background 
signal. Additionally, Figure 47 shows the baseline shifts characteristic of the product 
formation during enzyme turnover when analysed by ITC (Figure 47A and 47B). These 
show the baseline shift recorder during phosphorylation of IκBα by IKKβ, both in the 
presence and absence of NEMO. As previously demonstrated, these are indicative of 
stead-state kinetics and enzyme turnover (Lonhienne et al., 2001; Freyer and Lewis, 
2008), and are absent in the data where no phosphorylation of IκBα is observed (such 
as in the control experiment for IκBαS32A,S36A (Figure 47C). The results from Figure 47 
combined with the preliminary results from LC-MS analysis of the phosphorylation of 
IκBα, we are confident that we are capturing the kinetics of IKKβ: IκBα using ITC. 
 
The concentration dependence of IκBα versus the observed rate from our ITC assay is 
shown in Figures 40-42 and the data extracting from fitting is given in Table 4.  In the 
absence of NEMO (red data set), turnover appears to follow a sigmoidal relationship 
with respect to substrate concentration. These data therefore imply non-Michaelis-




Figure 40. Phosphorylation of IκBα by IKKβ in the presence and absence of NEMO as 
measured by isothermal titration calorimetry. All measurements were carried out at 20 
°C and with 1mM ATP. Shown in red is the corresponding experiment for the 
phosphorylation of IκBαS32,S36 (0-800 μM) into a solution of 30 nM IKKβ . Shown in grey is the 
corresponding experiment for phosphorylation of IκBαS32,S36 (0-800 μM) into a solution of 30 
nM IKKβ  and 1 μM NEMO.  The data in the absence of NEMO are fit to equation 20 are 
shown in red, and the data for phosphorylation in presence of NEMO fit to equation 21 are 
shown in grey. Solid lines are the fits to Eq 20 and Eq 21. All data are averages of n=3 







where , n is essentially the Hill number, reflecting the degree of cooperativity and, 
under some scenarios, the number of species involved in the cooperative interaction.  
 
In the presence of NEMO, there is a similar sigmoidal relationship, but now also 
apparent inhibition at higher substrate concentrations, potentially reflecting substrate 
inhibition. This is a complex kinetic scheme; cooperativity and putative substrate 











Where, Ki reflects the inhibition constant, putatively for the substrate. We note such a 
relationship is not uncommon, for example as typified by aspartate transcarbamylase 
(LiCata and Allewell, 1997). The data resulting from the fits to Eq.210and Eq.21 (shown 
in Figure 40) are given in Table 4. 
 
Table 4. Results of fitting data shown in Figures 40-42 for IκBα phosphorylation to 
Eq.20 and Eq.21.  
 kcat (s-1) KM (μM) n Ki (μM) 
IκBα 1027.2 ± 17.6 55.62 ± 1.4 7.4  ± 1.2 - 
IκBα + NEMO 2443.3± 895.0 8.71 ± 3.9 1.8  ± 0.6 40.0 ± 23.2 
IκBαS32  881.9 ± 20.0 53.53 ± 3.4 12.8  ± 11.8 - 
IκBαS36  863.3 ± 22.7 53.0 ± 7.9 15.5  ± 40.0 - 
IκBαS32+NEMO  1246.3 ± 16.9 5.1 ± 0.2 3.5  ± 0.4 >5000 
IκBαS36+NEMO  1454.1 ± 16.9 5.10 ± 0.1 3.5  ± 0.3 >5000 
 
From Figure 40 and Table 4, The calculated kcat values in the presence and absence of 
NEMO shows some difference, with kcat showing a  ~2-fold increase in the presence of 
NEMO 1027.2 ± 17.6 s-1, compared to 2443.3 ± 895.0 s-1 in the absence. These data 
suggest that the addition of NEMO increases the phosphorylation rate of the IκBα 
peptide. Previous studies report much smaller values for rate of IκBα phosphorylation, 
ranging from 3.7 x 10-2  s-1  (Heilker et al., 1999) to 18 s-1  (Li et al., 1998). The 
differences in these values might be explained by the low ATP values used in previous 
studies, 50 μM (Heilker et al., 1999) and 1.3 μM (Li et al., 1998), suggesting the 
observed rate might not be saturated in these studies. It has been reported that ATP 
depletion can affect the rate of phosphorylation, with de-phosphorylation observed in 
other protein system upon depletion of ATP (Sturani et al., 1988). It is precisely for this 
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reason we use a relatively high concentration of ATP (1 mM). Similarly, the differences 
in the rates observed may also be due to the sensitivity of the detection method used.  
Previous studies have relied on autoradiography and used very low concentration of 
peptide 0.5-8 μM substrate (Heilker et al., 1999), compared to the values presented in 
Table 4, ranging from 2.7 -746 μM. ITC is a highly sensitive method, offering direct 
measurement of the kinetic reaction studied, especially compared to autoradiography 
methods, which report on the kinetic parameters indirectly and have poor sensitivity.  
 
Despite the differences in reported rate constants, previous studies are in agreement 
with our findings, also reporting an increase in the rate of phosphorylation under 
conditions where NF-κB proteins are present during the phosphorylation reaction; 
their reported values show a 5-fold increase in the phosphorylation rate (Zandi et al., 
1998), whereas we observe a two-fold increase in the rate, as discussed above. We 
note that NEMO and the NF-κB proteins are distinct, but it is of interest that both 
appear to increase the rate of IKKβ turnover. The increase in kcat upon addition of NF-
κB proteins has been suggested to arise from stabilisation of the IKKβ: IκBα interaction, 
which would also allow for a more efficient phosphorylation reaction. We propose that 
NEMO behaves similarly in ensuring the formation of a more stable IKKβ: IκBα 
complex.  Studies exploring the half-life of cytoplasmic IκBα report that in stimulated 
cells, IκBα is rapidly degraded, with unstimulated cells showing a three orders of 
magnitude decrease in the degradation of IκBα (O’Dea et al., 2007). While our 
conditions studied using ITC do not take into account the presence of a NF-κB stimulus, 
the hallmark of such would be the presence of NEMO and its interaction with IKKβ, 
which we believe allows for a similar effect to be observed whilst also decreasing the 
complexity of the experimental conditions.  Our results show a similar trend, with the 
rate of IκBα phosphorylation being much slower in the absence of NEMO (indirect 
mimic of ‘unstimulated’ cells). 
  
From Table 4, there is a decrease in the Km, from KM = 55.62 ± 1.40 μM in the absence 
of NEMO to KM = 8.7 ± 3.9 when NEMO was present. Potentially the difference in Km 
could be due to an increased affinity of IKKβ for IκBα in the presence of NEMO. 
However, without knowing the intrinsic rate constants for the ‘on’ and ‘off’ rate of 
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ligand binding, this interpretation should be treated extremely cautiously.  That said, 
previous studies report the KM for the IKKβ: IκBα complex to also increase in the 
presence of NF-κB proteins, from 2.2 μM ® 1.4 μM (Zandi et al., 1998).  
 
The data in Figure 40 show a kinetic scheme for IKKβ:IκBα interactions, with apparent 
cooperativity both in the presence and absence of NEMO. The value of n is increased 
in the absence of NEMO and decreases in the presence of NEMO, n = 7.4 ± 1.2 and 1.8 
± 0.6, respectively. At a simple level, evidence for cooperativity might suggest a 
cooperative relationship between IκBα or cooperativity for each of the two serine 
residues present on a single IκBα peptide (inter / intra-peptide cooperativity). 
Potentially, the magnitude of n can be used to infer the number of species involved in 
the cooperative interaction. The number increased in the absence of NEMO and it is 
difficult to construct a realistic model where 7/8 species are involved. In the presence 
of NEMO n ~ 2 and this might further suggest the origin of the putative cooperativity is 
based on the two available serines on IκBα or two monomers the IκBα peptide. 
 
The most striking difference between the kinetic data in the presence/absence of 
NEMO is that in the presence of NEMO there is apparent substrate inhibition, or at 
least the data fit to a model that includes an inhibitory affect with increasing substrate 
concentration. The extracted Ki value only shows ~4 times increase compared to the 
Km, Ki = 40.0 ± 23.2 and Km = 8.7 ± 3.9, respectively. This leads to a relatively ‘sharp’ 
concentration dependence on kobs, where the maximal observed rate is restricted to a 
relatively small window of IκBα concentrations (Figure 40). It is tempting to speculate 
that this ‘restriction of function’ of IKKβ by NEMO might be an important biologically 
relevant control mechanism and we discuss this further below. 
 
Given the potential for kinetic complexity arising from the phosphorylation of S32 and 
S36 on the IκBα peptide, and in the context of the putative cooperativity observed in 
the kinetic plots (as above), the turnover with single serine variant IκBα was explored 
in the presence and absence of NEMO, shown in Figures 41 and 42, respectively. The 
resulting data from the fits is given in Table 4. The peptides, IκBαS36A and IκBαS32A are 
single serine to alanine mutants, S36A and S32A, respectively. We note that previous 
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studies have reported phosphorylation of S32 of IκBα by IKKβ to proceed at 3.7 x 10-2 s-
1, in the presence of 50 µM ATP, with KM 1.7 ± 0.6 µM (Heilker et al., 1999). 
 
 
Figure 41. Phosphorylation of IκBα peptides by IKKβ in absence of NEMO as 
measured by isothermal titration calorimetry. All measurements were carried out at 20 
°C and with 1mM ATP. Shown in red is the corresponding experiment for phosphorylation of 
IκBαS32,S36 (0-800 μM) by 30 nM IKKβ. Shown in red is the corresponding experiment for the 
phosphorylation of IκBαS32,S36 (0-800 μM) by 30 nM IKKβ. The phosphorylation of  IκBαS32A 
and IκBαS36A  by 30 nM IKKβ in presence of 1 μM NEMO in shown in yellow and green, 
respectively. The solid lines are the fits to Eq.20. All data are averages of n=3 biological 
replicates. The data for phosphorylation of IκBαS32,S36 (red dataset) is the data presented in 
Figure 39 but superimposed onto the traces obtained from phosphorylation of single serine 
phosphorylation of IκBα peptides to emphasize the similarity in the overall trend observed.   
 
We note that our calculated kcat is much higher (1027.2 ± 17.6 s-1)  compared to 
previous studies (3.7 x 10-2  s-1  and 18 s-1) and believe this is due to the detection 
methods used and potentially the rather higher concentration of ATP as described 
above. Moreover, Heilker et al have calculated the value of kcat based on association 
and dissociation data obtained from surface plasmon resonance studies (Heilker et al., 
1999) and not directly as we have though ITC.  
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Figure 42. Phosphorylation of IκBα peptides by IKKβ in presence of NEMO as 
measured by isothermal titration calorimetry. All measurements were carried out at 20 
°C and with 1mM ATP. Shown in grey is the corresponding experiment for phosphorylation 
of IκBαS32,S36 (0-800 μM) by 30 nM IKKβ in the presence of  In yellow and green The 
phosphorylation of  IκBαS32A and IκBαS36A  by 30 nM IKKβ in presence of 1 μM NEMO in 
shown in yellow and green, respectively. The solid lines are fits to Eq. 20 for IκBαS32,S36 
phosphorylation, and Eq.21 for IκBαS32A and IκBαS36A. All data are averages of n=3 biological 
replicates. The data for phosphorylation of IκBαS32,S36 (grey dataset) is the data presented in 
Figure 39 but superimposed onto the traces obtained from phosphorylation of single serine 
phosphorylation of IκBα peptides to emphasize the differences in the overall trend observed 
between the peptides tested. 
 
From Figure 41 and 42 and Table 4 we find that the serine deletion variants of IκBα 
show a decrease in the extracted kcat values both in the presence and absence of 
NEMO. In the absence of NEMO, the decrease is relatively small, being  881.93 ± 20.01 
μM s-1 for IκBαS3 and 863.20 ± 22.69 μM s-1  for IκBαS4, compared to 1027.21 ± 17.56 
μM s-1 for IκBα peptide. However, when NEMO is added, kcat =1246.3 ± 16.9 s-1 for 
IκBαS3 and kcat = 1454.1 ± 16.9 s-1 for IκBαS4 compared to kcat =2443.3 ± 895.0 s-1 for the 
two Ser IκBα in the presence of NEMO. Despite these differences in calculated kcat, we 




Above, we hypothesised that the putative cooperativity observed both in the absence 
and presence of NEMO might arise due to the presence of two phosphorylatable 
serines on the IκBα peptide, with the first phosphorylation potentially enhancing the 
propensity for phosphorylation of the next serine. From Table 4, the magnitude of n 
increases (approximately doubles) both in absence and presence of NEMO for single 
serine peptides. However, we note the error values in the absence of NEMO for single 
serine peptides potentially make this trend difficult to interpret. In the presence of 
NEMO, the magnitude of n approximately doubles outside of calculated error, 
suggesting this finding is bone fide. These data therefore suggest that the presence of 
only a single phosphorylatable serine increases the degree of cooperativity. It 
therefore does not appear likely that the observed cooperative relationships are 
attributable to intra-peptide cooperativity arising from different phosphorylatable 
serines on the same peptide, but more likely, inter-peptide cooperativity, where 
cooperativity arises from individual IκBα monomers. Cooperativity is a common 
control mechanism that ensures a specific dose-response relationship and one could 
easily envisage that this might have a biological role in the context of NFKB signalling. 
We consider this in more detail below. 
 
Finally, from Figures 42 and Table 4, we find that single serine variant IκBα peptides 
essentially ablate the putative substrate inhibition in the presence of NEMO. That is, 
the extracted Ki values increase (> 5 mM), essentially tending toward no effective 
substrate inhibition. These data suggest that the presence of multiple serines on IκBα 
induce substrate inhibition but only in the presence of NEMO. One of the potential 
functions of NEMO is to present the substrate (IκBα) to the enzyme (IKKβ). These data 
suggest that indeed NEMO does alter the geometry of IκBα relative to IKKβ, since the 
presence of NEMO induces substrate inhibition. Most likely this arises due to a non-
(less) productive binding geometry between IκBα and IKKβ that becomes accessible in 
the presence of NEMO. As we discuss above, the presence of substrate inhibition has 
potential benefits in terms of control and regulation of IKKβ activity. Our hypothesis 
was that NEMO might enhance the interaction between IκBα and IKKβ, possibly 
increasing affinity. However, it appears that NEMO also may have a role in presenting 
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NEMO is classically considered to function as a scaffold protein, with most reports 
suggesting a role in sub-cellular localisation of IKKβ. It is however intriguing that NEMO 
is able to bind both IKKβ, but also the substrate of IKKβ, IκBα. We hypothesised that 
NEMO might play an additional role in regulating the enzyme activity of IKKβ. Our 
study suggests that NEMO may alter the rate of IKKβ turnover somewhat (~2 fold), but 
in terms of a catalytic advantage this would seem relatively minimal. Instead we find 
the more major changes are in the equilibrium constants that govern the substrate 
interaction with IKKβ. Specifically, we find that the presence of NEMO ‘tunes’ the Km 
and induces substrate inhibition, such that the IKKβ enzyme operates in a relatively 
narrow window of IκBα concentrations. We suggest that this represents a regulation of 
IKKβ function at the level of substrate concentration. Such a model suggestion chimes 
well with the regulatory behaviour of very many enzymes involved in human 
metabolism and signalling. It is interesting to note that our data points to a role for 
conformational change (both ligand induced and NEMO mediated) within the control 




Post-paper discussion:  
This study aimed to resolve the role NEMO in mediating the interaction 
between IKKβ and IκBα. While published reports characterise NEMO as a scaffold 
protein, we believe its role in activating the signalling pathway in response to canonical 
stimuli extends beyond this. This study is the first to report the inhibitory effect of 
NEMO on IκBα phosphorylation by the IKKβ enzyme, and points to NEMO controlling 
not only the activation of NF-κB signalling, as well as modulating the length of the 
response. This is potentially important for the development of therapeutics targeting 
the uncontrolled activation of NF-κB, which fail to take into account the role of NEMO.  
Many previous attempts at characterising the IKKβ:IκBα interaction have been 
carried out using indirect phosphorylation detection methods. The results in Chapter 5 
offer a new alternative through the use of ITC kinetic measurements.  The main 
advantages consist of elimination of need to labelling or the use of coupled-assay, and 
the ability to continuously monitor the enzymatic reaction. However, this is to say that 
by no means ITC offers the best methods for this analysis. This study offers an 
excellent premise for future kinetic measurements, showing for the first time the 
kinetics of the IKKβ:IκBα in the presence of full-length IKKβ enzyme and NEMO. Future 
studies should aim to corroborate these findings with other assays, such as stopped- or 
continuous-flow assays, or even in-cell assays. The kinetics of TEM1 β-lactamase was 
monitored in vivo in HeLa cells using confocal microscopy, by using fluorogenic 
substrate and monitoring the product formation at a specific wavelength (Zotter et al., 
2017). This techniques potentially offers a better understanding of the cellular role of 
NEMO in mediating the IKKβ:IκBα interaction, seen as the intracellular milieu acts as 
an additional control to modulate NEMO structure and dynamics (Chapter 4).  
Understanding the role of NEMO oligomerisation for IKKβ kinetics should also be the 
focus of future studies. NEMO oligomeric state is still a matter of active debate, with 
no clear understanding of the relationship between oligomeric state and cellular roles. 
Cys54 and Cys347 are required for intermolecular disulphide bond formation in NEMO 
(Herscovitch et al., 2008); the effect disruption of these on the ability of NEMO 
mediate the IKKβ:IκBα interaction and kinetics should also be considered for a more in-
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depth analysis.  In addition, structural studies should be used alongside enzyme assays 
to better characterise the IKKβ:IκBα complex in association with NEMO. Recent 
advances in the field of cryo-electron microscopy allow for better a resolution of 
dynamic proteins (Bonomi et al., 2018), and such a complete characterisation of the 
NEMO: IKKβ:IκBα using cryo-EM should be attempted in the future fir a 
comprehensive analysis of the mechanistic activation of the IKK complex, which to 
date has yet to be fully understood.   
 
To validate the results from Chapter 5, a coupled enzyme assay should be 
carried out. As ATP is required for the kinetics of IKKβ, an assay measuring the 
consumption of ATP during phosphorylation of IκBα, as ATP is required for the kinetics 
of the phosphorylation reaction.  Similarly, monitoring the kinetics of IKKβ can in 
theory also be achieved using chromatography methods coupled with mass-
spectrometry, such as ion exchange chromatography or liquid chromatography 
coupled with MS. This technique offers increased sensitivity and is now frequently 
used to study enzyme kinetics (Winkler et al., 2013; Perna et al., 2018). However, 
many studies report that MS methods pose a series of limitation when used to detect 
and quantify  peptide phosphorylation (Arnott et al., 2003; Molina et al., 2007). 
Specifically, phosphorylation may have an effect on the enzymatic digestion of 
peptides prior to MS analysis (Steen et al., 2005). Similarly, phosphorylated and 
unphosphorylated peptides exhibit different ionisation efficiencies which may limit the 
comparison of measured ion currents for quantification of phosphorylation (Wu et al., 
2018).   
 
We have previously attempted to detect phosphorylation of IκBα using LC-MS 
(See figure 43). However, we were only able to detect phosphorylation of the single 
serine peptides, and due to the limitations of LC-MS discussed above, no further 
measurements were attempted. However, with the development of new 
improvements to sample preparations and software analysis, LC-MS may offer an 
alternative to radiolabelled assays or western blotting to study the phosphorylation of 
IκBα and the kinetics of the IKKβ enzyme.  
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Figure 43. Preliminary LC-MS data for phosphorylation of IκBα by IKKβ. The data show 
the phosphorylation in the presence and absence of NEMO, and the intensity detected for the 
phosphorylation of single serines. No detection for the phosphorylation of the double serine 
IκBα was detected using LC-MS. The experimental setup was: 1 mM ATP, 30 nM IKKβ, 1 μM 
NEMO, 1 mM IκBα. The data are from one single measurement.    
 
 In summary, the results presented in Chapter 5 show align with the original 
aims of this PhD in better understanding the role of cytoplasmic NEMO in the 
activation of the NF-κB signalling pathway. The data presented here demonstrate the 
extensive scaffold role of NEMO in mediating the interaction between the IKKβ 










This PhD project aimed to understand the effects of the biophysical factors 
governing the structure, function, and dynamics of the relevant human protein NEMO. 
Firstly, we established the use of an optical phenomenon known as Red edge 
excitation shift (REES) as a tool for monitoring and quantifying NEMO conformational 
change.  Using intrinsic NEMO fluorescence (W6), we captured the protein 
conformational change in response to binding of NEMO different peptides, NDB and 
IκBα. Using REES, we were able to establish that the two binding events induced 
different NEMO conformational changes, suggesting NEMO functional regulation by 
ligand binding, as well offering evidence for the dynamic nature of the protein. Much 
debate still exists around the structure of NEMO, with some reports suggesting a more 
rigid NEMO conformation (Bagnéris et al., 2015).  A united view on the dynamic 
structure of NEMO is hopefully achievable in the near future.  Improvements to more 
robust structural characterisation techniques such as SAXS or cry-EM microscopy are 
being carried out to allow for better sensitivity and incorporation of protein dynamics 
in the data analysis.  The notion of NEMO existing as a dynamic molecule as proposed 
by our REES W6 data (Chapter 3), was recently also confirmed by different structural 
biology techniques and computational methods. Using SAXS the structure of NEMO 
has been shown to be undergo conformational change upon ligand binding 
(Hauenstein et al., 2017), with the protein in general adopting a more dynamic 
conformation than the previously rigid structure (Bagnéris et al., 2015). Similarly, our 
proposed mechanism for ubiquitin-induced NEMO conformational change potentially 
selecting for functional NEMO conformations has also been verified using SAXS 
(Hauenstein et al., 2017). More recently, the flexibility of the NEMO N-terminal (W6 
region) has also been validated using X-ray crystallography and MD simulations 
(Barczewski et al., 2019). Here the authors report that NEMO exhibits a dynamic ligand 
binding interface and is capable of undergoing ligand-induced conformational change. 
The validation of the REES data presented in Chapter 3 using a number of structural 
techniques illustrates the sensitivity of the REES W6 probe and its application in 
understanding protein dynamics and conformational change without the need for 
labelling or extensive data refinement.   
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The effect of the intracellular milieu on protein dynamics and stability is slowly 
emerging as an important factor to consider in structural studies (Monteith et al., 
2015). The results presented in Chapter 4 describe the effect of the physical 
parameters of the intracellular environment on the structure and dynamics of NEMO. 
It was also important to compare free NEMO to ligand bound to understand whether 
the intracellular milieu exerted different effects on the free protein vs a functional 
NEMO conformation. The data show that the intracellular environment acts as an 
additional control for NEMO conformational change, with different cellular 
compartments either affecting the free or ligand bound protein. As a high proportion 
of NEMO is thought to be disordered (Catici et al., 2015), awareness of the regulatory 
nature of the intracellular milieu is potentially essential in understanding the current 
lack of consensus of NEMO structure and function. Our results from Chapter 4 offer 
guidelines for future structural and functional studies, by describing in 
thermodynamics details the conditions that induce changes in the dynamics of the 
protein. These could potentially be important for future structural studies where 
protein stability is an issues, thus knowing which conditions induced less solvent 
exposure in the NEMO structure could prove beneficial for choosing appropriate buffer 
systems. 
 
These findings are also important for studies looking to develop NEMO-based 
therapeutic targets, as they offer detailed description of in vivo conditions where the 
protein exists in more flexible, potentially more energetically favourable 
conformations. We understand the limitations that arise from using a mimic of the 
physical parameters of the intracellular environment. With improvements to whole 
cell methods (such as in cell-NMR), future studies should apply these to better 
understanding how the in vivo conditions influence the structure and dynamics of 
proteins (including NEMO) and improve in vitro methodologies to better mimic the 
effect of the intracellular environment. However, to date this is the first study to 
comprehensively describe the thermodynamics of NEMO conformational change in 
response to the intracellular environment, showing a potentially new regulatory role 
of the intracellular milieu on the dynamics and potentially function of NEMO. 
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 This study also offer a comprehensive analysis of the role of NEMO in 
activating the NF-κB pathway, by specifically mediating the interaction between the 
IKKb and its substrate, the inhibitor IκBα. Based on the result from Chapter 5, we 
propose that NEMO functions to ensure activation of the pathway through mediating 
the IKKb:IκBα interactions, as well control the length of the response by acting as an 
inhibitor of the IKKb enzyme.  We acknowledge that these results require further 
validation using other enzyme assays, but they also offer a better understating on the 
role of cytoplasmic NEMO and the molecular basis of canonical NF-κB activation. To 
our knowledge, no other NEMO functional studies have reported on the potential 
inhibitory role of NEMO during NF-κB activation. However, the results from Chapter 5 
could potentially help account for the lack of consensus on the characterisation of IKKb 
kinetics, as no other reports have analysed the effect of NEMO on the IKKb kinetics. 
Taking into account our data, we propose that the role of NEMO in the cytoplasm is 
not just a scaffold, but also an additional modulator of the phosphorylation of IκBα, 
controlling the activation of the NF-κB pathway, as well as the duration of the 
response. This is a potentially important notion to consider when designing 
therapeutics that target abnormal NF-κB activation, which ultimately results in a 
number of clinical conditions (Staudt, 2010; Nakagawa and Rathinam, 2018).  
 
Based on the results from Chapters 3-5 we propose a new model for the 
dynamics and function of NEMO in the intracellular milieu, shown in Figure 44. The 
scaffold role, we believe is attributable to NEMO when the protein is located at the cell 
membrane or possibly when inside the nucleus. Although not analysed in this study, all 
evidence for NEMO presence at these locations points to NEMO functioning to 
facilitate protein interactions; at the cell membrane, ubiquitinated NEMO is believed 
to recruit IKKβ at the membrane to allow for it to be activated by its corresponding 
kinases (Wang et al., 2001; Zhang et al., 2014; Catici et al., 2015). Is it also possible that 
NEMO functions as a scaffold in the cytoplasm, mediating the interactions between 
the functional IKK complex and their targets (as discussed in Chapter 5). The data for 
the role of NEMO inside the nucleus is scarce, but evidence suggests that it functions 
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to stabilise specific proteins, such as c-myc (Kim et al., 2010). Other studies have 
confirmed the presence of NEMO in the nucleus where  it is thought to competitively 
bind to cAMP-responsive element-binding protein-binding protein or CBP and block 
the interaction between other NF-κB proteins and CBP (Verma et al., 2004).For 
example, IKKα association with CBP is essential in ensuring transcription of NF-κB 
genes during cytokine stimulation (Yamamoto et al., 2003; Anest et al., 2003).  
 
Based on recently published NEMO findings and the results from Chapter 3-5, we 
proposed that depending on its subcellular localisation, NEMO is assigned different 
roles. A scaffold role at the cell membrane and nucleus, where the intracellular milieu 
affects ligand binding and induces a more ‘flexible’ conformation. Based on these, 
potentially NEMO functions to mediate specific interactions with other proteins and 
offers a stabilising role. A similar role may also be observed in the cytoplasm, where 
NEMO has also been shown to associate with the IKK complex and allow for its 
activation and subsequent activation of the NF-κB pathway signalling pathway. Here 
the intracellular milieu affects both ligand binding and unbound-NEMO. Seen as the 
interactome of NEMO contains over 150 members (Fenner et al., 2010), potentially the 
intracellular milieu acting as an additional control for NEMO structure and dynamics 
allows for specific selection of NEMO functional conformations, depending on the 
nature of the NEMO-ligand interaction. Finally, based on the findings discussed in 
Chapter 5 we propose that NEMO functions to control the interaction between IKKb 
and its substrate IkBa, specifically controlling the length of the phosphorylation of 
IkBa by IKKb. This has considerable implications for the development of NF-κB 
therapeutics of targets and shows the essential role in activating and modulating the 




Figure 44. Proposed mechanism for NEMO conformational change cellular functions 
based on findings presented in Chapters 3-5. A, NEMO conformational changes observed 
upon ligand binding and due to the effect of physical parameters of the intracellular milieu 
(based on results presented in Chapter 3 and 5). B, Cartoon representation of NEMO FEL 
changes taking into account the effect of the physical parameters of the intracellular 
environment and following ligand binding based on results presented in Chapter 4.  
 
In summary, based on the result presented in Chapter 3-5, we now know that NEMO is 
a dynamic protein, capable of undergoing conformational change in response to ligand 
binding or under the effect of the intracellular environment. Binding of ligands to 
NEMO allosterically modulates the protein, which can have important implications in 
activating the protein and ultimately NF-κB or even promote the formation of complex 
molecular complexes with NEMO and other cytoplasmic proteins. In the activation of 
NF-κB, the role of NEMO extends beyond its ‘scaffold only’ definition, with the protein 
not only required to activate the pathways by mediating the between the IKKb and its 
substrate IkBa, but also having a regulatory role in controlling the length of the 
response of the  NF-κB. The role of NEMO as the NF-κB essential modulator is thus 
two-fold, mediating the interaction between the activating enzyme IKKb and the 
inhibitors sequestering the NF-κB transcription factors in the absence of a stimulus, as 
well as ensure the correct response time to safeguard the appropriate response and 
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limit the development of any clinical conditions associated with abnormal NF-κB 






Figure 45. SDS-PAGE (12%) analysis by Coomassie blue stain of NEMO purification. 
The samples are: 1, Molecular weight marker; 2-11 NEMO purified fraction following affinity 
chromatography; 12, cell lysate prior to purification. White box to guide the reader in 




Figure 46. NEMO affinity chromatography purification profile following purification 
on a HisTrap FF crude 1ml column. Shown in blue is the trace shows the UV 
absorbance at 280 nm, green trace shown the % increase from 0-96 % 500mM 
Imidazole, and in red from A1-D1 are the sample fractions collected following 














Figure 47. Raw thermograms for IKKβ kinetics in presence (A) and absence of NEMO 
(B).  The data show the baseline shift accompanying kinetic measurement using ITC during 
phosphorylation of IkBa, in the presence and absence of NEMO, as μcal/sec vs duration of 
the experiment (min). The experimental setup is as described in figure 40. C, no baseline 
shift observed in the control experiment with IkBaS32A,S36A. This is due to the IkBaS32A,S36A 
peptide not containing any serine residues and as such  no phosphorylation and no baseline 
shifts are detected. The data on the right-hand side show a close-up of both experiments in 
order to observe the kinetic baseline shifts. The red line is to guide the reader in following 
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